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The deposition of normally soluble protein can occur in any organ in the human body and is 
associated with tissue dysfunction, cell death, and the progression of disease. Protein aggregation 
is concomitant with blindness as an outcome of cataract, life-threatening organ failure as a 
consequence of amyloidosis, and pronounced degeneration of the brain.  
The mutation responsible for Huntington’s disease causes an expansion of the 
polyglutamine domain of huntingtin exon 1 that directly promotes misfolding and refolding of 
huntingtin and huntingtin N-terminal fragments into amyloid-like fibrils in the basal striatum and 
cortex of the brain. Several fibril polymorphs have been identified, however the relationship 
between neurotoxicity and amyloid polymorphism is poorly understood. The P23T mutant of 
gamma-D-crystallin is associated with cataract formation in the eyes of very young children. 
Crystallins have been shown to form amyloid-like, native-like, as well as amorphous looking 
aggregates in vitro, accordingly it is unclear which class of aggregates P23T gamma-D-crystallin 
is most likely to form in cataract. Apolipoprotein A-I is a known anti-atherosclerotic factor and 
oxidation at methionine residues enhances its function. However, this oxidation also induces 
aggregation in vascular amyloidosis, which is interlinked with atherosclerosis progression. It is 
unclear whether apolipoprotein A-I aggregates misfold into amyloid-like fibrils as is usually the 
case in amyloidosis.  
Magic angle spinning solid state NMR (MAS ssNMR) is ideally suited to provide atomic 
resolution information on the structure and dynamics of insoluble, non-crystalline protein 
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 v 
aggregates. Transmission electron microscopy (TEM) allows for the visualization of 
morphological features of aggregates that cannot be observed by optical microscopy and can be 
used to identify polymorphs and aid in distinguishing between different classes of aggregates. In 
this dissertation, I use both MAS ssNMR and TEM in addition to other biophysical and structural 
techniques to investigate the differences in structure and dynamics between polymorphs of 
huntingtin exon 1, P23T gamma-D-crystallin, and apolipoprotein A-I. Enabled by my 
experiments, I narrow down the potential molecular mechanisms involved in these three distinct 
types of protein deposition diseases. I show that depending on the milieu, proteins have the 
potential for varied amyloidogenic and non-amyloidogenic self-assembly. 
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1.0 INTRODUCTION 
1.1 PROTEIN DEPOSITION IN HUMAN DISEASE 
Protein deposition diseases (PDDs) encompass several diseases including cataract, cystic 
fibrosis, amyloidosis-associated cancers and kidney diseases, and several neurodegenerative 
diseases [8]. The term amyloidoses is reserved for a class of PDDs that affects organs other than 
the central nervous system (CNS) [8]. For example, islet amyloidosis affects the pancreas and is 
found in type II diabetes [8-12]. Hereditary apolipoprotein A-I (apoA-I) amyloidosis can be 
localized (e.g. to the kidney, liver, etc.) or systemic, however its nonhereditary form is associated 
with localized plaque buildup in arteries defined as atherosclerosis [13-16]. Neurodegenerative 
PDDs are associated with deterioration of the CNS and include Alzheimer’s (AD), Parkinson’s 
(PD), and Huntington’s disease (HD), several dementias, and atypical parkinsonian conditions 
such as progressive supranuclear palsy (PSP) [8, 17-19]. Some neurodegenerative PDDs are 
contagious, e.g. kuru, which is transmitted through ritualistic cannibalism, and bovine 
spongiform encephalopathy (commonly called mad cow disease or variant Creutzfeldt-Jakob 
disease in humans) which is transmitted through contaminated beef [20-22].  
Protein aggregation in tissues is a hallmark of PDDs [8]. In this dissertation, I define 
aggregation as the chaperone-free self-assembly of normally soluble protein into an insoluble, or 
solid, state [8]. Protein deposition is often associated with misfolding of the native protein 
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structure and refolding into a disease state. This is pathogenic in nature, leading to tissue 
dysfunction, disease and death. Understanding the mechanisms by which proteins aggregate can 
aid in structure-based drug design for treatment or prevention of PDDs.  
1.2 BASICS OF PROTEIN STRUCTURE 
 
Figure 1.1. Secondary and tertiary structure of proteins 
(a) Model structure of amyloid httEx1 that includes a -hairpin motif (highlighted blue). Secondary structure 
components are indicated. The model was built in UCSF Chimera [23]. (b) Solution NMR structure of P23T D 
crystallin, generated in UCSF Chimera [23, 24]. The protein contains two domains, and each domain contains two 
Greek key motifs (highlighted blue).  
Proteins are translated from RNA as unstructured polypeptide chains that can fold into many 
different three-dimensional molecular structures. Most proteins are well folded in their 
functional, or native state, however some proteins are natively unfolded: the latter are defined as 
intrinsically disordered proteins (IDPs) [25]. Protein folding is driven by molecular interactions 
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and often facilitated by molecular chaperones that assist the folding process and prevent 
aggregation of misfolded protein [26]. Folded proteins are composed of secondary structures 
such as -helices and -sheets that are stabilized through hydrogen bonds and can interact with 
one another to form supersecondary structures called motifs (e.g. -hairpins, Figure 1.1, a) and 
domains (Figure 1.1, b). A domain can remain stable independent from the rest of the protein, 
however a motif cannot. 
1.3 CLASSES OF PROTEIN AGGREGATES 
In this section, I present an overview of aggregate morphologies and molecular structures for 
proteins that are associated with human disease.  Morphology refers to the appearance of the 
aggregates on the order of nanometers and micrometers. The morphology of a protein aggregate 
may be fibrillar or amorphous. Fibrils are threadlike polymeric assemblies that experience 
periodic growth on one axis. Amorphous aggregates contain molecules that are not arranged into 
a periodic repeating pattern. Some individuals also categorized crystals as another form of 
protein aggregates. Crystals contain molecules arranged into a periodic repeating pattern that can 
grow by the addition of molecules in three dimensions. Fibrils and amorphous aggregates are 
common in PDDs; crystal formation is rare and has only been reported for immunoglobulins in 
monoclonal gammopathies [27-30].  
An aggregate’s morphology is governed by its molecular structure, but the molecular 
structure cannot be discerned from the morphology alone. The aggregates in PDDs are typically 
amyloid-like, native-like, or disordered in their molecule structure. Some PDDs are associated 
with the formation of multiple classes of aggregate structures, and some varieties of proteins 
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(e.g. immunoglobulins) can aggregate into different structure classes in different diseases [8, 9, 
31, 32]. It is not uncommon for proteins to aggregate into multiple structure classes within the 
same disease [8, 9, 31-35]. 
1.3.1 Amyloid and amyloid-like fibrils 
To date, amyloid-forming peptides and proteins have been identified in 70 diseases broadly 
categorized as either amyloidoses or neurodegenerative amyloid-related PDDs [8]. 
Neurodegenerative amyloid-related PDDs are associated with amyloid deposition within the 
central nervous system (CNS), while the term amyloidoses is usually reserved for systemic or 
localized buildup of amyloid fibrils in tissues other than the CNS [8]. Alzheimer’s (AD) and 
Parkinson’s (PD) disease are considered predominantly sporadic neurodegenerative amyloid-
related PDDs, although hereditary forms have been documented [8, 17, 18]. In contrast, 
Huntington’s disease (HD) is distinctly hereditary, resulting from a specific mutation of the 
huntingtin gene (see section 1.4.1) [19].  
Many PDDs are associated with the formation of amyloid and amyloid-like fibrils [8]. 
Amyloid fibrils are characterized by an arrangement of -sheets parallel to the axis of the fibrils, 
with the strands arranged perpendicular to the axis [36]. The -sheets are often arranged in a 
parallel fashion, but antiparallel arrangements have also been observed [1, 37]. Fibrils are 
typically microns in length, less than 30 nm in width, and composed of twisting or laterally 
associating filaments (although fibrils made up of only one filament have been documented) 
[38]. Many amyloid forming proteins are IDPs in their native state [39]. The amyloid hypothesis 
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proposes that the accumulation of amyloid fibrils or their precursors is directly associated with 
progression of AD, however this hypothesis is recently under debate [8, 40]. 
Amyloid fibrils are frequently polymorphic [37, 38]. Polymorphism is defined as a state 
where a protein can form two or more molecular structures, which are often easily distinguished 
from one another by their morphologies. For example, individual polymorphs of A1-40, an 
amyloid found in AD, vary in the number of and arrangement of -sheets and side-chain 
interactions. This molecular level polymorphism leads to the formation of fibrils that can be 
distinguished at the atomic and molecular level by magic angle spinning solid state NMR (MAS 
ssNMR) and at the nanoscopic and microscopic level by transmission electron microscopy 
(TEM) [41-46]. Amyloid polymorphs can vary not only in their structure but also in their 
toxicity, and there is increasing evidence that amyloid polymorphism plays a key role in the 
neuropathology of neurodegenerative diseases [47]. For example, A1-40 fibrils generated in vitro 
from extracts derived from AD brains revealed several polymorphs of A1-40 that differ between 
patients but not between different areas of individual brains [44].  
The formation of amyloid fibrils from soluble protein regularly displays sigmoidal 
kinetics consisting of three phases: lag, elongation, and plateau (Figure 1.2, a) [8, 48, 49]. The 
lag phase represents the time during which the protein misfolds from its native state and nuclei 
are formed through a thermodynamically unfavorable process. Nuclei are defined as the smallest 
stable misfolded species from which fibril growth can be directly initiated, a process called 
primary nucleation. Nuclei can form from either monomeric (Figure 1.2, b) [8, 48, 50-52] or 
multimeric species (Figure 1.2, c) [8, 52-54]. Once nuclei or fibrils exist, they grow rapidly 
through the addition of monomers to the fiber ends [8]. Fibril growth dominates during the 
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elongation phase, which is concluded with a plateau phase that represents equilibrium, when 
most proteins are typically in the fibrillar state [8].  
Mature fibrils can act as nuclei to promote the formation of new fibrils through secondary 
nucleation (Figure 1.2, d), which may in some cases appear as branching (Figure 1.2, e), 
multiply through fragmentation (Figure 1.2, f). Moreover, fibrils can pack together isotropically 
to form a gel-like state (Figure 1.2, g), or associate laterally to form bundles with either blunt or 
frayed ends (Figure 1.2, h) [55, 56]. Both in vitro and in vivo, pre-existing fibrils can act as 
‘seeds’ to dramatically shorten the lag phase; accordingly, individual polymorphs can propagate 
their structure through seeding [44, 47, 57]. Seeding is thought to be responsible for the 
observation that a single polymorph is observed in samples of A1-40 propagated from varying 
regions of the same AD brain [44]. 
Several mathematical models exist to describe amyloid formation kinetics [58]. These 
models must account for nuclei formation and fibril elongation but may also account for seeding, 
misfolding, oligomerization and dissociation, conformational rearrangements, secondary 
nucleation, fragmentation, coagulation, or bundling [8, 48-54, 58-60]. Experimentally, the 
kinetics of amyloid formation in vitro can be monitored with dyes such as thioflavin T (ThT), as 
discussed in section 1.5.6.4 [61]. Alternatively, kinetics of aggregation can be monitored with 
methods where the soluble protein and the aggregates are separated through sedimentation or 
filtering, followed by quantification of the soluble protein. One method available for monitoring 
aggregation is a high performance liquid chromatography (HPLC) based sedimentation assay, as 
discussed in section 1.5.6.3 [54, 62, 63]. 
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Figure 1.2. Kinetics of amyloid formation 
(a) Amyloid formation displays sigmoidal kinetics with three phases: lag, elongation, and plateau. (b) Formation of 
monomeric nuclei from a misfolded monomer, followed by nucleated polymerization of a fibril. (c) Formation of 
misfolded multimer followed by nuclei formation through conformational conversion. (d) Secondary nucleation of a 
misfolded monomer followed by fibril growth. (e) Branching from preexisting fibril. (f) Fragmentation of a fibril 
followed by fibril growth. (g) Fibril packing into an isotropic gel-like phase, and (h) into bundles through lateral 
association. 
1.3.2 Aggregates with a conserved native-like structure 
In many PDDs, the native and functional molecular structure is lost during aggregation. 
However, there are documented cases where the native structure is mostly retained in the 
aggregates, e.g. as seen in the nonamyloid fibrils of hemoglobin S (HbS) that are found in sickle 
 8 
cell anemia [33]. The monomers that make up HbS fibrils aggregate through an end-to-end 
stacking mechanism, reminiscent of the formation of actin and tubulin fibrils [33]. Native-like 
aggregates can also form through domain swapping. In domain-swapping, domains or motifs 
swap between molecules, aided by loops and turns that act as hinges [34, 35]. This mechanism 
has been suggested for aggregation of crystallins, which has implications in cataract (see section 
1.4.2) [64-67]. However, recent solution NMR and small angle X-ray scattering results from the 
Gronenborn lab contest this mechanism [68]. Alternatively, small changes in charged or 
hydrophobic surface residues can lead to protein aggregation with a preserved native structure 
via a ‘condensation’ or ‘precipitation’ mechanism that does not rely on substantial misfolding or 
hinging [69-71]. Natively folded protein precipitates are neither fibrillar nor crystalline in nature. 
Interestingly, eye lens proteins have been observed to phase separate and precipitate in cold-
induced temporary cataracts in bovine, rat, and fish lenses and also in living mice [72-75]. 
1.3.3 Amorphous aggregates 
In several PDDs, aggregates that appear amorphous by TEM are often observed in addition to 
amyloid fibrils [8, 52]. It is usually assumed that amorphous-looking aggregates are poorly 
structured and disordered. Their appearance is considered nonpathogenic as the result of 
aggregation that is off-pathway to the formation of amyloid [8, 52, 76]. On the other hand, 
disordered oligomers that are on-pathway to amyloid fibril formation can have cytotoxic 
properties [77]. Yet again, off-pathway amorphous aggregates can actually have protective 
properties in many amyloid PDDs [78, 79]. Therefore, it is desirable to identify and implement 
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therapeutics that redirect aggregation from amyloid fibrils to off-pathway amorphous aggregates 
[79]. 
1.3.4 Functional aggregates 
It is important to note that not all peptide and protein aggregates are harmful and associated with 
human disease. For example, pre-melanosomal protein fibrils are important for regulating 
melanin condensation within melanosomes [80]. It is becoming increasingly recognized that 
aggregates can be desirable and have functional roles [81-84]. 
1.4 PROTEIN DEPOSITION DISEASES OF INTEREST 
The diseases of interest described in this dissertation illustrate several general aspects of PDDs. 
Huntington’s disease (section 1.4.1) illustrates one of several neurodegenerative diseases where 
the formation of amyloid fibrils in the brain is directly correlated with disease progression [8, 17-
19]. The mechanism(s) of protein aggregation implicated in cataract (section 1.4.2) is under 
intense debate, and could involve the formation of amyloid fibrils, native-like aggregates, or 
amorphous aggregates [64-68, 72-75, 85-88]. The role of apolipoprotein A-I aggregation in 
atherosclerosis (section 1.4.3) is unclear; oxidation at methionine is associated with an increased 
function and presumably preserves the native structure [89]. However, oxidation also promotes 
aggregation and aggregates of apolipoprotein A-I have been identified in vascular amyloidosis 
[89].  
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1.4.1 Huntington’s disease 
Huntington’s disease (HD) is a neurodegenerative disease that causes movement abnormalities. 
Disease progression is correlated with the aggregation and accumulation of amyloid-like fibrils 
made up of huntingtin (htt) and htt N-terminal fragments in the cortex and basal striatum of the 
brain [19]. Huntingtin is a large (~350 kDa) and promiscuous protein that acts as a scaffold for 
several binding partners that play important roles in cell signaling, membrane trafficking, and 
transcription regulation [90]. Wild type htt has anti-apoptotic properties, however apoptosis is 
accelerated in HD brains, resulting in a significant atrophy of cerebral tissue [19, 90]. 
The autosomal dominant mutation responsible for HD results in an elongation of a 
polyglutamine (polyQ) domain within the first exon (httEx1) of htt [19]. As shown in Figure 1.3, 
the polyQ domain of httEx1 makes up an antiparallel -sheet structure within the core of mature 
fibrils and is flanked by a highly conserved 17 residue -helical N-terminal domain (httNT) and a 
mixed PPII helix/random coil proline-rich domain (PRD) [1, 91-94]. Expansion beyond 35 
glutamine residues destabilizes the polyQ domain and causes htt to misfold, self-assemble, and 
aggregate; further polyQ expansion is directly correlated with increased aggregation kinetics [95-
97]. The mean age of onset occurs at 35 years of age, however this is strongly dependent on the 
length of the expanded polyQ domain; each addition of a glutamine residue within the polyQ 
domain is correlated with an earlier age of onset of HD symptoms and extreme cases of juvenile 
HD have been documented [98].  
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Figure 1.3. Model structure of huntingtin exon 1 
Model structure of huntingtin exon 1, built in UCSF Chimera [23]. The htt
NT
 domain (red) forms an -helix. The 
polyQ domain (blue) forms an antiparallel -hairpin. The proline rich domain (PRD, purple) has PPII helices and 
random coil components. This model was built using UCSF Chimera software [23]. 
Expanded httEx1 is sufficient to induce HD-like pathology and fibril formation in mouse 
models [99, 100]. Studies on neuronal cell cultures and mice brain extracts reveal that httEx1 
aggregates are polymorphic and exhibit a wide range of neurotoxicity [101, 102]. Additional 
studies on neuronal cells reveal the formation of prominent inclusion bodies whose contents vary 
between cell types and can contain amorphous and fibrillar aggregates [103-105]. Model polyQ 
peptides and httEx1 aggregates are also polymorphic in vitro [47, 106]. For example, httEx1 
fibrils formed in vitro by Dr. Nekooki-Machida and coworkers at 4 and 37 °C respectively were 
found to exhibit varying levels of cytotoxicity, indicating that changes in the structure and 
dynamics of the polyQ core and flanking domains have implications in HD cytotoxicity [47]. 
Although prior studies have attributed the polymorphism found in httEx1 aggregates to structural 
differences in the polyQ domain, these results are low-resolution and not definitive [47]. Given 
that fiber formation is related to cytotoxicity and disease progression, it is essential to gain 
insight into the structure and dynamics of httEx1 fibrils and the molecular mechanism underlying 
fibril formation and toxicity. 
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1.4.2 Cataract 
Cloudiness or coloring of the eye lens, medically defined as cataract, affects an estimated 22 
million (17.1%) Americans over age 40 and another 88 million (68.3%) people over age 80 
globally [107-109]. The number of affected individuals is expected to increase by another 39 
million by 2030 [107-109]. Surgical replacement of the lens is presently the only treatment for 
cataracts. Although fairly straightforward, this procedure is not globally available and in the US 
costs over $3.4 billion/year through Medicare; Thus, cheaper, more readily available, and less 
intrusive treatments are desirable [109]. A prerequisite for the development of new treatments is 
a thorough understanding of the mechanism of cataract formation through basic science and 
structural biology. 
The α and βγ crystallins make up 90% of lens proteins and are major constituents of 
cataracts [110, 111]. The α crystallins are multimeric complexes that act as chaperones, while the 
βγ crystallins are well-structured proteins that are necessary to maintain the high refractive index 
of the lens [112, 113]. Crystallins are exceptionally stable and soluble proteins that can withstand 
many environmental insults and undergo no protein turnover following infancy [70, 114]. The 
long lifetime of crystallins requires unusually high solubility: bovine crystallins can reach an 
estimated concentration of 520 mg/mL in the native eye lens nucleus [114, 115]. Crystallins 
likely have key structural features which allow them to be many times more soluble and stable 
than most proteins. 
It is generally accepted that damaged crystallins become insoluble, as opposed to 
degraded, in the lens during cataract formation [116, 117]. However, the mechanism by which 
crystallins associate and form insoluble aggregates is debated [64-68, 85-88]. Recently proposed 
mechanisms that have been advanced involve amyloid-like fibril formation or the formation of 
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highly-ordered domain-swapped aggregates [64-68, 85, 86]. Neither model is exclusive and 
additional models exist including the above-mentioned condensation based self-assembly 
observed in cold cataract [72-75, 87, 88]. 
1.4.2.1 Native structures of , , and  crystallins 
The  crystallins are small proteins that form very large multimers (Figure 1.4, a) [118, 119]. 
The β and γ crystallins have very similar structures to each other, however the β crystallins 
(Figure 1.4, b) form homodimers while γ crystallins (Figure 1.4, c) remain monomers in the 
native state [120, 121]. Each molecule of and crystallins contains two structural domains 
connected by a short linker, and each domain contains two highly conserved Greek key motifs 
(see Figure 1.1, b). The N-terminal and C-terminal domains are very similar in sequence and 
structure [120, 121]. 
 
Figure 1.4. Native structures of eye lens crystallins 
(a) Model of B-crystallin as a 24mer [119]. A single monomer is highlighted red. (b) Crystal structure of truncated 
B1-crystallin dimer [120]. (c) Crystal structure of WT D-crystallin [121]. 
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1.4.2.2 Congenital cataract: P23T hD crystallin 
The most abundant crystallin in the human eye lens is hγD crystallin. Accordingly, many 
mutations of hγD are associated with congenital cataract [122]. The autosomal dominant P23T 
mutation of hγD affects very young children, and the cataracts that form can be blue to white in 
color, coralliform (shaped similar to branching coral), aculeiform (needle-shaped, resembling 
crystals), or silica-like, and can be located in either the lamellar layers or nucleus of the lens 
[123-129]. P23T hγD is insoluble above 5 mg/mL at 37 °C, considerably less soluble than WT 
hγD. However, the native structure of P23T hγD is very similar that of WT hγD, so it is not clear 
why this mutation reduces the solubility of hγD drastically (Figure 1.5, a,b) [24, 130]. The most 
obvious structural difference involves the rotamers of His 22, which is sequentially next to the 
mutation site (Figure 1.5, c) [24, 130]. 
 
Figure 1.5. Native states of wild type and P23T hγD crystallin 
(a) Crystal structure of WT hγD and (b) solution NMR structure of P23T hγD [24, 130]. The mutation site is circled. 
(c) The His 22 residue experiences small rotamer changes between WT and P23T hγD. This figure was generated 
using PyMol software [131]. 
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1.4.3 Vascular amyloidosis and atherosclerosis 
The deposition of amyloid fibrils in vascular tissue is defined as vascular amyloidosis (VA) [89]. 
VA is common in aortic tissue and was found to be present in more than 97% of samples from 
patients over 50 years in age [132]. Atherosclerosis and VA are also highly correlated [89]. 
Several amyloidogenic proteins accumulate within atherosclerotic arteries, including 
transthyretin, immunoglobin , medin, and in the highest abundance apolipoprotein A-I (apoA-I) 
[132-142]. The presence of apoA-I in atherosclerotic plaques is in part surprising because apoA-
I, the main constituent of high-density lipoproteins (HDL), is known to have anti-atherosclerotic 
properties [16, 143]. Amyloidogenic apoA-I identified in atherosclerotic lesions was found to be 
oxidized in at least one, and possibly three, methionine sites [144]. The frequency of apoA-I 
deposition in VA and atherosclerosis combined with a poor understanding of the process of 
apoA-I amyloid formation warrants structural and mechanistic studies on methionine oxidized 
apoA-I. This topic is discussed further in Chapter 5.0. 
1.5 METHODOLOGIES 
Protein aggregates are insoluble and lack crystallographic order; they are therefore untenable for 
structural studies by traditional methods such as solution NMR and X-ray crystallography. In this 
section, I present an overview of some of the methodologies used in this dissertation, including 
methodologies I used to gain insight into aggregate structures. I provide several examples, 
primarily from results I gathered on httEx1 from a manuscript on which I was a co-author early 
in my Ph.D. research [3].  
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1.5.1 Magic angle spinning solid state NMR (MAS ssNMR) 
Magic angle spinning (MAS) solid state nuclear magnetic resonance (ssNMR) is ideally suited to 
study the structure and dynamics and of insoluble, non-crystalline aggregates at atomic 
resolution [145]. Its power has been convincingly demonstrated previously for many amyloid-
like fibrils and aggregated proteins [1, 37, 44, 92, 146, 147]. In this section, I provide an 
overview of a few MAS ssNMR concepts used later in this dissertation.  
1.5.1.1 Sample preparation 
Aggregated protein samples are most commonly analyzed by 
13
C and 
15
N MAS ssNMR. These 
isotopes exist infrequently (1.1% and 0.37%, respectively) in proteins at isotopic natural 
abundance (NA), therefore protein must be labeled with 
13
C and 
15
N isotopes in order to be 
detected in more than one dimension by MAS ssNMR. I overexpressed MBP-Q44-httEx1 in 
Escherichia coli for several experiments described in this and in the next chapters. For most non-
NMR experiments, the E. coli are grown in rich medium called lysogeny broth (LB) (also known 
as Luria-Bertani broth [148]) that contains nutrients at NA. In order to uniformly substitute the 
12
C and 
14
N isotopes found at NA, 
13
C and 
15
N isotopes are added to modified minimal M9 
medium during the protein expression process [149]. The M9 medium itself contains no carbon 
or nitrogen sources but does contain several additives necessary for E. coli growth. 
After expression, purification, and aggregation (as described in section 1.5.5), 
micrograms of protein are packed into small MAS ssNMR rotors (Figure 1.6) using a home-built 
ultracentrifugal packing tool over several hours (Figure 1.7) and the rotor is then sealed with a 
finned cap [4]. I found this packing tool extremely advantageous over traditional packing 
methods using a spatula in part because it ensures dense and near complete sample packing and 
 17 
retains sample hydration [4]. An NMR spectrometer equipped with an MAS ssNMR probe is 
necessary to perform MAS ssNMR experiments. I primarily used MAS probes capable of 
detecting 
1
H, 
13
C, and 
15
N at their resonance frequencies, measured as chemical shifts in parts per 
million (ppm).  
  
Figure 1.6. Schematic of MAS ssNMR sample preparation and experimentation 
Protein aggregates (far left) are packed into small MAS rotors prior to experimentation in an NMR spectrometer 
equipped with an MAS ssNMR probe. The obtained MAS ssNMR spectrum (far right) contains information on both 
protein structure and dynamics. I obtained the spectrum shown here from uniformly labeled 
13
C, 
15
N P23T hD. 
Inside the probe the rotor is tilted to precisely 54.7356°, which is referred to as the magic 
angle. A stream of air spins the rotor fast (e.g. 13 kHz or 13,000 times per second) during 
acquisition of the MAS ssNMR spectra. The spinning at the magic angle averages out the 
chemical shift anisotropy that would otherwise be observed in NMR studies of a static solid 
sample, resulting in isotopically averaged chemical shifts and sharp peaks comparable to what is 
obtainable by solution NMR [150]. The 
13
C-
13
C spectrum I obtained on P23T hD shown in 
Figure 1.6 contains peaks that are sensitive to both protein structure and protein dynamics. This 
spectrum contains many well resolved peaks, indicative of a homogenous sample (see Chapter 
4.0).  
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Figure 1.7. Process for packing ssNMR 3.2 mm rotors 
(a) The sample suspension is placed in the funnel, up to a 1 mL volume. (b) The packed tool is inserted in its 
swinging bucket and sealed. (c, d) During ultracentrifugation the bucket achieves a horizontal orientation that 
ensures even pelleting of the sample within the rotor. (e) After completion of the ultracentrifugation, excess 
supernatant is removed. (f) A small amount of supernatant is left to maintain excess hydration. (g) After disassembly 
of the packing tool the rotor is capped. Note that it is important to leave a small gap between the liquid and the 
spacer or cap. Reprinted with permission from Mandal, A., Boatz, J. C., Wheeler, T., van der Wel, P. C. A. On the 
use of ultracentrifugal devices for routine sample preparation in biomolecular magic-angle-spinning NMR, J. 
Biomol. NMR, 67(3):165-178. Copyright (2017) Springer Science + Business Media Dordrecht. 
1.5.1.2 Building blocks of MAS ssNMR experiments 
Many of the 
13
C and 
15
N MAS ssNMR experiments I performed over the course of my research 
were based on either direct polarization (DP), cross polarization (CP) or insensitive nuclei 
enhanced by polarization transfer (INEPT) experiments. In DP-based experiments, 
13
C or 
15
N 
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nuclei are directly polarized or excited by a radiofrequency (RF) pulse. The signal to noise of the 
peaks in a DP-based spectrum is related to the gyromagnetic ratio of the polarized nuclei [151]. 
The gyromagnetic ratio of a nucleus, e.g. 
13
C, is directly proportional to its magnetic strength, or 
more specifically, to the relationship between its magnetic dipolar moment and angular 
momentum [152]. The gyromagnetic ratio of 
1
H is higher than the gyromagnetic ratios of either 
13
C or 
15
N, therefore signal to noise can be enhanced by transferring polarization from 
1
H to 
13
C 
or 
15
N. In the CP-based experiments, RF pulses are applied on two channels: 
1
H and either 
13
C or 
15
N. This allows 
1
H polarization to be transferred to either 
13
C or 
15
N nuclei through 
heteronuclear dipole-dipolar interactions [153].  
Dipolar couplings occur between nuclei that are near each other in space. The strength of 
dipolar coupling constants depends on the product of the gyromagnetic ratio of each nuclei, and 
is inversely proportionate to the third power of the distance between the nuclei [154, 155]. 
Molecular motion can dramatically reduce dipolar couplings, consequently CP-based 
experiments are used to selectively measure the most rigid residues within protein aggregates. 
CP is often advantageous over DP; the low sensitivity of 
13
C and 
15
N nuclei is enhanced by 
multiple factors when 
13
C and 
15
N polarization is transferred from the highly sensitive 
1
H nuclei 
by CP. However, since DP experiments do not depend on dipolar couplings, spectra obtained via 
DP can capture signals from both rigid and mobile residues.  
Like CP-based experiments, in INEPT experiments polarization is transferred from 
highly sensitive 
1
H nuclei to nuclei with lower sensitivity [156]. However, polarization is 
transferred through J-based scalar couplings instead of through dipolar couplings. J-couplings are 
dependent on the covalent bonds between the donor 
1
H and acceptor nuclei, while dipolar 
couplings are not. Contrary to CP-based experiments, INEPT experiments can capture signals 
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from flexible residues that experience similar mobility to soluble proteins [156]. At the same 
time INEPT experiments are very sensitive to T2 (also called spin-spin and transverse) 
relaxation. Rigid residues relax quickly (microseconds), therefore in typical INEPT experiments 
their polarization is lost prior to acquisition. However, highly flexible residues relax slowly 
(milliseconds) and are amenable to detection by INEPT-based experiments. 
 
Figure 1.8. 1D MAS ssNMR spectra of httEx1 fibrils 
(a) Cross polarization, (b) direct excitation/DP, and (c) INEPT spectra of uniformly labeled 
13
C, 
15
N Q44-httEx1 
fibrils. The data were obtained at a set temperature of 277 K and 10 kHz MAS, independently of the results 
presented in Chapter 1.5 [3]. 
An example of 1D 
13
C DP, CP, and INEPT spectra are shown in Figure 1.8. I obtained 
these spectra on Q44-httEx1 fibrils at 10 kHz MAS and a set temperature of 277 K. The CP 
spectrum (Figure 1.8, a) is dominated by glutamine residues found within the rigid amyloid core, 
while the INEPT (Figure 1.8, c) spectrum selectively reports on mobile residues primarily found 
in the flanking domains. Direct excitation (DP) of the 
13
C nuclei results in a spectrum that reports 
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on both rigid and mobile residues (Figure 1.8, b), allowing for a more nuanced comparison 
between the CP and INEPT spectra. These spectra closely match the spectra of httEx1 fibrils 
recently reported by others and the Van der Wel lab [3, 157]. 
1.5.1.3 Two dimensional homonuclear experiments 
Insight into protein structures can be gained through looking at two dimensional CP-based 
spectra, e.g. 
13
C-
13
C dipolar assisted rotational resonance (DARR) and proton driven spin 
diffusion (PDSD) experiments, which selectively report on immobilized residues [158]. In 
DARR experiments, polarization is transferred through a CP step to 
13
C, and then is transferred 
again to nearby 
13
C nuclei through a process called DARR mixing. Low power 
1
H irradiation 
that matches the MAS rate is applied during the mixing period, resulting in rotational resonance 
recoupling that enhances the transfer between 
13
C sites [159]. 
At short DARR mixing times (e.g. 8 ms), correlations between covalently bound 
13
C 
nuclei with a bond distance of approximately 1.5 Å are primarily observed, e.g. between C and 
C nuclei within the same residue. Increasing the DARR mixing time (e.g. to 100 ms) allows for 
additional 
13
C-
13
C correlations to be observed that correspond to distances that do not exceed 7 Å 
[160]. Because dipolar coupling does not depend on chemical bonds, intramolecular correlations 
(e.g. C and Cnuclei within the same residue), and intermolecular correlations (e.g. two C 
nuclei in closely interacting but different molecules) can be observed [160]. At even longer 
mixing times, we use PDSD experiments in which 
1
H irradiation is turned off during the 
13
C-
13
C 
mixing step in order to prevent damage to both the sample and the MAS ssNMR probe. 
As already noted, CP-based DARR and PDSD report only on the most rigid residues in 
aggregated protein samples. In order to instead identify 
13
C-
13
C correlations within flexible 
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residues, a 2D INEPT-based experiment with total through bond correlation spectroscopy 
(TOBSY) mixing based on scalar couplings can be applied [161].  
 
Figure 1.9. MAS ssNMR results on an amyloid forming acyl-peptide chimera assembly 
a) Position of residue-specific 
13
C,
15
N-labeling (arrows). (b) 2D 
13
C-
13
C MAS ssNMR spectrum of labeled [C18-
(PEPAu)2]
M-Ox
 assemblies. Dashed and colored lines connect sets of peaks from labeled P10 (black dashed) and A1 
residues (solid lines). Three A1 conformations are marked with red (A1a), blue (A1b), and green (A1c) lines. (c) 
Secondary structure analysis of A1 ssNMR signals, showing A1a and A1b to be part of the -sheet core. (d) 
Secondary structure distribution in the three peptide conformers seen by ssNMR, along with their relative ssNMR 
peak intensities (right). Modified and reprinted with permission from Merg, A. D., Boatz, J. C., Mandal A., Zhao, 
G., Mokashi-Punekar, S., Liu, C., Wang, X., Zhang, P., van der Wel, P. C. A., Rosi, N. L. Peptide-Directed Assembly 
of Single-Helical Gold Nanoparticle Superstructures Exhibiting Intense Chiroptical Activity, J. Am. Chem. Soc. 
138(41): 13655-13663. Copyright (2016) American Chemical Society. 
An example DARR spectrum I ran on an amyloid-forming synthetic acyl-peptide chimera 
(sequence in Figure 1.9, a) is presented in Figure 1.9, b [2]. Isotopic 
13
C labels were introduced 
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at two residues: Ala1 and Pro10. Interestingly, three peaks are observed that represent 
correlations between C and C in Ala1. The same phenomenon is observed for C/CO and 
C/CO correlations. This indicates that Ala1 exists in three distinct structure types (‘a’, ‘b’, and 
‘c’) within the amyloid assembly.  
1.5.1.4 Heteronuclear experiments 
Two- and three-dimensional heteronuclear MAS ssNMR experiments are essential for assigning 
13
C and 
15N resonances to specific residues within a protein’s sequence. Many heteronuclear 
MAS ssNMR experiments exist, including NCA, NCO, NCACX, NCOCX, CONCA, and 
CANCO [162]. In NCA experiments, a 
1
H-
15
N CP step is followed by a 
15
N-
13
C CP step that 
selectively transfers polarization from backbone 
15
N nuclei to the C nuclei within the same 
residue (Figure 1.10, top left) [162]. In NCO experiments, the polarization is instead transferred 
to the CO carbons in the preceding n-1 residue (Figure 1.10, top right). A DARR mixing period 
can be added to NCA and NCO experiments to allow mixing from the C and CO nuclei to 
nearby carbons: these experiments are referred to as NCACX (Figure 1.10, bottom left) and 
NCOCX (Figure 1.10, bottom right), respectively. Alternatively, multiple CP steps can be 
combined to transfer polarization from the C to the backbone 15N to the CO nuclei (CANCO), 
or to transfer polarization in the reverse direction (CONCA). The process of assigning ssNMR 
peaks to individual nuclei from such experiments is described in more detail by Hong [163] and 
Castellani, et. al. [164]. 
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Figure 1.10. Heteronuclear NMR 
During NCA experiments magnetization is transferred from the 
15
N amide in the peptide backbone to the 
13
C 
position within the same residue (top left, solid black arrow), while in NCO experiments (top right) the 
magnetization is transferred instead to the backbone carbonyl 
13
C in the n-1 position. An addition of a DARR mixing 
step to the NCA or NCO experiment causes magnetization to transfer from the C or CO to nearby 13C; these 
experiments are referred to as NCACX (bottom left) and NCOCX (bottom right) experiments, respectively. Short 
DARR mixing times will mostly result in 
13
C-
13
C magnetization transfers over short distances through space, e.g. the 
equivalent of a 1-bond distance (dotted arrow). Increasing the DARR mixing time allows magnetization to transfer 
over a longer distance through space, as depicted by the dashed arrows.  
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1.5.1.5 Secondary structure determination 
A chemical shift indexing (CSI) method can be applied to determine the secondary structure for 
assigned amino acids [2, 165]. This method subtracts average random coil chemical shifts from 
the observed chemical shifts for each atom [166]. Atoms that likely exist in a -sheet secondary 
structure will display a negative secondary chemical shift difference (); conversely, atoms that 
exist in an -helix will have a positive . For example, in in Figure 1.9, c, the CSI results 
indicate that ‘a’ and ‘b’ type Ala1 adopt a -sheet structure, likely within the amyloid core, while 
the ‘c’ type Ala1 adopts an undefined structure (Figure 1.9, d).  
A similar phenomenon is observed in polyQ peptides and httEx1 fibrils; two sets of 
glutamine signals (‘a’ and ‘b’) are observed, indicative of two distinct glutamine structures 
present within the rigid polyQ core in equal amounts [3]. CSI indicates that both ‘a’ and ‘b’ type 
glutamine have a -sheet secondary structure. A smaller set of signals represents ‘c’ type 
glutamine residues that exist outside of the rigid polyQ core. 
1.5.1.6 Folded structure and beyond 
Although I do not discuss these approaches in Chapters 3 - 5, it is important to recognize that 
several strategies are available that can lead to three-dimensional structure determination by 
MAS ssNMR. These strategies include experiments and simulations that can be used to 
determine several structural restraints including torsion angles and long-range intramolecular and 
intermolecular contacts [167-173]. MAS ssNMR been successfully applied to solve the folded 
structure for several proteins and peptides including membrane proteins, protein crystals, and 
amyloid fibrils [45, 145, 173-184]. 
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In additional to structural information, MAS ssNMR can also be used to probe molecular 
dynamics. Some of the methods available that yield insight into the dynamics of protein 
aggregates were discussed above. Many more strategies are available to probe dynamics, 
including simulations and experiments that utilize anisotropic interactions or spin relaxation to 
gain insight into dynamics at various timescales and motional amplitudes [185]. 
1.5.2 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) allows for the visualization of protein assemblies that 
cannot be observed by optical microscopy. A few microliters of sample are sufficient to deposit 
sample onto a TEM grid, which can then be imaged to obtain thousands of TEM micrographs. 
Features as small as a few nm can be visualized within a single electron micrograph [186]. 
1.5.2.1 Negative stain transmission electron microscopy 
Negative staining is a method of increasing contrast in electron micrographs. In negatively 
stained grids, protein samples do not take up stain and therefore appears lighter against a dark 
background. Electron dense salts are often used as staining agents due to their ability to provide 
decent contrast and protect the sample from radiation damage [186]. However, a focused beam 
can rapidly degrade the sample and nonetheless, contrast is low in focused images [186]. Images 
are usually obtained slightly under focus in order to maintain sample integrity and contrast. 
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Figure 1.11. Negative stain TEM images of biological samples. 
(a) TOCL/DOPC/cholesterol vesicles bound to cytochrome c. Scale bar is 500 nm (b) K2Q31K2 fibrils. Scale bar is 
50 nm. (c) Oxidized apolipoprotein A-I fibrils. Scale bars are 100 nm. (d) Aggregates of V75D hD. Scale bar is 100 
nm. Panel (a) reprinted with permission from Mandal, A., Boatz, J. C., Wheeler, T., van der Wel, P. C. A. On the 
use of ultracentrifugal devices for routine sample preparation in biomolecular magic-angle-spinning NMR, J. 
Biomol. NMR, 67(3):165-178. Copyright (2017) Springer Science + Business Media Dordrecht. Panel (c) reprinted 
with permission from Witkowski, A., Chan, G. K. L, Boatz, J. C., Li, N. J., Wong, J. C., van der Wel, P. C. A., 
Cavigiolio, G. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation, 
The FASEB Journal 32(6):3149-3165. Copyright (2018) Witkowski, A., et. al. 
I used negative stain TEM to describe a range of samples in the Van der Wel lab (Figure 
1.11), mostly to study the macromolecular morphology of both amorphous-looking and fibrillar 
aggregates [1, 3-6]. I also used negative stain TEM to distinguish amyloid polymorphs from one 
another and to visualize the aggregation of amyloid fibrils over time. For example, I prepared 
unlabeled Q44-httEx1 samples and analyzed macromolecular features of temperature-dependent 
polymorphs by TEM (Figure 1.12, a-d) [1].  
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Figure 1.12. Huntingtin exon1 fibril formation monitored by TEM. 
(a–e) Negatively stained TEM as a function of time after Factor Xa release of unlabelled exon1. (a) Uncleaved htt 
exon1 MBP fusion protein. (b) Oligomers observed 1 h after cleavage. (c) By 3 h, fibrils have begun to form. (e) 
After 25 h, fibrils have grown and oligomers are no longer visible on the grid. (e) Mature [U-
13
C,
15
N]-labelled 
fibrils prepared for ssNMR. (Scale bars: 200 nm.)‏ Modified and reprinted with permission from Hoop, C. L., Lin H. 
K., Kar K., Magyarfalvi, G., Lamley, J. M., Boatz, J. C., Mandal, A., Lewandowski, J. R., Wetzel, R., van der Wel, P. 
C. A. Huntington exon 1 fibrils features an interdigitated -hairpin-based polyglutamine core, PNAS 113(6):1546-
1551. Copyright (2016) Hoop, C. L., et. al. 
I also used negative stain TEM to distinguish the difference in fibril widths between 
different to fibril polymorphs formed at 22 and 37 °C, respectively. I primarily analyzed TEM 
micrographs with ImageJ software, which contains several tools to aid in fibril width analysis 
[187]. For example, a histogram of fibril widths can be obtained by carefully measuring several 
fibrils with the straight-line Free-Hand tool. Analysis of TEM micrographs revealed that narrow 
fibrils can be formed at 37 °C and have an average width of 6-7 nm (Figure 1.13, a,b,e) [3]. At 
22 °C, thicker fibrils form, which have an average width of 15-16 nm (Figure 1.13, c,d,f) [3]. 
These results are reproducible in independently prepared samples, and were the focus of one of 
my co-authored publications [3]. 
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Figure 1.13. TEM data comparing polyQ-expanded htt exon1 fibrils formed at 22 and 37 °C 
(a,b) Negative stain TEM of htt exon1 fibrils formed at 37°C, at two levels of magnification. (c-d) Negative stain 
TEM of htt exon1 fibrils formed at 22°C, at two levels of magnification. All scale bars are 100 nm. (e,f) Fibril width 
derived from negative-stain TEM on the mature fibrils formed at 37 °C (597 measurements over 99 fibrils) and 
22 °C (219 measurements over 73 fibrils). Modified and reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., 
Kodali, R., Hou, Z., Wetzel, R., Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects 
immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core, Nature 
Communications 8:15462. Copyright (2017) Lin, H. K., Boatz, J. C., et. al. under Creative Commons Attribution 4.0 
International License. 
Alternatively, individual fibrils can be manually ‘picked’ and vertically aligned (Figure 
1.14, a). In these cases, Fourier transform filters may be used to increase visibility of the fibril 
edges. I manually picked, aligned, and applied Fourier transform filters to several individual 
fibrils. High pass filters (Figure 1.14, b) keep the high frequencies from the Fourier transform of 
the macrographs while removing the low frequencies; the reverse is true for low pass filters. 
High pass filters are useful for observing the fine details of TEM micrographs. However, signal 
is decreased while the noise remains the same; therefore, the contrast between the grid and the 
sample worsens. Low pass filters are useful for increasing the contrast of micrographs, however 
in doing so the fine details are lost (Figure 1.14, c). A band pass filter can be applied to 
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micrographs in order to increase image contrast while retaining most of the fine details (Figure 
1.14, d,e). Band pass filters are also useful to inspect dense bundles of fibrils, which can appear 
as large black masses in micrographs with decreased visibility of fibrils frayed far from the 
bundle center (Figure 1.15).  
 
Figure 1.14. Fourier transform filtering of negatively stained httEx1 fibrils 
(a) Manually ‘picked’ and vertically aligned fibril without applying Fourier transform filters, (b) after applying a 
high-pass filter, (c) low-pass filter, and (d,e) band pass filters. The Fourier transform filters applied are shown 
below the TEM image, depicted in reciprocal space. The white areas indicate frequencies which have been removed. 
(f) Profile plots from panels a, d, and e, overlaid. Filtering was done in ImageJ [187]. 
After picking individual fibrils, I obtained profiles of gray values along the fiber axis 
(Figure 1.14, g). High gray values are associated with areas of negative stain. The width of 
individual fibrils can then be obtained by measuring the half-height of a plot of gray values 
(Figure 1.14, g). Band pass filters can also be used to improve profile plots of gray values in 
order to better estimate the half-height when measuring fibril width. Profiles are also valuable for 
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distinguishing individual filaments within fibrils. The stain penetrates the area between 
individual filaments in a manner that is not always easily detected by eye. By plotting the 
average gray value over the fiber axis, filaments interacting side-by-side can be distinguished 
with increased certainty. 
 
Figure 1.15. Bundling of Q44-httEx1 fibrils.  
(a) Bundle of Q44-httEx1 fibrils. (b) Image was subjected to a band-pass filter to increase contrast and highlight the 
fibrils flayed from the bundle and the density of the bundled fibrils. (c) Image was subjected to a band-pass filter to 
deemphasize the density of the bundled fibrils and better visualize individual fibrils. All scale bars are 100 nm. 
Filtering was done in ImageJ [187]. 
1.5.3 Fourier transform infrared spectroscopy (FTIR) 
Fourier transform infrared spectroscopy (FTIR) is a useful technique for determining the 
secondary structure elements present within protein structures, and it is advantageous as a 
complementary technique to MAS ssNMR. The amide I and amide II bands in an FTIR spectrum 
respectively report on the vibrational stretching of the C=O bond and the bending of the N-H 
bond [188]. These bonds are involved in hydrogen bonding that stabilizes -helices, -sheets, 
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and other secondary structure elements, therefore the position of the amide I and II bands are 
sensitive to secondary structure [188]. FTIR requires much less sample than MAS ssNMR, does 
not require isotopic labeling, and can be used to rapidly analyze both soluble and the aggregated 
proteins. 
 
Figure 1.16. FTIR on httEx1 fibril polymorphs 
(a) Second-derivative FTIR of htt exon1 fibrils formed at 37 °C and (b) 22 °C, for fibrils dispersed in either H2O or 
D2O. The colored arrows mark the most notable differences between the fibril types. (c) Reference data on fibrillar 
K2Q31K2, HNTF (htt
NT
Q30P10K2) fibrils, and aggregated α-helical htt
NT
 in PBS buffer. (d) Resonance frequencies of 
different secondary structure elements. Reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, R., Hou, 
Z., Wetzel, R., Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects immobilized non-
amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core, Nature Communications 8:15462. 
Copyright (2017) Lin, H. K., Boatz, J. C., et. al. under Creative Commons Attribution 4.0 International License.  
Panel (f) was adapted with permission from Sivanandam, V. N., et al, Copyright (2011) American Chemical Society. 
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Dr. Ravindra Kodali obtained FTIR results on samples that I prepared, which were used 
to observe subtle structural differences between temperature-dependent Q44-httEx1 polymorphs 
[3]. FTIR measurements show that both fibril types display the same dominant secondary 
structure features present in model polyQ peptide aggregates (Figure 1.16), however there are 
minor but distinct differences in signals associated with the PPII helices in the PRD (red arrows, 
Figure 1.16), which can be understood by the magic angle spinning solid state NMR results 
discussed in section 2.2 [3]. The FTIR results are reproducible in independently prepared 
samples [3]. 
1.5.4 X-ray diffraction 
X-ray diffraction of amyloid fibrils generate specific patterns that indicate a high order of 
repetitive -sheet structure. Specifically, the -sheets are arranged parallel to the axis of the 
fibrils [189]. Two reflections are observed in amyloid, which correspond to 4.7-4.9 and 8-12 Å 
repetitive spacings [189]. The former reflection reveals the distance between -strands that are 
interacting via hydrogen bonds, while the latter reveals the distance between -sheets within the 
core. Un-oriented fibrils produce diffraction patterns referred to as a “powder” pattern; because 
the fibrils within the sample are not aligned with respect to one another, the reflections 
associated with intra- and inter--sheets experience a complete radial averaging [189]. Aligned 
fibril samples diffract X-rays into a cross- fiber diffraction pattern where half-moon shaped 
reflections appear perpendicular to each other along the meridian and equator of the pattern 
[189]. Of note, X-ray diffraction of fibrils does not permit the reconstruction of the atomic 
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structure, however it can be used to provide valuable structural constraints than can supplement 
higher resolution structural techniques. 
 
Figure 1.17. PolyQ amyloid structure 
(a) X-ray powder diffraction on hydrated K2Q31K2 fibrils shows the cross-β dimensions of polyQ amyloid. (b) X-ray 
powder diffraction on hydrated Q44-httEx1 fibrils. (c) Cartoon depicting spacings between -strands and -sheets 
in polyQ peptides and httEx1. (d) The glutamine side chains interdigitate in polyQ peptides and httEx1. Panels a 
and d modified and reprinted with permission from Hoop, C. L., Lin H. K., Kar K., Magyarfalvi, G., Lamley, J. M., 
Boatz, J. C., Mandal, A., Lewandowski, J. R., Wetzel, R., van der Wel, P. C. A. Huntington exon 1 fibrils features an 
interdigitated -hairpin-based polyglutamine core, PNAS 113(6):1546-1551. Copyright (2016) Hoop, C. L., et. al. 
The X-ray powder diffraction data I collected from K2Q31K2 peptide fibrils reveal that the 
backbone-to-backbone distances between -strands and -sheets are 4.7 and 8.4 Å respectively 
(Figure 1.17, a). The diffraction pattern of mature Q44-httEx1 aggregates is less well resolved, 
however the observed distances of ~ 4.8 Å and 8.2 Å (Figure 1.17, b) are not significantly 
different from the distances observed for the K2Q31K2 peptide fibrils and are consistent with prior 
findings [190]. These results point to the idea that the amyloid core of polyQ peptides and polyQ 
containing proteins is very similar (Figure 1.17, c). Of particular note is the short 8.2 - 8.4 inter-
sheet distance, which indicates that the -sheet backbones are very close together in space and 
the glutamine side chains interdigitate in a steric zipper fashion (Figure 1.17, d).  
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1.5.5 Protein production and purification 
Structural and biophysical studies require the ability to reconstitute the aggregation process in 
vitro. This requires the production of protein. HttEx1 is expressed as a fusion construct to 
maltose-binding protein (MBP), designated MBP-httEx1, with a Factor Xa specific proteolytic 
cleavage site located on a short linker between the MBP and the httEx1 (Figure 1.18, a) [3]. 
HttEx1 has several binding partners and can be modified post-translationally, as indicated in 
Figure 1.18, b. Cleavage of MBP-Q44-httEx1 by Factor Xa (FXA) results in the release of 
monomeric Q44-httEx1, which rapidly forms oligomeric species and later fibrils that elongate 
over time. A C-terminal his-tag allows for purification of the MBP-httEx1 fusion protein by 
affinity over a nickel-column, and size-exclusion with a gel column can subsequently remove 
lysozyme if it is introduced during cell lysis. The yield in minimal media is sufficient to produce 
milligrams of uniformly isotopically labeled protein (
13
C, 
15
N) that is necessary for MAS ssNMR 
structural studies. A construct with a disease-relevant 44-residue-long polyQ domain was used 
for several experiments. 
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Figure 1.18. Huntingtin exon 1 sequence and domain structure 
(a) Design of the MBP fusion protein, with the sequence of the Factor Xa cleavage site in the linker shown below. 
(b) The domain structure and sequence of htt exon1 is shown at the top. The locations of post-translational 
modifications (PTMs), binding sites of various antibodies, and other htt-binding proteins are also indicated [93, 
191-200]. Modified and reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, R., Hou, Z., Wetzel, R., 
Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects immobilized non-amyloid flanking 
domains of huntingtin exon1 rather than its polyglutamine core, Nature Communications 8:15462. Copyright (2017) 
Lin, H. K., Boatz, J. C., et. al. under Creative Commons Attribution 4.0 International License. 
1.5.6 Kinetics of aggregation and amyloid formation 
1.5.6.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
I used SDS-PAGE during sample preparation and in order to estimate the rate of httEx1 release 
from the MBP-httEx1 fusion protein (Figure 1.19). The MW of MBP-Q44-httEx1 is 57 kDa at 
isotopic natural abundance (NA). The release of MBP (43 kDa) and the disappearance of the 
fusion protein can both be monitored over time after proteolysis by FXA. By combining SDS-
PAGE cleavage assays and TEM (see section 1.5.2), I found that the morphology of mature Q44-
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httEx1 fibrils depends partially on the rate of release of the Q44-httEx1 monomer (see Chapter 
3.0). 
 
Figure 1.19. Kinetics of httEx1 release from fusion construct monitored by SDS-PAGE 
The MBP fusion protein (Cntl lane) is exposed to FXA, and release of the MBP (new band in additional lanes) and 
disappearance of the fusion protein is monitored over time. The release of MBP correlates 1:1 to the release of 
httEx1.  
1.5.6.2 Electrospray ionization time of flight mass spectrometry 
Mass spectrometry (MS) is an analytical technique used to detect protein(s) within sample(s) and 
identify their MWs. Protein samples are ionized into a vapor, and the ions are then separated 
through an electromagnetic field based on their mass-to-charge ratio (m/z), which is plotted vs 
intensity as a mass spectrum. Depending on the ionization method used, MS can detect as little 
as attomole concentrations of protein with MWs of up to 300,000 Da [201]. When combined 
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with other analytical techniques, MS can be a powerful tool for protein quantification and is 
therefore ideal for assessing protein purity.  
The specific form of MS employed in these studies was electrospray ionization time of 
flight mass spectrometry (ESI-TOF MS). There are several advantages of ESI-TOF over other 
MS techniques. The most notable advantage is its impressive sensitivity; ESI-TOF can 
accurately determine the MW of intact protein within ± a single Da [201]. This is essential to 
quantify the percentage of 
13
C and 
15
N atoms (vs 
12
C and 
14
N) within an isotopically labeled 
sample.  
 
Figure 1.20. MBP release from MBP-Q44-httEx1 fusion protein monitored by ESI-TOF MS 
(a) UV absorbance following of LC-MS elutions for MBP-Q44-httEx1 before (top) and after (bottom) proteolytic 
cleavage. (b) ESI-TOF mass spectra corresponding to the entirety of the peaks depicted in panel a. 
ESI-TOF MS was also integral for several proteolytic cleavage assays described in 
Chapter 3.0. I used ESI-TOF MS coupled with high performance liquid chromatography (HPLC) 
to quantify the rate of httEx1 release from the fusion protein and identify additional cleavage 
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products resulting from proteolysis. An HPLC column is used to separate protein within a 
sample, and protein elutions are monitored by UV absorbance. This is shown in Figure 1.20, a, 
for MBP-Q44-httEx1 both before (top) and after (bottom) cleavage. Mass spectra measured over 
the entirety of the elution peaks are shown in Figure 1.20, a. Prior to cleavage, MBP-Q44-httEx1 
is observed as a single peak at 56684.9 Da/z (Figure 1.20, b, top), and in some samples also at 
28242.8 Da/z. The latter represents the MW of MBP-Q44-httEx1 ions with a charge of z = +2. 
MBP is observed after cleavage at 42884.0 Da/z (Figure 1.20, bottom) and occasionally at 21442 
Da/z when z = +2. Additional cleavage products may also be observed by ESI-TOF MS, 
including httEx1. 
 
1.5.6.3 High performance liquid chromatography (HPLC) based sedimentation assays 
I used HPLC to quantify the kinetics of peptide and protein aggregation [3, 54, 202]. I thank Dr. 
Ravi Kodali for his mentorship and help with my initial sedimentation assays. Briefly, 
aggregation of amyloid-like fibrils was initiated, often by proteolytic cleavage, in the presence 
and absence of pre-formed amyloid seeds. At various time points, aggregates were removed from 
aggregating reaction mixtures by sedimentation via (ultra)centrifugation and aliquots of the 
supernatant were then diluted into formic acid and loaded onto an HPLC column. The column is 
necessary to separate the monomers of amyloidogenic peptides and protein from proteases, 
soluble cleavage products, and other contaminants. The elution of amyloidogenic monomers is 
monitored by UV absorbance at 215 nm (A215), which reports on the relative concentration of 
peptide backbone in the sample in the absence of tryptophan residues in the protein sequence. An 
ESI-TOF MS instrument was used to automatically determine the molecular weight of the 
molecules present in each elution. Manual integration of the A215 peaks compared to negative 
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and positive controls allows for the quantification of monomeric species remaining in the 
aggregating sample over time.  
1.5.6.4 Thioflavin T (ThT) fluorescence 
Thioflavin T (ThT) is a small dye that usually fluoresces in the presence of amyloids but not in 
the presence of non-amyloid (e.g. amorphous) aggregates. Upon binding to amyloids, the 
dynamics of the ThT dye changes, and this change induces fluorescence [203, 204]. The 
intensity of the induced ThT fluorescence correlates linearly with the concentration of amyloid 
fibrils, therefore ThT assays are highly quantitative [205]. I used this dye to measure the kinetics 
of amyloid formation for both httEx1 and P23T hD [3, 5]. I found that kinetics of fibril 
formation is strongly dependent on the length of the expanded polyQ domain and the 
concentrations of protease and substrate, with only minimal dependence on temperature. 
As discussed above, amyloid formation follows sigmoidal kinetics (Figure 1.2). As 
monomers begin to aggregate and form amyloid fibrils, ThT fluorescence typically increases in a 
sigmoidal fashion. This indicates that the ThT dye preferentially binds to a structural motif 
present in both the nuclei and fibrils and does not favor binding to species prior to nuclei 
formation. In Figure 1.21, ThT fluorescence is shown for two timepoints following httEx1 
release via Factor Xa (FXA) proteolytic cleavage of the MBP fusion protein. Importantly, release 
of httEx1 reached completion within 15 minutes for this particular assay (as verified by SDS-
PAGE). After 1 hour from the addition of FXA protease, httEx1 (mostly monomeric, some 
oligomers potentially present) does not exhibit significant ThT fluorescence compared to control 
samples without FXA proteolysis. After 3 days, mature fibrils bind readily to the ThT dye and 
induce fluorescence. 
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Figure 1.21. ThT fluorescence of httEx1 monomer and mature fibrils 
After 60 minutes from FXA proteolysis, no significant increase in fluorescence is observed compared to negative 
control. After 4350 minutes (3 days), mature fibrils have formed, and significant ThT fluorescence is observed. 
1.5.6.5 Amyloid seeding assays 
I performed several assays to test the ability of amyloid fibrils to propagate through seeding. 
During my work on httEx1 aggregation (as discussed in Chapter 1.5 and Chapter 3.0), we 
observed different polymorphs for Q44-httEx1 aggregated at 22 and 37 °C [3]. Both fibril types 
are capable of seeding expanded polyQ protein (Figure 1.22) and shorter model polyQ peptides 
(Figure 1.23) [3]. This is shown with a ThT fluorescence assay (Figure 1.22, a,b; Figure 1.23, 
a,c) that monitors the production of amyloid over time at 22 °C [3]. When no seeds are present, 
amyloid formation begins after a long lag phase. In the presence of 20mol-% of pre-aggregated 
seeds, the lag phase is abolished. The rate of amyloid formation in the elongation phase is much 
faster in the presence of seeds. As expected, amyloid formation was found to be correlated with 
aggregate formation detected through HPLC-based sedimentation assays (Figure 1.22, c,d; 
Figure 1.23, b,d), performed in parallel to the ThT assays [3], as discussed above in section 
1.5.6.3. 
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Figure 1.22. PolyQ protein recruitment through seeding 
(a) Aggregation kinetics at 22 °C in the absence (solid black and grey lines) and presence (dashed lines) of pre-
made seed aggregates, detected as ThT fluorescence at indicated time points after complete trypsin cleavage of the 
htt exon1 fusion protein. Dark blue and magenta dashed lines reflect the aggregation in presence of 20 mol-% htt 
exon1 aggregates formed at 22 and 37 °C, respectively. The unseeded reactions have lag phases exceeding 4 h, 
which are eliminated by the seeds. Error bars indicate s.d., with n=2–3. (b) Expansion of the first 500 min. (c,d) 
Results of a single (n=1) HPLC measurement of the residual monomer concentration after aggregate sedimentation, 
applied to the same samples, as a complementary measure of aggregation. Error bars reflect the estimated peak 
integration error. Modified and reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, R., Hou, Z., 
Wetzel, R., Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects immobilized non-amyloid 
flanking domains of huntingtin exon1 rather than its polyglutamine core, Nature Communications 8:15462. 
Copyright (2017) Lin, H. K., Boatz, J. C., et. al. under Creative Commons Attribution 4.0 International License. 
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Figure 1.23. Seeding assay results on htt
NT
 Q23P10K2 peptide 
(a) Seeding effects on the aggregation of htt
NT 
Q23P10K2 peptide [54] at 37 °C, monitored by ThT fluorescence 
measurements. Reactions were performed without seeds (black; solid), and with 20-mol-% htt exon1 seeds prepared 
either at 22 °C (dark blue; solid), or 37 °C (magenta; dashed). Error bars indicate s.d. with n=2 or n=3. (b) In the 
same samples, sedimentation followed by reverse-phase HPLC was used to monitor the percent monomer remaining 
in the supernatant. (c,d) Expansion of the first 200 minutes of panels (a) and (b), respectively. Both types of 
polymorphs are capable of cross-seeding the aggregation of this peptide featuring a shorter polyQ length that is 
below the HD threshold. In the earliest stages (see panels c,d) the fibrils formed at 37 °C appear to be more 
effective at seeding this aggregation reaction. Reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, 
R., Hou, Z., Wetzel, R., Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects immobilized 
non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core, Nature Communications 
8:15462. Copyright (2017) Lin, H. K., Boatz, J. C., et. al. under Creative Commons Attribution 4.0 International 
License. 
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1.5.7 Toxicity studies 
To test whether our polymorphic protein fibrils were cytotoxic, I prepared several samples for 
toxicity studies, which were performed and analyzed by my collaborators Inge Krabbendam and 
Dr. Amalia M. Dolga at the University of Groningen [3]. Immortalized murine hippocampal and 
human differentiated dopaminergic neuronal cell lines were exposed to each Q44-httEx1 
temperature polymorph to probe potential cytotoxic effects. The results are plotted in Figure 
1.24, e,f [3]. Cell death was not observed at 0.5 M concentrations in either cell type. At 1 M, 
cell death was induced in the dopaminergic cell line but not in the immortalized cells, however at 
5 M cell death was induced in both cell lines. There appears to be a slightly larger cytotoxic 
affect in the presence of 37 °C fibrils, as indicated by differences in the morphology of treated 
dopaminergic neurons (Figure 1.24, a-d) [3]. 
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Figure 1.24. Treated and untreated human dopaminergic neurons 
(a) Control neurons compared to treated neurons 24 h after administering (b) PBS buffer only, (c) 5 μM of the thick 
22 °C fibrils in PBS, and (d) 5 μM of the thinner 37 °C fibrils in PBS. Scale bars are 50 μm. (e) Cellular viability of 
human dopaminergic neuronal cells upon exposure to varying concentrations of pre-formed fibrils prepared at 22 
and 37 °C. The data reflect MTT reduction assays performed after 24 h (n=2; two biological replicates with three 
technical replicates each—shown is the mean with s.d. compared to non-treated controls set at 100%). (f) Cell 
viability assay data for a 24 h exposure of immortalized HT-22 neurons (n=2; two biological replicates with 6 
technical replicates each–shown is the mean with s.d. compared to non-treated controls set at 100%; *P<0.05, 
Mann–Whitney non-parametric test). Modified and reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., 
Kodali, R., Hou, Z., Wetzel, R., Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects 
immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core, Nature 
Communications 8:15462. Copyright (2017) Lin, H. K., Boatz, J. C., et. al. under Creative Commons Attribution 4.0 
International License. 
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2.0 STRUCTURAL INSIGHTS ON EXPANDED HUNTINGTIN EXON 1 
Here, I summarize conclusions from recent results that the Van der Wel lab has published, which 
report high-resolution data on the structure and dynamics of the individual domains of Q44-
httEx1 polymorphs. It is vital to understand the results and conclusions presented in these 
manuscripts prior to reading Chapter 3.0. Together, these results demonstrate that the polyQ 
amyloid core arranges into an interdigitated antiparallel -sheet structure that is robust between 
model polyQ peptides and Q44-httEx1 polymorphs. The flanking domains were found to have 
the same structure in two temperature-dependent Q44-httEx1 polymorphs, however interactions 
between flanking domains and the exposure of the flanking domains to the solvent were found to 
be important factors that dictate the polymorphism. 
2.1 SUMMARY: HUNTINGTIN EXON 1 FIBRILS FEATURE AN 
INTERDIGITATED -HAIRPIN-BASED POLYGLUTAMINE CORE 
Hoop, C. L., Lin H. K., Kar K., Magyarfalvi, G., Lamley, J. M., Boatz, J. C., 
Mandal, A., Lewandowski, J. R., Wetzel, R., van der Wel, P. C. A. 
Huntington exon 1 fibrils features an interdigitated -hairpin-based 
polyglutamine core, PNAS 113(6):1546-1551. Copyright (2016) Hoop, C. L., 
et. al. 
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I contributed data towards two figures in this manuscript, reprinted with 
permission as Figure 1.17, a, and Figure 1.12. Specifically, I obtained X-ray 
powder diffraction patterns (section 1.5.4) on K2Q31K2 peptide fibrils, and I 
monitored the time course of Q44-httEx1 fibril formation by TEM (section 
1.5.2). I also obtained negative stain TEM images on U-
13
C,
15
N labeled Q44-
httEx1 fibrils. 
 
The polyQ amyloid core of Q44-httEx1 fibrils forms antiparallel -sheets and the extended and 
rigid glutamine side chains form two distinct structure types (‘a’ and ‘b’) in equal amounts. Each 
-strand is found to present only one glutamine side chain type. The polyQ domain of httEx1 
displays the same chemical shift signature representative of amyloid structure in several model 
polyQ peptides; peak patterns for ‘a’/’b’ type glutamine remain the same in the presence and 
absence of model flanking domains, with only one or two sequential residues labeled, and 
regardless of the length of the polyQ domain. Together, these data are indicative of a conserved 
polyQ structure between multiple polyQ model peptides and Q44-httEx1 polymorphs.  
Glutamine side chain N and backbone C atoms from different molecules were found to 
be close in space, revealing an interdigitated glutamine steric-zipper between strands. These 
results, together with solvent exposure studies, are consistent with an intramolecular -hairpin 
structure made up of both ‘a’ and ‘b’ strands in the polyQ domain of Q44-httEx1 fibrils. A third 
type ‘c’ glutamine likely populates the -turns within the hairpin, which are typically four or 
more residues in length. Because signals from ‘c’ type glutamine make up at most 10% of the 
total glutamine signal in the Q44-httEx1 fibrils, it is predicted that there is a single -turn per 
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molecule. This implies that each -strand in Q44-httEx1 is 20-residues in length. Kinetics studies 
on model polyQ peptides suggest that the minimum polyQ length required for -hairpin 
formation is 26 residues, therefore the minimum -strand length in polyQ -hairpins is predicted 
to be 11 residues long [1, 146, 206]. 
2.1.1 Proposed stochastic formation of -hairpins 
Peak doubling is also observed whenever a single glutamine residue is labeled in model peptides; 
this is consistent with the idea of stochastic formation during nucleation or fibril elongation. For 
Q44-httEx1 fibrils, this implies that in half of the molecules the first 20 glutamine residues (Q18-
Q37) adopt a type ‘a’ structure and the last 20 glutamine residues (Q42-Q61) adopt a type ‘b’ 
structure. The remaining half of the molecular population adopts a type ‘b’ structure in residues 
Q18-Q47 and a type ‘a’ structure in residues Q42-Q61. The observed peak doubling appears 
independent of polyQ length and is also observed in D2Q15K2 peptides that are unlikely to form a 
-hairpin but do assemble into fibrils in an antiparallel fashion.  
2.2 SUMMARY: FIBRIL POLYMORPHISM AFFECTS IMMOBILIZED NON-
AMYLOID FLANKING DOMAINS OF HUNTINGTIN EXON1 RATHER THAN ITS 
POLYGLUTAMINE CORE 
Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, R., Hou, Z., Wetzel, R., 
Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects 
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immobilized non-amyloid flanking domains of huntingtin exon1 rather than its 
polyglutamine core, Nature Communications 8:15462. Copyright (2017) Lin, H. 
K., et. al. 
 
I directly contributed towards two main text figures and three supplementary 
figures in the published manuscripts, some of which are reprinted with permission 
as Figure 1.22, Figure 1.23, and Figure 1.13. I produced protein and prepared 
several fibril samples (section 1.5.5), monitored aggregation by HPLC 
sedimentation assays (section 1.5.6.3), monitored amyloid formation by ThT 
fluorescence (section 1.5.6.4), performed several seeding assays (section 1.5.6.5), 
and obtained micrographs of fibrils by negative stain transmission electron 
microscopy (section 1.5.2). I thank Dr. Ravindra Kodali for his help and guidance 
with the assays utilizing HPLC and ThT fluorescence. I also prepared samples 
that were used in toxicity studies (section 1.5.7) performed by my collaborators 
Inge Krabbendam and Dr. Amalia M. Dolga at the University of Groningen, and 
for FTIR measurements (section 1.5.3) performed by Dr. Ravindra Kodali. 
 
Temperature during fibrillation affects the width of mature Q44-httEx1 fibrils as seen in my 
TEM data (see section 1.5.2); 15-16 and 6-7 nm fibrils are formed at 22 and 37 °C, respectively. 
Both polymorphs are capable of propagating through seeding and are cytotoxic to neuronal cell 
lines. There is a small but noticeable heightened cytotoxicity of the 37 °C fibrils on 
dopaminergic neurons. Subtle differences are observed by FTIR in signals that originate from the 
PRD. In both fibril types the polyQ signature is the same. The htt
NT
 and PRD feature - and PPII 
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helices that are immobilized, and the polyQ-proximal sections of each flanking domain displays 
restricted motion.  
The temperature-dependent polymorphs present variable dynamics and solvent 
accessibility in the PRD that affects the binding ability of antibodies. The thinner fibrils formed 
at 37 °C display several highly flexible solvent-exposed residues in the PRD and readily bind to 
MW7 and MW8 antibodies. Conversely, the fibrils formed at 22 °C display restricted motion and 
less solvent-accessibility in the PRD, which results in decreased binding to MW7. This contrasts 
with prior studies which attributed polymorphism to differences in the structure of the polyQ 
domain [47].  
2.2.1 Proposed model of htt exon1 fibrils 
The results presented in this manuscript and prior studies from the Van der Wel lab were best 
explained by a structural model of Q44-httEx1 fibrils that is presented in Figure 2.1. 
Intermolecular -hairpins makeup the polyQ domain, which places the flanking domains near 
each other in space. The htt
NT
 forms an -helix and a short linker connects the polyQ domain to 
a PPII helix within the PRD. This arrangement additionally constrains the motion of the polyQ-
proximal segments of the flanking domains and limits the accessibility of the flanking domains 
to the solvent. The polyQ amyloid core features -strands consisting of 20 residues each and 
spanning 6-7 nm, consistent with the width of the 37 °C fibrils observed by TEM. The 22 °C 
fibrils are proposed to consist of two interacting filaments that primarily interact through the 
PRD, which results in restricted flanking domain motion and reduces solvent exposure. The 
filaments present in the 37 °C sample do not interact, leaving the flanking domains solvent 
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accessible with less constrained motion. Together these results show that differences in the 
solvent exposure and interactions of the polyQ flanking domains are important for Q44-httEx1 
fibrillar structure and function. 
 
Figure 2.1. Schematic proposed model of htt exon1 fibrils 
(a) The htt
NT
 α-helices (dark blue) and PRD PPII helices (light blue) are immobilized and tightly clustered on the 
perimeter of the rigid amyloid core (green β-strands). C-terminal domains show increased dynamics, either in the 
form of the unstructured C-terminal tail or a subpopulation of more exposed PRDs (top right; red). An individual 
protein monomer with its β-hairpin-based polyQ core is shown with lighter (yellow) β-strands. (b) Schematic 
illustration of interfilament flanking domain interactions that we propose to explain the larger TEM-based widths of 
the fibrils formed at 22 °C, as well as the observed differences in accessibility and immobilization of the PRD. 
Reprinted from Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, R., Hou, Z., Wetzel, R., Dolga, A. M., Poirier, M. 
A., van der Wel, P. C. A. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin 
exon1 rather than its polyglutamine core, Nature Communications 8:15462. Copyright (2017) Lin, H. K., Boatz, J. 
C., et. al. under Creative Commons Attribution 4.0 International License. 
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3.0 ROLES OF CONCENTRATION AND THE N-TERMINAL FLANKING 
DOMAIN IN MUTANT HUNTINGTIN EXON 1 FIBER POLYMORPHISM 
Jennifer C. Boatz, Talia Piretra, Irina Matlahov, James F. Conway, Patrick C. A. 
van der Wel. (2018) Roles of concentration and the N-terminal flanking domain 
in mutant huntingtin exon 1 fiber polymorphism, manuscript in preparation. 
 
Data availability: Assigned chemical shifts of Q44-httEx1 fibrils were reported previously [3] 
and deposited into the Biological Magnetic Resonance Data Bank (BMRB) as entry 27045. All 
other data are available from the corresponding author. 
 
I performed all MAS ssNMR, X-ray diffraction, mass spectrometry, and 
fluorescence/seeding experiments and analyzed the associated data. I also 
collected all TEM micrographs, which Talia Piretra, Irina Matlahov, James F. 
Conway, and I analyzed. Talia Piretra and I performed and analyzed all monomer 
release (cleavage) assays. All samples were prepared by me, Talia Piretra, and 
Irina Matlahov. I designed all experiments with Patrick C. A. van der Wel, I 
created all figures, and I wrote the manuscript with input from all co-authors, 
especially from Patrick C. A. van der Wel and James F. Conway. 
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Huntington’s disease is a progressive neurodegenerative disease caused by expansion of the 
polyglutamine domain within the first exon of the huntingtin protein. The extent of 
polyglutamine expansion in huntingtin directly correlates with disease progression and the 
formation of amyloid-like fibrillar deposits of huntingtin and huntingtin fragments within the 
brain. Several amyloid polymorphs have been identified at the microscopic level, both in vivo 
from cerebral tissue and in vitro. Amyloid polymorphism can exhibit a dramatic influence on 
cytotoxicity. Understanding the conditions and mechanisms that dictate the formation of 
polymorphs in Huntington’s disease is therefore of considerable importance. We examine the 
conditions that govern huntingtin exon 1 polymorphism, including the role of the highly 
conserved huntingtin N-terminal domain that has high biological significance.  
 54 
3.1 INTRODUCTION 
Huntington’s disease (HD) is one of several heritable polyglutamine expansion diseases that are 
characterized by the abnormal expansion of a CAG trinucleotide repeat that codes for a 
polyglutamine stretch (polyQ) in the mutant protein [19]. In HD, polyQ expansion occurs within 
the first exon of the huntingtin protein (htt; httEx1); see Figure 3.1, a,b. PolyQ expansion results 
in the aggregation of htt N-terminal fragments (including httEx1) into insoluble amyloid fibrils 
that accumulate in neuronal inclusion bodies. The formation of htt fibrils is associated with a 
toxic gain-of-function that ultimately results in neuronal cell death [100, 207].  
HttEx1 is composed of three domains: a 17 residue N-terminal domain (htt
NT
), a polyQ 
domain, and the proline-rich domain (PRD). The expanded polyQ domain forms antiparallel -
sheets that make up the amyloid core in mature fibrils [1, 3]. The htt
NT
 domain and the PRD 
flank the polyQ domain in the httEx1 sequence and have countering influences on the kinetics of 
httEx1 aggregation [208, 209]. The PRD contains PPII helices and a random coil region [3, 91, 
210-212]. The -helical httNT domain is very important for htt function, acting as a binding 
partner for membranes, chaperones including TRiC, and several other proteins with implications 
in membrane trafficking, cell signaling, and the regulation of gene expression and transcription 
[3, 90, 91, 200, 210, 213, 214]. Additionally, the htt
NT
 domain is the target of several post-
translational modifications that directly influence htt function [199, 215].  
As seen in other amyloid-forming proteins, httEx1 fibrils are varied in their morphologies 
at the microscopic level, and individual polymorphs are thought to be capable of propagating 
through seeding [3, 47, 56, 104, 216, 217]. Notably, flanking domains are considered crucial for 
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the biological properties of amyloid polymorphs and have been shown to directly affect fibril 
polymorphism in httEx1 and in other amyloid systems [218-222].  
 
Figure 3.1. Huntingtin exon 1 and MBP based fusion protein 
(a) Schematic of wild type httEx1 that does not contain an expanded polyQ domain, and (b) of Q44-httEx1, which 
contains an expanded polyQ domain. (c) Top: representation of the MBP-httEx1 fusion protein involved in these 
studies. Bottom: Cleavage with Factor Xa (FXA) protease results in the release of httEx1 and free MBP (bottom). 
The width of each domain indicated in (a)-(c) is to scale with the length of the primary protein sequence. 
We previously reported two temperature-dependent polymorphs of Q44-httEx1 fibrils 
that can be distinguished by transmission electron microscopy (TEM) [3]. Both polymorphs 
propagate through seeding and are cytotoxic to neuronal cell lines, which contrasts with other 
reports showing that polymorphism of httEx1 fibrils can dramatically affect cytotoxicity [3, 47]. 
It was expected that these differences between the polymorphs are a direct result of 
polymorphism in the molecular structure or assembly of httEx1 within mature fibrils. 
Intriguingly, the polyQ fingerprint derived from magic angle spinning solid state NMR (MAS 
ssNMR) is the same for both temperature-dependent polymorphs that we observed, indicating 
that the polyQ core is structurally the same [3]. The htt
NT
 and PPII helices in the PRD are 
immobilized with restricted motion proximal to the polyQ domain [3]. The PRD as a whole 
presents variable dynamics and solvent accessibility between polymorphs, which affects the 
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ability of the polymorphs to bind antibodies [3]. These results show that the flanking domains are 
important for Q44-httEx1 fibril polymorphism [3].  
The amyloid formation progresses through sigmoidal kinetics [8, 48, 49]. PolyQ peptides 
that resemble elongated httEx1 progress in the lag phase while forming early oligomeric 
aggregates prior to the formation of -sheet rich nuclei [208]. Fibril elongation follows the 
formation of nuclei and proceeds as rapid polymerization along the fibril axis until the non-
fibrillar population of httEx1 is mostly depleted, resulting in an observed plateau phase. Kinetics 
of amyloid formation are modified by the presence of “seeds”, which are preformed fibrils and 
fibril fragments that can propagate their structure by acting as nuclei for monomers and 
multimers that have not yet aggregated [8]. Seeds dramatically shorten the lag phase and can be 
used to mimic conditions present in the brain following the formation of amyloid fibrils [8]. For 
example, seeding in vivo is considered to be responsible for the observation that a single A1-40 
polymorph (or ‘strain’) propogates within an individual Alzheimer’s brain despite the fact that 
multiple strains are observed between patients [44]. The polymorphs of A1-40 can be readily 
distinguished through TEM and MAS ssNMR [41-46].  
Magic angle spinning solid state NMR (MAS ssNMR) is a structural biology tool that is 
ideally suited to reveal structure and dynamic information of amyloid fibrils at atomic resolution, 
which is otherwise challenging to obtain by solution NMR nor X-ray crystallography due to 
innate insolubility and lack of crystallographic order within amyloid fibrils [1, 37, 44, 92, 145-
147]. NMR chemical shifts, measured in parts per million (ppm), are exquisitely sensitive to 
protein structure; thus, the isotopic chemical shifts observed for individual nuclei by MAS 
ssNMR can be used to rapidly identify protein secondary structure and identify structural 
changes between two different polymorphs [166].  
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Our starting point for this work was to understand the temperature-dependent 
polymorphism we previously observed [3]. Here, we find that polymorphs can be formed at 37 
°C that we had not observed previously, indicating that additional experimental conditions that 
dictate fibril polymorphism. Here, we also investigate the role of the N-terminal flanking and 
observe that the concentration and cleavage rate of the fusion protein play a critical role. 
3.2 METHODS 
3.2.1 Protein expression and purification 
We employed a previously described MBP-fusion featuing mutant htt exon1 with 44 consecutive 
glutamine residues within the polyQ domain, subcloned into a pMALc2x plasmid [3, 223]. The 
fusion protein MBP-Q44-httEx1 was overexpressed in E. coli BL21(DE3)pLysS cells 
(Invitrogen, Grand Island, NY) using an optimized isotopic labeling protocol as previously 
described, for samples at isotopic natural abundance as well as samples that were uniformly 
13
C,
15
N labeled [3]. Cells were harvested by pelleting at 7,000g and then stored at -20 C 
overnight. Lysis was done by microfluidization (Microfluidics, Newton, MA) until the lysate 
appeared nearly clear. Debris was removed by centrifugation at 38,720g for 1 hour and 
subsequently by filtering over 0.22 m PES membranes. 1 mM PMSF (phenylmethanesulfonyl 
fluoride) was added to the resuspended cells just prior to lysis and replenished every 0.5 hour 
after lysis until the lysate was filtered. The soluble fusion protein was purified using a nickel 
column and imidazole gradient. The molecular weight, isotopic labeling, and purity were verified 
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by ESI-TOF MS and SDS-PAGE [92]. After exchanging into imidazole-free buffer, the 
concentration of the fusion protein was determined by its average absorbance (n = 3) at 280 nm, 
which was measured in a 100 L quartz cuvette with a 1 cm path length by a DU 800 UV-visible 
spectrophotometer (Beckman Coulter, Brea, CA). The extinction coefficient of the fusion protein 
is estimated to be 66350 M
-1
 cm
-1 
(determined using the ProtParam tool by ExPASy) [224]. 
3.2.2 Fibril formation 
MBP-Q44-httEx1 was cleaved to release Q44-httEx1 by treating with Factor Xa (FXA) protease 
(Promega, Madison, WI), or cleaved to release N15-Q44-httEx1 by treating with N-tosyl-L-
phenylalanine chloromethyl ketone treated trypsin lyophilized powder from bovine pancreas 
(SKU T1426 from Sigma-Aldrich, St. Louis, MO) re-dissolved in PBS buffer with 3 M HCl. 
The progression of protein cleavage was monitored by SDS-PAGE (Bio-Rad Mini-Protein 
Precast TGX Gels 12%) or by ESI-TOF MS as described below [3]. For the TEM studies on 
Q44-httEx1, MBP-Q44-httEx1 was treated with FXA using MBP-Q44-httEx1 concentration and 
fusion protein to protease molar ratios of: 98.9 M/4.25:1, 7.2 M/25:1, 28.6 M/25:1, 98. 9 
M/42.5:1, 28.6 M/62.5:1, 14.3 M/62.5:1, 14.3 M/150:1, 78.8 M/170:1, 28.6 M/250:1, 
88.9 M/382:1, 10.1 M/510:1, 98.9 M/847:1, 14.3 M/1500:1 as indicated in Figure 3.3 and 
Figure A.4. The protein was allowed to aggregate at 37 °C over 3 days. For ThT studies on 
N15-Q44-httEx1, 11.6 M MBP-Q44-httEx1 was aggregated for 13 days at either 22 or 37 °C, 
with the MBP-Q44-httEx1 to trypsin ratios of 3:1. ThT seeding assays, TEM imaging, and MAS 
ssNMR studies were performed on samples of Q44-httEx1 that were prepared at 22 °C from 11.6 
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M MBP-Q44-httEx1. Unless otherwise indicated, in all N15-Q44-httEx1 preparations the 
trypsin cleavage reaction was quenched after 10 minutes with addition of PMSF to a final 
concentration of 26 nM.  
3.2.3 Transmission electron microscopy 
Prior to EM imaging, fibrils were pelleted and washed with PBS buffer three times to remove 
free MBP and un-aggregated monomers and oligomers. Aliquots of fibril suspensions were 
diluted into PBS buffer and then 5 L were deposited and adsorbed onto freshly glow-discharged 
400 mesh size carbon-coated copper grids for 30 seconds to 2 minutes, and then excess buffer 
was removed by blotting. Staining agents used were either 1% (w/v) uranyl acetate (UA) or 1% 
phosphotungstic acid (PTA), as indicated. Negative stain was applied to the grids for 
approximately 5 seconds, and then removed by blotting, and grids were air dried for 5 minutes. 
Images of the negatively-stained samples were obtained by transmission electron microscopy on 
a Tecnai T12 TEM (FEI, Hillsboro, OR) operating at 120 kV and equipped with an UltraScan 
1000XP CCD camera (Gatan, Pleasanton, CA). Fibril widths were measured from micrographs 
using the straight Free-Hand tool of ImageJ (NIH, Bethesda, MD) [187]. Three measurements 
were obtained per fibril transverse to each fiber axis. In fibrils where the width varied 
significantly, measurements were obtained at both the thickest and thinnest part of the fibril and 
also at an intermediate area. In select cases, widths were verified on isolated and vertically 
aligned fibrils using the Plot Profile tool of ImageJ, which plots average gray scale intensity 
values across a rectangular region [187]. The width of the resulting peak was measured at its 
estimated half-height. Fourier transform band pass filters were applied to aid in half-height 
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estimations, and to images of fibril bundles to aid in visibility of individual fibrils, as indicated 
[187]. 
3.2.4 X-ray powder diffraction 
Fibrils were pelleted by ultracentrifugation at 100,000 g for 4 hours (Beckman Coulter Optima 
MAX Ultracentrifuge, with TLA 120.2 rotor) and then the supernatant was removed. The 
hydrated pellet was packed into a glass capillary (0.7 mm) using a spatula and PBS buffer was 
inserted on both ends of the capillary by syringe. Capillaries were then sealed with wax. A 
Rigaku FR-E generator (2kW, spot size 0.07 mm) with a source wavelength of 1.541780 Å was 
placed 65 mm from the sample and diffraction data was collected on a Rigaku Saturn 944 CCD 
camera (Tokyo, Japan) operating at -45 °C. The sample remained at room temperature during 
data collection. Diffraction data was analyzed in Structure Studio (Rigaku). 
3.2.5 Thioflavin T fluorescence and seeding assay 
Thioflavin T (ThT) fluorescence assays were obtained on seeded and unseeded samples of Q44-
httEx1 following FXA cleavage as described previously [3]. Fibrils of Q44-httEx1 produced at 
22 °C were used as seeds. The seeds were washed with PBS buffer and resuspended by vortex 
for thirty minutes prior to the seeding assays. For the ThT assays, 11.6 M of fresh MBP-Q44-
httEx1 was cleaved with FXA with a fusion protein to protease ratio of 25:1. Sonicated seeds 
were added to the reaction mixture immediately at a molar ratio of 20% to Q44-httEx1. The 
 61 
mixture was then vortexed and allowed to aggregate at 22 °C. ESI-TOF MS and HPLC 
measurements obtained from the supernatant were used to verify that cleavage was complete 
after 30 minutes [3]. Samples were mixed by vortex at specific time points and aliquots of 
sample suspensions were immediately diluted into ThT stock solution for a total volume of 400 
L. Samples were excited at 445 nm through a 2 nm excitation slit on a FluoroMax-4 
spectrofluorometer (Horiba; Kyoto, Japan). Emission was recorded at 489 nm through a 4 nm 
emission slit. Two measurements were obtained for each sample per timepoint. Curves were fit 
using AmyloFit using the Nucleated Elongation Unseeded and Nucleated Elongation seeded 
models [225]. 
3.2.6 Cleavage kinetics assays by SDS-PAGE and ESI-TOF MS 
The kinetics of monomer release by FXA or trypsin cleavage on MBP-Q44-httEx1 was 
monitored by SDS-PAGE for samples indicated in Figure A.2 and Figure A.1. Samples (15 L) 
were removed from the reaction mixture at the indicated time points and mixed with an equal 
volume of SDS-PAGE loading dye to terminate the reaction. An SDS-PAGE gel (Bio-Rad Mini-
Protein Precast TGX Gels 12%) stained with Coomassie R-250 dye analyzed by the Gel analyzer 
tool in ImageJ was used to analyze the results [187]. Kinetics of cleavage were also measured in 
samples with 1:1 molar ratio of MBP-Q44-httEx1 to either FXA protease or trypsin protease, as 
indicated in Figure 3.6. Aliquots of a few L were removed and quenched with formic acid at 30 
second, 1 minute, 5 minute, and 6 hour time points. ESI-TOF MS was used to analyze the 
kinetics of cleavage and identify cleavage products, as described below. 
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3.2.7 Potential trypsin cleavage products of MBP-Q44-httEx1 
ExPASy’s PeptideCutter tool [224] was used to determine all 42 of the possible trypsin cleavage 
sites within MBP-Q44-httEx1. These potential cleavage sites were marked onto the predicted 
structure of free MBP adapted from the structure of fusion protein MBP-L30 (PBD ID 1NMU) 
using UCSF Chimera [226]. The molecular weights of all fragments were calculated using 
ExPASy’s ProtParam tool [224] assuming 42 active cleavage sites. The molecular weights of all 
possible fragments assuming selective cleavage sites were calculated by combining the 
molecular weights of individual fragments and adding 18 Da (the molecular weight of water) for 
each peptide bond formation. A total of 945 possible cleavage products were identified, 760 of 
which have molecular weights above 5000 Da. 
3.2.8 Mass Spectrometry 
The mass of the MBP-Q44-httEx1 fusion protein (56.685 kDa) was confirmed within ± 1 Da by 
ESI-TOF MS using a MaXis II ESI-QTOF mass spectrometer (Bruker Daltonics, Billerica, MA). 
Mass spectra were deconvoluted by maximum entropy using Compass Data Analysis Hystar 4.1 
software (Bruker Daltonics, Billerica, MA), with lower and upper limits of 5000 and 100,000 
m/z. MBP-Q44-httEx1 was deemed usable for additional experiments if the MS deconvolution 
curve indicated the presence of a single species without any indication of prior protease 
cleavage.  
To identify the trypsin cleavage products of MBP-Q44-httEx1, the fusion protein was 
cleaved in 7 independent trials and the mass spectra were obtained within the first six hours 
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following the addition of trypsin. PMSF was not added to any of the reaction mixtures. All peaks 
observed in the resulting deconvoluted mass spectra were screened against the expected 
molecular weights of 760 possible cleavage products within ± 2 Da. An additional 4 independent 
trials were analyzed after 1 day of aggregation. 
3.2.9 Magic Angle Spinning solid state NMR spectroscopy 
Isotopically labeled samples were prepared and then packed by pelleting a hydrated suspension 
of purified protein aggregates into 3.2 mm zirconia thin wall MAS rotors (Bruker Biospin, 
Billerica, MA) using a home-built ultracentrifugal packing device under centrifugation at ~ 
130,000 g in a Beckman Coulter Optima L-100 XP ultracentrifuge equipped with a SW-32 TI 
rotor [4]. For N15-Q44-httEx1, 7 mg were packed into the MAS rotor. Caps were sealed to the 
rotor with epoxy glue to maintain hydration and the samples were subsequently studied by MAS 
ssNMR in an unfrozen state. All MAS ssNMR experiments were performed using a wide-bore 
Bruker Avance I NMR spectrometer operating at a 
1
H Larmor frequency of 600 MHz (14.1 
Tesla) and equipped with a 3.2 mm MAS probe with an HCN ‘EFree’ coil (Bruker Biospin). 
Immobilized and rigid parts of the fibrils were studied using 1D 
13
C and 2D 
13
C-
13
C Cross 
polarization (CP) based experiments at 12.5 kHz MAS. 
13
C-
13
C correlations were obtained from 
2D experiments with a ramped 
1
H-
13
C CP step and 8ms dipolar-assisted rotational resonance 
(DARR) 
13
C-
13
C mixing [158]. Dipolar-recoupling curves based on 
13
C-
13
C 2D Proton-Driven 
Spin Diffusion (PDSD) experiments were acquired with mixing times of 0, 25, 250, and 500 ms. 
The volumes of 2D peaks were integrated using the Sparky NMR software package and 
normalized to the corresponding peak volume at the diagonal in the PDSD experiment that 
 64 
employed 0 ms mixing [3]. Mobile parts of the fibrils were identified from 1D J-coupling-based 
13
C spectra which were acquired using rotor-synchronized refocused insensitive nuclei enhanced 
polarization transfer (INEPT) 
1
H-
13
C transfers at 8.333 kHz MAS rate. 2D spectra showing 
13
C-
13
C correlations between highly mobile carbons were obtained by combining INEPT 
1
H-
13
C 
transfers with 
13
C-
13
C transfers using the P9
1
3 total through bond correlation spectroscopy 
(TOBSY) pulse sequence [161].  
Experimental details for each MAS ssNMR experiment performed are available in Table 
A.4. For all 1D experiments, two-pulse phase modulation 
1
H decoupling (typically at 83 kHz) 
was applied during acquisition, and for all 2D experiments the same 
1
H decoupling was applied 
during evolution and acquisition [227]. All spectra were acquired with Bruker Topspin, 
processed in NMRPipe [228], and analyzed with the CcpNmr Analysis program developed by 
the Collaborative Computation Project for the NMR community (CCPN). The chemical shifts of 
13
C and 
15
N were indirectly referenced to 4,4-dimethyl-4-silapentane-1-1 sulfonic acid and liquid 
ammonia based on external measurements of the 
13
C signals of adamantane [92, 229]. 
3.3 RESULTS 
3.3.1 Concentration of MBP-Q44-httEx1 affects width of mature fibrils 
We previously reported that fibrillation temperature affects the average width of mature Q44-
httEx1 fibrils [3]. ‘Thin’ fibrils (average 5 - 7 nm) are generated at 37 °C and ‘thicker’ fibrils 
(average 15 – 16 nm) are generated at 22 °C [3]. We performed experiments to probe in more 
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detail the parameters that affect this polymorphism. At increased MBP-Q44-httEx1 
concentrations, we observe the formation of even thicker fibrils (> 16 nm) at 37 °C. In order to 
verify this apparent concentration dependent effect on fibril polymorphism, we performed TEM 
on three Q44-httEx1 samples generated at 37 °C from 14.3, 28.6, and 98.9 M MBP-Q44-
httEx1. Thin fibrils are generated at 14.3 M (Figure 3.2, a) [3]. At 28.6 M, most fibrils are 
between 5 - 7 nm in width, however a small population of 14 - 17 nm fibrils are observed (Figure 
3.2, b). At 98.9 M MBP-Q44-httEx1, two predominant populations of Q44-httEx1 fibrils are 
observed with average widths of 5 - 7 and 21 - 23 nm (Figure 3.2, c). These data show that the 
width of Q44-httEx1 fibrils generated at 37 °C is concentration dependent, and the populations 
of thicker fibrils increases with the protein concentration. 
 
Figure 3.2. Dependence of Q44-httEx1 fibril width on the starting concentrations of MBP-Q44-httEx1 prior 
to cleavage by FXA at 37 °C 
Histogram of fibril widths observed from samples prepared at: (a) 14.3 M MBP-Q44-httEx1 and FP:P = 62.5, (b) 
28.6 M MBP-Q44-httEx1 and FP:P = 62.5, and (c) 98.9 M MBP-Q44-httEx1 and FP:P = 42.5.  
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3.3.2 Kinetics of Q44-httEx1 monomer release by Factor Xa protease 
One complication in the above experiment is that they involve aggregation of Q44-httEx1 
released from a fusion protein by proteolytic cleavage. As such, the concentration of Q44-httEx1 
is actually changing during the assay. Because MBP-Q44-httEx1 is not incorporated into the 
Q44-httEx1 fibrils [3], we hypothesized that the width of the Q44-httEx1 fibrils is not dependent 
on MBP-Q44-httEx1 concentration per se, but instead dependent on the concentration of free 
Q44-httEx1 monomer available during fibril formation. To address this, we first analyzed in 
detail the kinetics of monomer release from MBP-Q44-httEx1. To do so, we monitored the 
disappearance of the fusion protein and production of free MBP over time from SDS-PAGE gels. 
Monomer release rates were calculated using the Gel Analyzer tool in ImageJ [187]. The release 
rates of MBP-Q44-httEx1 by FXA show only negligible difference at 22 and 37 °C (Figure A.2, 
a).  
The molar ratio of the fusion protein (FP) to protease (P). When FP:P is 15,000:1 (FXA), 
no noticeable monomer release is detectable after 41 hours (Figure A.2, a). In contrast, moderate 
but incomplete release is detected when FP:P (FXA) is 1500:1 and 150:1, respectively, after 41 
hours (Figure A.2, a) [187]. At FP:P (FXA) of 1500:1 and 14.3 M MBP-Q44-httEx1, 
significant fibril formation is observed by TEM after 3 days. Interestingly, at this point the 
monomer release is only ~15% complete after 41 hours and the estimated released Q44-httEx1 
monomer concentration at this timepoint is 2.15 M.   
Decreasing the FP:P (FXA) to 2:1 results in >50% release within 5 minutes (Figure A.2, 
d, lane 2) and complete monomer release in less than 16.5 minutes (Figure A.2, c). At FP:P 
(FXA) to 5:1 and 10:1, incomplete release is observed at 15 minutes (Figure A.2, d) but 
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complete release is expected within 30 minutes. We note that at 14.3 M MBP-Q44-httEx1 and 
FP:P (FXA) of 5:1, the lag phase lasts for approximately 6 hours (Figure A.3, b). Therefore, the 
concentration of Q44-httEx1 monomer can reasonably reach 14.3 M early during the lag phase. 
Interestingly, the rate of monomer release also appears to be dependent on the length of the 
polyQ domain; release from MBP-Q20-httEx1 is significantly faster rate than release from MBP-
Q44-httEx1 (Figure A.2, e). 
3.3.3 The rate of Q44-httEx1 release from MBP-Q44-httEx1 affects sample heterogeneity 
After developing a better understanding of Q44-httEx1 monomer release kinetics, we performed 
a systematic analysis of the fibril morphology at several FP:P (FXA) values across a range of 
initial MBP-Q44-httEx1 concentrations. Histograms depicting the distribution of fibril widths 
observed for each sample are shown in Figure A.4. Trends derived from these histograms are 
presented in the scatterplot in Figure 3.3. The FP:P ratio and the concentration of MBP-Q44-
httEx1 both dramatically affect the microscopic morphology of the resulting mature Q44-httEx1 
fibrils.  
‘Thin’ fibrils (defined as having an average width <9 nm) form at 7.2- 28.6 M MBP-
Q44-httEx1 when FP:P is between 250:1 and 25:1 (quadrant III, blue circles). ‘Thick’ fibrils 
(defined as having an average width > 16 nm) are produced from 78.8 - 98.9 M MBP-Q44-
httEx1. Apparent branching is observed in Figure 3.4, a,b (additional examples are available in 
Figure A.5, a,b). A substantial population of thin fibrils is also observed in these samples. 
‘Intermediate’ fibrils (defined as having an average width between 9 and 16 nm) are observed at 
10.1 and 14.3 M MBP-Q44-httEx1 with FP:P of 510:1 and 1500:1, respectively (quadrant I, red 
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triangles). Interestingly, thin fibrils but not thick fibrils are produced at 98.9 M MBP-Q44-
httEx1 when FP:P is 847:1 (quadrant II).  
A notable feature of the thicker fibrils is that they show apparent branching (Figure 3.4, 
a,b, highlighted). Striations likely indicating individual filaments are often observed across the 
fibril axis of many of the thick fibrils, as indicated in an isolated and vertically aligned section of 
a thick fibril (Figure 3.4, d). These striations are confirmed by plotting the gray value across the 
fibril axis of the isolated section; three peaks are observed (Figure 3.4, e). Unlike the thick 
fibrils, the surface of both the thin and intermediate fibrils frequently appears fuzzy and this 
fuzziness may obstruct the visibility of individual filaments within these fibrils.  
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Figure 3.3. Classification of fibril polymorphs by average width in relation to the initial concentration of 
MBP-Q44-httEx1 and the Fusion Protein to Protease ratio 
Scatterplot of conditions used during fibril formation, comparing the effect of the concentration of MBP-Q44-httEx1 
vs the moles of MBP-Q44-httEx1 available per mole of FXA protease. Blue circles indicate conditions where a 
majority of the fibrils were found to be ‘thin’ by TEM, red diamonds indicate conditions where a majority of the 
fibrils were found to be ‘thick’, and yellow squares represent conditions where the mixture of ‘thin’ and ‘thick’ 
fibrils was considerably heterogeneous (see raw data in Figure A.4). Dashed lines are used for visual purposes only 
to divide the results into quadrants. 
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Figure 3.4. Fibril heterogeneity as observed by TEM 
(a,b) Thick fibril with apparent branching, with and without highlights. Scale bars are 100 nm(c) Fibril bundle, with 
band pass filter applied to the image to balance contrast. The original image is available in Figure A.5. Scale bar is 
100 nm. (d) Thick fibril with visible striations. (e) Striations from (d) are confirmed by plotting the average gray 
value vs the distance across the fibril axis. Scale bar in panels (d) and (e) are 10 nm. 
Large bundles of fibrils with frayed ends are observed in many of the samples, seemingly 
independent of MBP-Q44-httEx1 concentration and FP:P ratio (Figure 3.4, c). Fibril bundles 
appear extremely dark when imaged, so a Fourier transform band pass filter was applied to the 
image to balance contrast and deemphasize the density of the bundles while still allowing 
individual fibrils splayed from the bundles to be visible. The original image and an alternatively 
filtered image with enhanced contrast is available in Figure A.5, c. Fibrils of several lengths were 
observed, however long fibrils on the order of 1 m in length were primarily observed in bundles 
while most unbundled fibrils appeared to be on the order of 0.1 to 0.5 m.   
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3.3.4 Heterogeneity between and within Q44-httEx1 fibrils 
 
Figure 3.5. TEM images of Q44-httEx1 fibrils formed at 28.6 M MBP-Q44-httEx1 and Fusion Protein to 
Protease ratio of 62.5:1 
(a-c) Width length analysis of individual fibrils shows there is heterogeneity of fibril widths within the sample. (d) 
Fibril with varying width along the fiber axis.  
The Q44-httEx1 fibrils within a single sample demonstrate heterogeneity in fibril width, as 
shown in Figure 3.5. Although the majority of the fibrils observed in this sample are ‘thin’, 
fibrils with widths up to 30 nm were observed (Figure A.4). An accurate estimate of individual 
fibril widths from this sample can be achieved by isolating and vertically aligning individual 
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fibrils and plotting the average gray value across the Y axis of the image vs the image width 
(Figure 3.5, a-c). Low gray values indicate areas of the grid where stain is present. Two 
examples of thin fibrils with average widths of 8.3 and 5.9 nm are shown in Figure 3.5, a, and 
Figure 3.5, c. An intermediate fibril with a width of 16.8 nm is shown in Figure 3.5, b. In Figure 
3.5, d, we show an example of a fibril with varying width across the fibril axis; the center of the 
fibril is thicker than either end. We noted several instances of the width varying across the fibril 
axis under most sample conditions. The increase in width at either end appears in quantified 
steps, as opposed to a gradual change.  
3.3.5 Trypsin protease releases N15-Q44-httEx1 from MBP-Q44-httEx1 with high 
activity 
Prior work has proposed the existence of two competing aggregation mechanisms, driven either 
by the polyQ of the htt
NT
 domain [218-222]. Given that these competing mechanisms were 
concentration dependent, we considered the possibility that this plays a role in polymorphism. 
The htt
NT
 domain is known to accelerate the aggregation kinetics of Q44-httEx1, presumably by 
htt
NT
 driven oligomerization that forces an increased local concentration of expanded polyQ [91, 
106, 230]. We set out to study how eliminating the htt
NT
 domain would affect fibril 
polymorphism.  
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Figure 3.6. Trypsin protease cleavage of MBP-Q44-httEx1. 
(a) MBP-Q44-httEx1 is cleaved at R[-1] into free MBP and Q44-httEx1. (b) The htt exon1 monomer is subsequently 
cleaved into N6-Q44-httEx1 and N9-Q44-httEx1 at K399 and K402, respectively. N6-Q44-httEx1 and N9-
Q44-httEx1 are cleaved at K408 to form N15-Q44-httEx1. (c,d) ESI-TOF mass spectra of 1 M MBP-Q44-httEx1 
(56685.5 Da) cleavage via 1 M FXA (c) or 1 M trypsin (d), at 30 sec, 1 min, 5 min, and 6 hours. In (c), MBP-
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Q44-httEx1 is observed at 30 sec, 1 min, and 5 min but is not observed at 6 hours, and free MBP (42883.1 Da) is 
observed at 5 min. In (d), release of free MBP from MBP-Q44-httEx1 is complete by 5 min and there is noticeable 
release of free MBP detected within the first 30 sec. (e) Zoomed in mass spectra of (d) between 12000 and 14000 
m/z. Q44-httEx1 and N9-Q44-httEx1 are observed after 30 sec trypsin cleavage. By 5 min, Q44-httEx1 is no longer 
detectable, and N15-Q44-httEx1 is observed. By 6 hours, only N15-Q44-httEx1 is observed. (f) Cleavage of 10 
M MBP-Q44-httEx1 with 10 M trypsin protease: MBP-Q44-httEx1 to trypsin molar ratio of 1:1. (g) Cleavage of 
10 M MBP-Q44-httEx1 with 0.16 M trypsin protease: MBP-Q44-httEx1 to trypsin molar ratio of 625:10. Full 
gels for (f) and (g) are available in Figure A.1. 
To do so, we considered the use of trypsin cleavage sites near the htt
NT
/polyQ boundary. 
To develop a better understanding of the trypsin cleavage protease we investigated the cleavage 
kinetics and the cleavage products. In Figure 3.6, the trypsin cleavage is examined by SDS-
PAGE and ESI-TOF MS. The MBP-Q44-httEx1 fusion protein is mostly depleted after 30 
seconds and is no longer observed at 5 minutes. Free MBP and Q44-httEx1 (13819.7 Da) are 
initially observed at 30 seconds in Figure 3.6, e, but soon the Q44-httEx1 peak decreases. At 5 
minutes, Q44-httEx1 is no longer observed and N15-Q44-httEx1 is instead observed at 12096.9 
Da, which becomes the dominant species at the 6 hour time point. Additional data and more 
detailed analysis is in section A.1 and Figure A.1. No additional Q44-httEx1 products are 
observed, however a total of five MBP cleavage products are observed by SDS-PAGE (Figure 
A.1, e) and ESI-TOF (Figure A.2). An in-depth analysis of these cleavage products is available 
in section A.2. 
Altogether, our data reveal that trypsin preferably cleaves MBP-Q44-httEx1 at residue 
R[-1] (the last residue in the fusion protein prior to Q44-httEx1) to release Q44-httEx1 (Figure 
3.6, a), but it then sequentially and efficiently cleaves Q44-httEx1 from the htt
NT
 N-terminus to 
C-terminus at K6, K9, and K15 (Figure 3.6, b). Thus, under these conditions, trypsin cleavage 
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allows us to rapidly generate N15-Q44-httEx1, which is expected to be unable to assemble via 
the htt
NT
 pathway.  
3.3.6 Aggregates of N15-Q44-httEx1 fibrils  
We removed the first 15 amino acids of the 17 residue htt
NT
 domain with trypsin and monitored 
amyloid formation with Thioflavin T (ThT) in the presence and absence of Q44-httEx1 seeds 
that were originally generated by FXA proteolysis [3, 63]. We observed that that the ThT 
fluorescence is ~2.5x lower when FXA protease is utilized for this seeding assay in place of 
trypsin (Figure A.3, a) and seeding behavior is retained (Figure A.3, b). This suggests a structural 
change upon the removal of the htt
NT
 domain that allows the ThT dye to more readily bind to the 
rigid polyQ amyloid core.  
TEM images of the resulting N15-Q44-httEx1 fibrils demonstrate that the majority of 
fibrils have widths between 8-15 nm and an average width is 11.6 nm (Figure 3.7, b). There is a 
small population of fibrils with a width exceeding 15 nm. The width of the N15-Q44-httEx1 
fibrils also varies along the fiber axis in some fibrils, however at much lower frequency than 
observed for Q44-httEx1. Both isolated fibrils and bundled fibrils with frayed ends are observed. 
Fibrils associated with bundles are approximately 1 m in length, similar to what was observed 
for Q44-httEx1 fibrils. Fibrils that are not associated with bundles are shorter, on the order of 0.1 
m in length. Striations were visible in a small number of fibrils; however, it is difficult to say 
whether these striations are indicative of multiple filaments interacting within one fibril (Figure 
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3.7, e). Apparent branching is not observed, potentially highlighting the role for the htt
NT
 domain 
in the process. 
 
Figure 3.7. TEM of [U-
13
C-
15
N] N15-Q44-httEx1 fibrils  
(a) MBP-Q44-httEx1 releases free MBP and N15-Q44-httEx1 upon cleavage by trypsin protease. (b) Distribution 
of widths measured for [U-
13
C-
15
N] N15-Q44-httEx1 fibrils. The average width measurement was between 11-12 
nm, however there was a wide distribution of widths observed. (c-e) Width length analysis (right) of individual 
fibers (left) reveals heterogeneity in widths between fibrils. The analysis in (e) was done on the straightened inset. 
3.3.7 Comparison between Q44-httEx1 and N15-Q44-httEx1 fibrils using MAS ssNMR 
Next, we used MAS ssNMR to probe the structure and dynamics of these amyloid fibrils. 1D 
13
C 
cross-polarization (CP) experiments were used to compare the rigid residues of Q44-httEx1 and 
N15-Q44-httEx1 fibrils, both aggregated at 22 °C (Figure 3.8, a). The spectra area very similar, 
however more peaks are visible in the spectrum of Q44-httEx1. Missing peaks previously 
attributed to htt
NT
 are consistent with the removal of the first 15 residues of the 17 amino acid 
htt
NT
 in the N15-Q44-httEx1 fibrils. The aliphatic peaks (between 10 - 80 ppm) that are present 
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in both samples overlap in their chemical shifts. The most intense peaks in this region also 
appear with similar intensities in the two samples.  
To get a better understanding of what peaks are missing in the N15-Q44-httEx1 
spectrum, the N15-Q44-httEx1 CP spectrum was subtracted from the Q44-httEx1 spectrum 
(Figure 3.8, a, overlay in green). When normalized to the signals in the Q44-httEx1 spectrum and 
compared directly to the CP spectra of both fibril types, key differences are observed. There is a 
noticeable difference observed in the carbonyl/carboxyl region (between 165 and 190 ppm), 
primarily a result of the htt
NT
 truncation. A small positive shoulder associated with the carbonyl 
chemical shift for residue A2 is marked in the subtraction spectrum, indicating that A2 is absent 
in N15-Q44-httEx1 (Figure 3.8, b) [1, 3]. It is difficult to assign the remaining peaks in this 
region due to signal overlap. More insight can be interpreted from the aliphatic region of the 
subtraction spectrum. Residue types A2, E5, K6, and A10 are marked as positive peaks. A broad 
positive peak can also be assigned to the typical C chemical shift, indicative of a loss of C 
nuclei from the htt
NT
 domain in the N15-Q44-httEx1 sample. A negative peak is assigned to 
Pro residues. 
Solution-like experiments based on the INEPT scheme were used to identify flexible 
residues (Figure 3.8, c). INEPT experiments capture signals from residues within the aggregates 
with similar mobility to soluble protein. Like the CP spectra, the peaks that appear in the 
aliphatic region of both INEPT spectra overlap in their chemical shift and peak intensities of 
these peaks are relatively similar. Intensity for the Pro residues do not differ significantly. We 
note a decrease in intensity in the peaks in the aromatic region of the spectra (80 - 165 ppm). 
Peaks in this region can only be assigned to two Phe residues, both of which are present in the 
htt
NT
 domain, and His residues primarily present in the His-tag. 
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Figure 3.8. Comparison of N15-Q44-httEx1 and Q44-httEx1 by Magic Angle Spinning solid state NMR 
(a) Top, left: 1D cross polarization spectrum of Q44-httEx1 [3] and (bottom, left) N15-Q44-httEx1, and (right) 
their comparison to the subtraction between N15-Q44-httEx1 and Q44-httEx1, normalized to the peak intensities 
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of the CP spectrum for Q44-httEx1. (b) Subtraction N15-Q44-httEx1 and Q44-httEx1, zoomed in on the carbonyl 
(left) and aliphatic (right) regions. (c) From top to bottom: 
13
C INEPT of Q44-httEx1, N15-Q44-httEx1, and 
overlaid. (d) DARR spectrum of Q44-httEx1 [3] and (e) N15-Q44-httEx1. (f) 13C-13C INEPT-TOBSY spectrum of 
‘thick’ Q44-httEx1 fibrils formed at 22 °C [3]. (g) 13C-13C INEPT-TOBSY of N15-Q44-httEx1. The spectra of Q44-
httEx1 in panels (a), (d), and (f) are reprinted with permission from Lin, H. K., Boatz, J. C., Krabbendam, I. E., 
Kodali, R., Hou, Z., Wetzel, R., Dolga, A. M., Poirier, M. A., van der Wel, P. C. A. Fibril polymorphism affects 
immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core, Nature 
Communications 8:15462. Copyright (2017) Lin, H. K., et. al. [3] 
More insight into structural differences between the N15-Q44-httEx1 and Q44-httEx1 
fibrils can be gained with two dimensional spectra, e.g. the 
13
C-
13
C dipolar assisted rotational 
resonance (DARR) spectra. For Q44-httEx1 (Figure 3.8, d), several peaks are assigned to the 
htt
NT
 domain [1, 3]. A large glutamine signal is observed that corresponds with the chemical 
shifts of glutamine types ‘a’, ‘b’, and ‘c’ [1, 3]. Several peaks are assigned to an -helical httNT 
[1, 3, 210]. The most prominent cross peaks attributed to the PRD in the 
13
C-
13
C CP-DARR 
spectrum of Q44-httEx1 are attributed to a PPII helix structure, with additional signals from a 
random coil structure (ProRC) [1, 3, 210].  
The 2D 
13
C-
13
C DARR spectrum of N15-Q44-httEx1 (Figure 3.8, e) overwhelmingly 
consists of Gln and Pro cross-peaks; several cross-peaks assigned in the Q44-httEx1 DARR 
spectrum are absent in the DARR spectrum of N15-Q44-httEx1. Notably, httNT signals are 
missing. Additionally, peaks representing an alanine residue with a random coil secondary 
structure (ARC) in addition to two peaks representing V103 are absent. Both these residues are 
within the random coil region of the PRD in Q44-httEx1. Interestingly, the intensity of the peaks 
representing proline residues with a PPII secondary structure (ProPPII) is decreased for N15-
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Q44-httEx1 in the 
13
C-
13
C DARR. Peaks representing proline residues with a random coil 
secondary structure (ProRC) are missing completely. However, ProRC peaks do occur in a proton 
driven spin diffusion (PDSD) experiment with 250 ms of 
13
C-
13
C mixing (Figure A.6). PDSD 
experiments are extremely similar to DARR experiments, however subtle differences between 
PDSD and DARR spectra are common. The PDSD experiment shown in Figure A.6, optimized 
to observe long-range intermolecular contacts shows no differences compared to Q44-httEx1 [1, 
3]. Thus, the immobilized core of the polyQ and PRD is largely unchanged in structure. 
However, some indications of dynamic changes are observed. As expected, signals assigned to 
the htt
NT
 are missing. 
2D 
13
C-
13
C INEPT-based total through bond correlation spectroscopy (TOBSY) spectra 
were also obtained to aid in residue assignments. There are more peaks observed in the 2D 
TOBSY spectrum of Q44-httEx1 (Figure 3.8, f) than in N15-Q44-httEx1 (Figure 3.8, g) [3]. 
The missing peaks are consistent with residues found in the htt
NT
 domain. Peaks assigned as Arg 
residues that cannot be assigned to the htt
NT
 are also missing in the N15-Q44-httEx1 2D spectra 
when compared to the Q44-httEx1 spectra. We note that one small signal is observed in the 
TOBSY spectrum of N15-Q44-httEx1 that we previously assigned to M1 for Q44-httEx1 [3]. 
This is likely the result of a slight incomplete trypsin cleavage, or an indication that this nuclei 
was incorrectly assigned previously [3].  
3.3.8 Dynamics of the PRD of N15-Q44-httEx1 fibrils 
Previously, we noted dynamic differences in the immobilized core of Q44-httEx1 polymorphs, 
detected by CP-based experiments [3]. We performed an analogous series of PDSD experiments 
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with variable mixing times from 0 - 500 ms in order to compare N15-Q44-httEx1 to Q44-
httEx1 [3]. Polarization transfer between directly bonded C-C carbons is rapid in a rigid 
lattice, with maximum polarization transfer (10 - 20%) reached within 10 - 20 ms [3].  
As before, such a fast buildup curve is observed for C-C glutamine peaks within the 
amyloid core of Q44-httEx1 fibrils [3]. This indicates that the core of the fibrils experiences 
crystal-like rigidity. However, the one-bond polarization buildup curves for PPII and ProRC 
residues in the PRD of N15-Q44-httEx1 experience a  much slower buildup and lower peak 
maximum, indicating that the PRD experiences less rigidity (Figure A.7, c) [3]. A more dramatic 
difference was observed for two-bond C-C polarization transfers, signifying that the ProRC 
residues experience more dynamics than those with a PPII structure. The buildup curves 
measured for the PRD of the N15-Q44-httEx1 are available in Figure A.7, b. The polarization 
buildup profile of ProRC has a lower peak maximum than what was observed for Q44-httEx1. 
The PPII residues also appear to have a lower peak maximum, but this effect is much less 
pronounced. Additionally, peaks representing V103 and an Ala residue in the PRD are missing in 
the DARR spectrum. Peaks with low intensity associated with AlaRC are observed in the PDSD 
spectrum, however peaks associated with V103 do not. Combined, these MAS ssNMR results 
show that the PRD is more dynamic in N15-Q44-httEx1 than in Q44-httEx1.  
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3.4 DISCUSSION 
3.4.1 Threshold concentration of Q44-httEx1 monomer necessary to induce the 
production of thick Q44-httEx1 fibrils 
We found that the concentration of MBP-Q44-httEx1 and FP:P (FXA) ratio are both important 
for controlling the production of specific Q44-httEx1 polymorphs at 37 °C. We interpret this to 
reflect a dependence on the concentration of free Q44-httEx1 monomers in the reaction mixture. 
A threshold concentration of free Q44-httEx1 monomer is necessary to induce the formation of 
thick fibrils, rather than the thinner fibrils.  
3.4.2 Comparison of N15-Q44-httEx1 and Q44-httEx1 fibrils 
Trypsin was found to significantly improve the cleavage rate of MBP-Q44-httEx1, allowing for 
near immediate release of N15-Q44-httEx1 monomers. As expected, aggregation proceeded at 
a slower rate than observed in Q44-httEx1. Additionally, improved ThT fluorescence indicates a 
likely structural change between N15-Q44-httEx1 and Q44-httEx1 fibrils. Trypsin cleavage of 
MBP-Q44-httEx1 results in the release of N15-Q44-httEx1 monomers that contain only two 
residues from the htt
NT
 domain. We consider these residues insufficient for multimer formation 
to be driven by the htt
NT
 domain and we expect polyQ driven multimer formation to prevail. 
The N15-Q44-httEx1 fibrils were found to have an average width of 11.6 nm, unlike 
any of the fibril types observed for Q44-httEx1 polymorphs generated at 37 °C, and some thick 
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fibrils (17 - 20 nm) are also observed. Isolated fibrils were on average several times shorter in 
length when compared to isolated Q44-httEx1 fibrils. The N15-Q44-httEx1 fibrils were also 
observed to vary in width across the length of the fibril, display visible striations, and form 
bundles with frayed ends. However, the N15-Q44-httEx1 fibrils were not observed to form 
branches. The population of thicker fibrils and fibrils with striations indicates that the N15-
Q44-httEx1 fibrils can be composed of multiple filaments. Because the htt
NT
 domain is missing, 
free monomers are expected to interact with each only other through the polyQ domain, leading 
to a symmetric distribution of PRD domains across the length of mature fibrils, which in turn 
discourages branching sites. Secondary nucleation events can also only occur between the PRDs 
of preformed filaments and free monomers. The propensity for fibrils to form secondary 
nucleation sites does not appear to be disrupted upon removal of the htt
NT
 domain; this is 
consistent with our prior findings that filaments interact through the PRDs [3]. 
The PRD domains within the N15-Q44-httEx1 fibrils experience similar rigidity to what 
we previously reported in Q44-httEx1 fibrils formed at 22 °C [3]. These 22 °C Q44-httEx1 
fibrils are predicted to be composed of two filaments each interacting through the PRD [3]. 
Accordingly, we interpret that the majority of the fibrils in the N15-Q44-httEx1 sample are 
composed of filaments interacting through the PRD. If there was only one filament in the N15-
Q44-httEx1 fibrils, the PRD would experience high dynamics similar to the thin 37°C Q44-
httEx1 fibrils and would not mimic the dynamics we observe in the 22 °C Q44-httEx1 fibrils. 
The average width of N15-Q44-httEx1 fibrils is approximately 4 nm less than the average 
width of the 22 °C Q44-httEx1 fibrils, likely as a result of the removal of the htt
NT
 domain. 
Strikingly similar peak patterns in the CP-DARR and INEPT-TOBSY spectra indicate 
that atomic level structure of the polyQ and PRD within N15-Q44-httEx1 and Q44-httEx1 
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fibrils is the same. The most notable difference observed by MAS ssNMR between the N15-
Q44-httEx1 and 22 °C Q44-httEx1 samples is in the random coil region of PRD. Particularly, the 
ProRC residues are not present in the DARR spectrum of N15-Q44-httEx1 under the same 
conditions they are present in the DARR spectrum of Q44-httEx1 that was aggregated at 22 °C. 
These residues appear in PDSD spectrum at longer mixing time, indicating that the ProRC 
residues are less rigid in the N15-Q44-httEx1 sample. PDSD-derived polarization transfer 
curves support the idea that the random coil region of the PRD is more dynamic in the N15-
Q44-httEx1 fibrils, however the PPII helices experience similar dynamics between samples. 
Altogether, the MAS ssNMR results suggest that the N15-Q44-httEx1 fibrils are very similar in 
structure and dynamics to the 22 °C Q44-httEx1 fibrils which we previously reported, with the 
most significant difference noted in the random coil region of the PRD [3].  
3.4.3 The effect of monomer polymorphism on fibril polymorphism 
Misfolded monomers of Q44-httEx1 may adopt a variety of structures. Prior literature describes 
both extended both native-like (Figure 3.9, b, left) [231] and tadpole-like (Figure 3.9, c, left) 
[232] compact monomers. Native-like monomers are thought to interact through the htt
NT
 
domains (Figure 3.9, b, right) [233], while tadpole-shaped monomers are expected to interact 
through the polyQ domain (Figure 3.9, c, right) [232]. We expect these monomer polymorphs to 
vary in their stability and propensities to form multimeric intermediates. We predict native-like 
monomers are stable at low monomer concentrations and tadpole-like monomers are transient; at 
higher concentrations, tadpole-like monomers are expected to be stabilized through 
intermolecular interactions [232]. We propose that the polyQ driven formation of multimers 
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leads to the formation of fibrils with an extremely symmetric distribution of flanking domains 
along the fiber axis (Figure A.8, a, left), and that htt
NT
 driven formation of multimers leads to an 
extremely asymmetric distribution (Figure A.8, b, left).  
3.4.4 Fibril polymorphism may be explained by secondary nucleation events on the fibril 
surface 
Fibril surfaces can act as seeds to promote the conversion of monomers to nuclei through 
secondary nucleation events [8]. As long as monomers are continuously introduced into the 
system, secondary nucleation events are expected to be frequent once fibrillation begins. We 
interpret the fuzziness of the thin and intermediate Q44-httEx1 fibrils observed by TEM to be 
indicative of several secondary nucleation surface events followed by the growth of short 
protofilaments (Figure 3.9, d, left, and Figure A.8, a,b, left). Apparent fibril widening occurs at 
high fusion protein concentrations and low FP:P ratios where the rate of monomer release is 
high. This leads to an increased monomer concentration that we expect to promote the elongation 
of the nucleated protofilaments into mature filaments that remain associated with the fibril 
originally used as a nucleation site (Figure 3.9, d, center and Figure A.8, a,b, center). This results 
in fibrils made up of multiple interacting filaments from a mechanism that is fundamentally 
different than preformed filaments coming together to form a thicker fibril. 
If the distribution of flanking domains on the nucleating filament is extremely symmetric, 
and tadpole shaped Q44-httEx1 monomers are predominant in solution, then we expect the 
elongation of the nucleated filament to be uninhibited by steric hindrance from the flanking 
domains (Figure A.8, a, center). Nucleation with elongation is also possible when the distribution 
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of flanking domains is extremely asymmetric and the predominant Q44-httEx1 monomer type is 
native-like. However, steric hindrance is likely to inhibit elongation of protofilaments nucleated 
from asymmetric filaments after the addition of just a few monomers (Figure A.8, a,c). A 
mixture of both native-like and tadpole-like monomers likely contributes to the formation of 
fibrils, leading to a semi-random distribution of flanking domains over the length of a filament 
(Figure 3.9). 
 
Figure 3.9. Hypothetical models of Q44-httEx1 fibril growth 
(a) Cartoon of wild type httEx1 and its individual domains: htt
NT
 (yellow), polyQ (blue), and PRD (green). (b) 
Clustering of native-like Q44-httEx1 monomers via the htt
NT
 domains [233]. (c) Clustering of ‘tadpole-like’ Q44-
httEx1 monomers via the polyQ domains [232]. 
Apparent fibril widening is expected when the concentration of Q44-httEx1 is high. This 
idea is supported by the fact that three filaments appear to be present in the thick fibrils, as 
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indicated by the observation of striations by TEM. We note that the appearance of striations 
often “disappeared” when moving across the fiber axis and we interpret this to mean that 
filaments are very tightly interacting in these regions and less tightly interacting in the regions 
where striations are observed (Figure 3.9, d, right). The strength of the interactions between the 
filaments is dictated by the distribution of flanking domains over the length of the filament. 
Clusters where the flanking domains are extremely symmetric should promote filament-filament 
interactions, whereas asymmetric clusters inhibit the interactions. This idea supports the 
observation that the width of individual fibrils was often observed to vary across the length of the 
fibril. Secondary nucleation events can explain also the apparent fibril branching that was 
observed in the thick fibrils; we propose that branch points occur in locations on the nucleating 
fibril that contain an asymmetric cluster of flanking domains. We note that fibril branching has 
been reported for httEx1 fibrils previously [234].  
The model explained above does not account for the apparent contradictory observation 
that fibrils with an intermediate width are preferentially formed at low MBP-Q44-httEx1 
concentrations and high FP:P ratios. We would expect under this condition that thin fibrils 
composed of one filament each would be favored. Instead, the intermediate fibrils appear 
strikingly similar to the fibrils we previously reported that are formed at 22 °C, which we 
determined were likely to be composed of two filaments each [3]. The presence of MBP-Q44-
httEx1 may also influence the distribution of native-like and tadpole-like monomer structures, 
which can in turn affect the propensity for secondary nucleation events to occur on fibril 
surfaces. As MBP is shown not to interact with httEx1, the interactions between Q44-httEx1 and 
MBP-Q44-httEx1 are not expected to involve the polyQ domain instead of the MBP solubility 
tag [235]. The propensity for httEx1 monomer to interact with the MBP-Q44-httEx1 surface may 
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also be temperature dependent, which could explain the intermediate fibril morphology we 
observe in fibrils formed at 22 °C. 
3.4.5 Conclusion 
Together, our results indicate that polymorphism is driven not only by temperature, but also by 
the concentration of monomer in solution. The htt
NT
 domain does not appear to largely affect 
polymorphism and is not necessary for secondary nucleation events, however the htt
NT
 domain 
does appear to be important for initiating fibril branching. Overall, these results are important 
because they provide a better understanding of fibril polymorphism and yield some insight into 
the mechanisms that dictate fibril formation at low concentrations, as may exist in vivo. Amyloid 
fibril formation is expected to undergo complicated kinetics under conditions that mimic 
physiological sample mixtures, which can contain monomers, several intermediate species, 
intermediates, off-pathway aggregates, amyloid fibrils, and fibril fragments. These species may 
further modulate the kinetics of amyloid formation and the morphology and properties of the 
formed aggregates. This is an important topic that warrants further investigation. 
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4.0 CATARACT-ASSOCIATED P23T -D-CRYSTALLIN RETAINS A NATIVE-
LIKE FOLD IN AMORPHOUS-LOOKING AGGREGATES FORMED AT 
PHYSIOLOGICAL PH 
Adapted and reprinted from: Boatz, J.C., Whitley M.J., Li M, Gronenborn A.M., 
and van der Wel, P.C.A. Cataract-associated P23T D-crystallin retains a native-
like fold in amorphous-looking aggregates formed at physiological pH, Nature 
Communications 8, 15137. Copyright (2017) Boatz, J. C., et. al. under Creative 
Commons Attribution 4.0 International License. 
 
Data availability: The ssNMR chemical shifts of P23T hD aggregated at pH 7 that were 
assigned are available in Table B.2, and have been submitted to the BMRB.  
 
I prepared samples and performed all transmission electron microscopy, X-ray 
diffraction, thioflavin T, and aggregation experiments. I also conducted the magic 
angle spinning solid state NMR experiments with Dr. Patrick C. A. van der Wel. I 
directly contributed data that presented in Figure 4.2, Figure 4.3, Figure 4.4, 
Figure 4.5, Figure 4.6, Figure 4.7, Figure 4.8, Figure 4.9, and Figure 4.10, and I 
prepared Figure 4.1, Figure 4.2, Figure 4.3, Figure 4.4, Figure 4.5, Figure 4.6, 
Figure 4.7, and Figure 4.8. I designed the transmission electron microscopy and 
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X-ray diffraction experiments performed on the samples prepared at pH 7, all 
experiments performed on the samples prepared at pH 3, and all thioflavin T 
experiments. 
 
Cataracts cause vision loss through the large-scale aggregation of eye lens proteins as a result of 
aging or congenital mutations. The development of new treatments is hindered by uncertainty 
about the nature of the aggregates and their mechanism of formation. We describe the structure 
and morphology of aggregates formed by the P23T human D-crystallin mutant associated with 
congenital cataracts. At physiological pH, the protein forms aggregates that look amorphous and 
disordered by electron microscopy, reminiscent of the reported formation of amorphous deposits 
by other crystallin mutants. Surprisingly, solid-state NMR reveals that these amorphous deposits 
have a high degree of structural homogeneity at the atomic level and that the aggregated protein 
retains a native-like conformation, with no evidence for large-scale misfolding. Non-
physiological destabilizing conditions used in many in vitro aggregation studies are shown to 
yield qualitatively different, highly misfolded amyloid-like fibrils. 
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4.1 INTRODUCTION 
Cataract formation is the leading cause of blindness, and age-related and congenital cataracts 
affect close to 100 million people across the globe [108]. The underlying cause of eye lens 
opacification is the formation of protein aggregates [107]. As such it is but one example of a 
broad family of protein-aggregation-related diseases, in which normally-soluble proteins end up 
as insoluble protein deposits in affected organs [236]. Current treatments of protein aggregation 
diseases (including cataracts) are limited to the invasive removal of affected tissue or treatment 
of symptoms, rather than a reversal, prevention or inhibition of the underlying aggregation 
process. A limiting factor in efforts to achieve the latter is our poor understanding of the 
molecular mechanism by which the protein aggregation occurs. 
The -, -, and -crystallins, which constitute 90% of the total eye lens protein mass, are 
found in cataract-associated protein deposits. The -crystallins are small heat shock proteins that 
perform protein quality control and counteract protein aggregation, misfolding, and cataract 
formation [118, 237]. The - and -crystallins are thought to be responsible for generating and 
maintaining the proper refractive index of the eye lens [238]. To do so, the -crystallins are 
present at concentrations of 400 mg/mL in healthy lenses. Cataract formation occurs when the 
high solubility of -crystallins is compromised as a result of changes induced by mutations or 
chemical damage that accumulates with aging [107, 108]. However, it has proved difficult to 
relate specific mutations and structural changes to a molecular mechanism of cataract-associated 
protein aggregation [65-67, 69-71, 239]. X-ray crystallographic and solution NMR studies have 
yielded atomic structures for many of the structurally related -crystallins, including both wild-
type (WT) proteins and proteins with either disease-associated mutations or mutations 
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mimicking aging-induced damage [24, 121, 130, 240, 241]. Figure 4.1 shows the structure of the 
P23T mutant of human D-crystallin (hD), with the Greek key motifs that characterize the 
native fold of the -crystallins [24, 241]. As examined in detail in prior work [24, 69, 130, 242, 
243], this mutant protein is structurally very similar to the WT protein. This is reflected in a 
backbone RMSDs of 0.4 and 0.5 Å for the N-terminal (NTD; cyan) and C-terminal domains 
(CTD; pink), respectively (comparing the X-ray structures), or solution NMR per-residue 
chemical shift differences () of less than 0.2 ppm (except for the 0.4 ppm  for the residue 
after the P23T mutation) [24, 241]. Nonetheless, the mutant protein has lost the remarkable 
solubility of WT hD and is associated with autosomal dominant congenital cataracts that form 
early in a child’s development, affecting families across the globe [24, 69, 116, 130, 242, 243]. 
 
Figure 4.1. Structure of P23T hD 
(a) Primary sequence and (b) solution NMR structure [24]. The mutation site is underlined and highlighted dark 
blue. The NTD (cyan) and CTD (pink) make up two independently folded symmetric domains, separated by a short 
linker (black). (c) Schematic of the -sheet-based Greek key motifs present in each domain.  
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Based on in vitro studies, two prominent mechanisms have been put forward to explain 
the aggregation propensity of mutated or modified crystallins associated with cataract formation. 
These either focus on misfolding-induced aggregation, in analogy to the amyloid formation 
associated with neurodegenerative diseases [236, 239], or suggest that crystallin solubility is lost 
in absence of extensive misfolding [65-67, 69-71]. Depending on the aggregation mechanism, 
mutated or damaged -crystallins are predicted to yield protein aggregates with distinct 
molecular structures. As a result, there is much interest in the structure of aggregated -
crystallins. However, no atomic resolution structural data are currently available for any such 
aggregate, due to the fact that they are not suitable for solution NMR or X-ray crystallographic 
study. A further complicating factor is that even the reported morphology of the aggregates 
varies, a situation similar to the aggregate polymorphism commonly observed among 
amyloidogenic proteins [244-247]. Two distinct types of crystallin aggregates are widely 
reported in vitro, which are generally categorized as either ‘amorphous’ or ‘fibrillar’ [248-252]. 
This exact nomenclature reflecting two distinct types of protein aggregates is also reported for 
other aggregation-prone proteins [244-247]. Thus, this appears to be a more general phenomenon 
not constrained to cataract-related protein aggregation. Amorphous aggregates are often assumed 
to be disordered or poorly structured, while the amyloid-like fibrils are typically described as 
more ordered [248, 249]. It is worth noting that the nm-scale morphology of cataract-associated 
protein aggregates formed in vivo is also under debate, although the balance of evidence 
disfavors a large role for amyloid-like fibrils [107, 253, 254]. Previously reported arguments in 
favor of amyloid formation in vivo are largely based on the ability of mouse model cataracts to 
bind amyloid-binding dyes [253]. However, such dyes are not a foolproof measure of amyloid 
structure as both false positives and false negatives occur [46, 255]. This is borne out by studies 
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that show dye binding by both non-cataract eye lenses and -crystallins in a non-amyloid state 
[249, 255, 256]. 
To gain insight into the structural features of congenital-cataract-related protein 
aggregates we here investigate these aggregates by magic-angle-spinning (MAS) solid-state 
NMR (ssNMR) spectroscopy and complementary techniques. MAS ssNMR has emerged as the 
tool of choice for atomic-resolution studies of non-crystalline protein aggregates [1, 257, 258]. In 
particular, we study distinct aggregated states of the abovementioned P23T hD that is associated 
with congenital cataracts (Figure 4.1). This mutant protein forms both worm-like fibrils and 
amorphous-looking aggregates, depending on the experimental conditions. We observe that the 
former is generated at low pH and display all the characteristics of highly misfolded amyloid-like 
fibrils. The amorphous-looking aggregates form at physiological pH and lack all of the amyloid 
hallmarks. Despite their appearance, these aggregates are shown by ssNMR to contain the 
aggregated protein in a well-ordered native-like conformation, with no evidence of dynamic or 
static disorder.  
4.2 METHODS 
4.2.1 Expression and purification of P23T hD 
The mutant P23T hD gene (CRYGD) was cloned into a pET14b vector as described previously 
[24]. Transformed One Shot Escherichia coli BL21star (DE3) cells were grown in LB broth or 
M9 minimal media at 37 °C to an OD600 of 0.6, induced with 1 mM IPTG, and allowed to 
 96 
overexpress at 37 °C for four hours. Isotopically labeled protein was obtained by growing cells 
in modified M9 minimal medium containing 2 g/L U-
13
C-D-glucose and 1 g/L 
15
N-ammonium 
chloride (Cambridge Isotope Laboratories, Tewksbury, MA). Cell pellets were resuspended in 
QA buffer (50 mM Tris at pH 8.2, 1 mM EDTA, 1 mM dithiothreitol (DTT), and lysed via 
microfluidization (Microfluidics, Newton, MA). Nucleic acids were removed from the cell lysate 
by precipitation with 1% (w/v) polyethyleneimine, and cell debris was removed by 
centrifugation at 39,000 g for 20 minutes (Sorvall RC 3C Plus, H-6000A rotor). The protein was 
purified essentially as described previously [24, 241]. Briefly, clarified cell lysate was loaded 
onto a pre-equilibrated HiTrap Q XL anion exchange column (GE Healthcare) in QA buffer, and 
the flow-through fraction was collected and dialyzed overnight at 4 °C into SA buffer (10 mM 
MES at pH 6.0, 1 mM EDTA, 1 mM DTT, 2% v/v glycerol). Precipitates were removed from the 
dialyzed flow-through by centrifugation at 39,000 g for 20 minutes. The supernatant was loaded 
onto a pre-equilibrated HiTrap SP cation exchange column (GE Healthcare) in SA buffer and 
eluted using a linear gradient of 0 to 1 M NaCl. Fractions containing P23T hD were collected 
and further purified by gel filtration on a Superdex 75 26/60 column (GE Healthcare) in 100 mM 
sodium phosphate buffer (pH 7), containing 5 mM DTT and 0.02% (wt/vol) NaN3. The 
concentration of the final purified protein was determined with a NanoDrop 1000 
spectrophotometer (Thermo Scientific) using an A280 molar extinction coefficient of 42.86 mM
-1
 
cm
-1
. 
 97 
4.2.2 Preparation of P23T hD aggregates 
To prepare aggregates under acidic conditions, 10% and then 1% (w/w) HCl was added drop-
wise to 1.28 mg/mL (62 μM) solutions of P23T hD on ice, until the pH reached 3.0 [85]. The 
sample was immediately vortexed after the addition of each HCl droplet to insure proper mixing 
and also to avoid any local areas of low pH within the sample. After adjusting the pH to 3.0, the 
protein was allowed to aggregate overnight or longer, at 37 °C. To prepare aggregates under 
neutral conditions (pH 7), P23T hD was concentrated to > 10 mg/mL (0.49 mM) over four 10-
min and one 5-min steps using 3 kDa Centriprep centrifugal filters spinning at 3,200 g 
(Eppendorf 5810 R, A-4-81) at 4 °C in 100 mM sodium phosphate buffer (pH 7) containing 5 
mM DTT and 0.02% (wt/vol) NaN3. The protein concentration was measured occasionally using 
UV absorbance until the sample appeared cloudy by eye (Figure 4.2) or reached the desired 
concentration. Subsequently, the protein was allowed to aggregate overnight at 37°C [243]. [U-
13
C-
15
N]-labeled P23T hD aggregates were formed using the same conditions and 
concentrations (in mg/mL) used to form the unlabeled aggregates. 
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Figure 4.2. P23T hD aggregation 
(a) Appearance of P23T hD aggregates. Left: 1.3 mg/mL suspension of fibrils formed at pH 3. Right: 9.2 mg/mL 
suspension of aggregates formed at pH 7. (b) Concentration-dependent aggregation of P23T hD at neutral pH. 
Starting with an initial concentration of 1.8 mg/mL, the solution was gradually concentrated at 4 °C using a 
centrifugal concentrator. Triangles mark the total protein concentration determined by UV-VIS spectrometry after 
different times of centrifugal concentration. Solid triangles indicate time points prior to the onset of aggregation. 
The open triangle indicates the total protein concentration at the onset of aggregation (>12 mg/mL). The solid 
square shows the residual monomer concentration after the aggregation has completed (1.7 mg/mL). Note that the 
solubility of wild-type hD is at least one to two orders of magnitude larger, with measurements ranging from 170 to 
more than 400 mg/mL depending on conditions.  
4.2.3 Transmission electron microscopy 
Aggregates of P23T hD formed under acidic (pH 3) and neutral (pH 7) conditions were imaged 
using transmission electron microscopy. Samples (5 μL) were adsorbed on freshly glow 
discharged 400 mesh size carbon-coated copper grids for 15 seconds, and the excess was 
removed by blotting with filter paper. The sample grids were subsequently stained with 1% (w/v) 
sodium phosphotungstate for 5 seconds and blotted. Grids were imaged at 11,000-fold (pH 7) 
and 21,000-fold (pH 3) magnification using a Technai T12 transmission electron microscope 
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(FEI; Hillsboro, OR) operating at 120 kV and equipped with an UltraScan 1000 CCD camera 
(Gatan; Pleasanton, CA). 
4.2.4 X-ray powder diffraction 
Aggregates of P23T hD formed under acidic (pH 3) and neutral (pH 7) conditions were pelleted 
by centrifugation. Aggregates formed under neutral conditions were pelleted with a tabletop 
centrifuge at 14,000 g for 20 minutes in a table-top VWR Galaxy 14D centrifuge, while 
aggregates formed under acidic conditions were pelleted by ultracentrifugation at 100,000 g for 4 
hours (Beckman Coulter Optima MAX Ultracentrifuge, with TLA 120.2 rotor). The majority of 
the supernatant was removed, and the pellet was resuspended in the remaining buffer and packed 
into a glass capillary (0.7 mm) using a syringe. Capillaries were sealed with wax to retain 
hydration of the samples. Diffraction data was measured at room temperature with a Rigaku 
Saturn 944 CCD camera (Tokyo, Japan). A Rigaku FR-E generator (2 kW, spot size 0.07 mm) 
was used as the X-ray source. Aggregates formed under neutral conditions were exposed for 75 
seconds, while aggregates formed under acidic conditions were exposed for 210 seconds. 
Diffraction data were processed and analyzed in Structure Studio (Rigaku). 
4.2.5 Thioflavin T fluorescence measurements 
Suspensions of approximately 25 μg of aggregates formed under acidic (pH 3) and neutral (pH 7) 
conditions were diluted 20x to 200x (depending on the pre-aggregation concentration) into a ThT 
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stock solution (50 μM ThT, 10 mM sodium phosphate, 150 mM NaCl, pH 7). Samples were 
excited at 445 nm and fluorescence emission was recorded at 489 nm using a Fluoromax-4 
Research Spectrofluorometer (Horiba; Kyoto, Japan). Excitation and emission slits were 2 nm 
and 4 nm, respectively. In addition, ThT fluorescence measurements were also performed on a 
systematic series of P23T hD aggregates formed at pH 3 to pH 8 in 0.5 pH increments. To 
prepare these aggregates, the pH of a low concentration solution of P23T hD (0.13 mg/mL) was 
adjusted using 10% and 1% (w/w) HCl and 0.5 M NaOH. Samples were allowed to aggregate at 
37 °C for five days, after which approximately 2.5 μg (20 L) of the resuspended P23T hD 
aggregates were diluted to 400 L in the same ThT buffer mix, for each ThT fluorescence 
measurement. 
4.2.6 MAS ssNMR spectroscopy 
Hydrated [U-
13
C-
15
N]-labeled P23T hD aggregates formed under acidic (pH 3) and neutral (pH 
7) conditions were separately packed into regular- and thin-walled 3.2 mm zirconia MAS rotors 
(Bruker Biospin, Billerica, MA). The sample packing was done by pelleting the hydrated sample 
suspension directly into the MAS rotor using an ultracentrifugal packing device, as previously 
described [4]. This was done by centrifugation at ~130,000 g for 2-3 h in a Beckman Coulter 
Optima L-100 XP ultracentrifuge with a SW-32 Ti rotor. Excess supernatant was removed, the 
fully hydrated sample was sealed, and subsequently studied by ssNMR in an unfrozen and 
hydrated state. All MAS ssNMR experiments were performed with a widebore Bruker Avance I 
NMR spectrometer operating at a 
1
H Larmor frequency of 600 MHz (14.1 T) using a 3.2 mm 
MAS ssNMR probe with an HCN “EFree” coil (Bruker Biospin). A constant flow of cooled gas 
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was used to control the sample temperature. Spectra were acquired with Bruker Topspin 
software, processed in NMRPipe, and analyzed with Sparky software and the CcpNmr Analysis 
program developed by the Collaborative Computation Project for the NMR community (CCPN) 
[259, 260]. A 90
o
 shifted sine bell followed by a Lorentzian-to-Gaussian transformation function 
was applied in all three dimensions of the NCACX and NCOCX spectra during processing. 
13
C 
and 
15
N chemical shifts were indirectly referenced to 4,4-dimethyl-4-silapentane-1-1 sulfonic 
acid (DSS) and liquid ammonia, respectively, based on external reference measurements of the 
13
C signals of adamantane [261]. Cross-polarization (CP) spectra were used to study the 
immobilized parts of the protein aggregates. Note that soluble proteins would not be visible in 
the CP experiments, such that the signal must be from the aggregated protein. 1D 
13
C CP spectra 
were acquired at a 12.5 kHz MAS rate using ramped 
1
H-
13
C CP. Intra-residue through-space 
13
C-
13
C correlations were obtained from 2D experiments that combined ramped 
1
H-
13
C CP with 8 ms 
dipolar assisted rotational resonance (DARR) 
13
C-
13
C mixing [158]. Partial assignments (Table 
B.2) were obtained for the aggregates formed under neutral conditions, with the aid of the 
13
C-
13
C spectra as well as 2D and 3D 
15
N-
13
C correlation experiments (NCO, NCA, NCOCX, 
NCACX), measured at 10 and 12.5 kHz MAS. These experiments involved 1.5 ms of 
1
H-
13
N CP, 
5.0 ms of ramped 
13
C-
15
N SPECIFIC CP (spectrally induced filtering in combination with cross 
polarization) [162] and 15.0 ms of 
13
C-
13
C DARR mixing, where applicable. The rotor-
synchronized refocused INEPT (insensitive nuclei enhanced by polarization transfer) scheme 
was used to acquire 1D J-coupling-based 
13
C spectra at a 8.333 kHz MAS rate [156]. These 
experiments employed τ1 = 1.2 ms and τ2 = 1.0 ms for aggregates formed at neutral pH, and τ1 = 
1.5 ms and τ2 = 1.0 ms for the fibrils formed at pH 3. 2D spectra showing through-bond 
13
C-
13
C 
correlations between highly mobile carbons were obtained using a combination of 
1
H-
13
C INEPT 
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and 6.0 ms total through bond correlation spectroscopy (TOBSY) 
13
C-
13
C mixing [161]. Two-
pulse phase modulation (TPPM) 
1
H decoupling of typically 83 kHz was applied during 
acquisition for all 1D experiments, and during acquisition and evolution for 2D experiments 
[227]. Additional experimental details can be found in Table B.1. 
4.2.7 Synthetic MAS ssNMR spectra 
Synthetic NMR spectra were generated for both native and amyloid-like reference structures 
using methods similar to those used in our prior work [262]. Spectra representative of the native 
protein structure were generated starting with the published solution NMR chemical shifts of 
soluble P23T hD [24]. Alternatively, a hypothetical completely parallel -sheet structure of 
P23T hD was built using the PyMOL Molecular Graphics System (Schrödinger, LLC), from 
which chemical shifts were predicted using the SPARTA+ program [263]. Subsequently, 
synthetic 2D NMR spectra showing the predicted one-bond cross-peaks were generated using 
utilities from the NMRPipe software package [259]. The solution NMR peak markers in Figure 
4.9 were generated from the solution NMR chemical shifts [24] using the synthetic peak list 
creation routines of the CcpNmr Analysis program [260]. 
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4.3 RESULTS 
4.3.1 Polymorphic aggregation of P23T hD 
First, we compare the aggregation that occurs under physiological and denaturing conditions. At 
physiological pH (pH 7), the 20.6 kDa P23T hD is soluble at dilute concentrations but 
undergoes a temperature-sensitive aggregation at 10-15 mg/mL concentration (Figure 4.2). 
Negative-stain transmission electron microscopy (TEM) reveals the aggregates to be non-
fibrillar, with an amorphous appearance (Figure 4.3, a). Under acidic conditions (pH 3), we 
observe aggregation of P23T hD, even at 1.3 mg/mL, which yields 7 nm-wide worm-like 
unbranched fibrils (Figure 4.3, b). In fluorescence assays using the amyloid-binding dye 
thioflavin T (ThT), the two aggregates show a dramatically different response (Figure 4.3, c). 
Consistent with their fibrillar appearance, the acid-induced aggregates lead to high ThT 
fluorescence, while the amorphous-looking aggregates do not. In a systematic ThT-binding 
screen across a broad range of pH values (Figure 4.3, d) high ThT fluorescence response is 
observed at both low and high pH, but not under the neutral pH conditions present in eye lenses 
[264]. ThT assays are not foolproof measures of amyloid structure [46, 255]. Therefore, we also 
performed X-ray powder diffraction measurements on the hydrated aggregates. Bona fide 
amyloids exhibit a characteristic cross- diffraction pattern, dominated by inter--sheet and 
intra--sheet repeat distances of ~4.7 and ~8-10 Å, respectively (e.g. see the polyglutamine data 
in Figure 4.3, g [1]). This amyloid hallmark is observed for the aggregates formed at pH 3 
(Figure 4.3, e), but is absent for those that form at pH 7 (Figure 4.3, f). The latter show a 
different diffraction pattern, featuring 12.6, 16.3 and 28 Å repeat distances. Thus, the fibrils 
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formed upon exposure to acidic denaturing conditions have all amyloid hallmarks, but the 
amorphous-looking aggregates formed under more physiological conditions feature none of 
them. 
4.3.2 The amorphous-looking aggregates have high internal order 
MAS ssNMR was used to probe the molecular structure of both types of deposits prepared from 
uniformly 
13
C and 
15
N (U-
13
C,
15
N)-labeled P23T hD. First, cross-polarization (CP) ssNMR 
experiments are used to select for the signals of only the immobilized parts of protein deposits. 
The 1D 
13
C CP spectrum of the pH 7 aggregates is shown in Figure 4.4, a. The observed peaks 
have relatively narrow widths, as low as 35 Hz for methyl side chain peaks. More detailed 
information can be gleaned from 2D spectra, such as the 
13
C-
13
C spectrum in Figure 4.4, b. In 
this spectrum, the off-diagonal cross-peaks reflect pairs of carbons that are connected via one or 
two bonds. Despite the amorphous appearance of the aggregates, the spectrum shows many well-
resolved peaks with remarkably narrow peak widths. The narrow linewidths indicate a high 
degree of structural homogeneity (i.e. little structural variation among individual molecules 
throughout the sample) and a lack of line-broadening dynamics. It appears that the crystal-like 
structural homogeneity applies to much or all of the aggregated protein, given that these narrow 
peak widths are seen throughout the spectrum. The 2D spectrum is also characterized by a high 
degree of peak dispersion, which is normally associated with a well-folded state, especially for 
proteins with multiple types of secondary structure. 
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Figure 4.3. Characterization of aggregates formed at 37° C under different pH conditions 
(a, b) Negative-stain TEM images of P23T hD aggregates, formed at pH 7 and pH 3, show amorphous-looking 
aggregates and worm-like fibrils, respectively. (c) ThT fluorescence assay for both of these P23T hD aggregates. 
(d) ThT fluorescence data for 0.13 μM P23T hD incubated at several pH values. (e, f) X-ray powder diffraction of 
hydrated P23T hD aggregates formed at pH 3 and pH 7, respectively. Prominent repeat distances are indicated. 
(g) X-ray powder diffraction on hydrated K2Q31K2 polyglutamine fibrils, showing the characteristic amyloid cross- 
dimensions of 4.7 Å and 8.4 Å, as indicated [1].  
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Figure 4.4. MAS ssNMR spectra of uniformly 
13
C,
15
N-labeled P23T hD aggregates formed at pH 7 
(a) 1D 
13
C CP spectrum. The width at half height (FWHH) of one of the methyl peaks is indicated. (b) 2D 
13
C-
13
C 
ssNMR spectrum with an 8 ms DARR mixing time, resulting in one- and two-bond cross-peaks. Spectra were 
obtained at 600 MHz (
1
H) and 12.5 kHz MAS. Spinning side-band peaks are marked with asterisks (*). Dashed 
boxes mark Ala C-C and Thr C-C peaks.  
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4.3.3 Solid-state NMR of the acid-induced fibrils 
Analogous ssNMR data were obtained for the acid-induced fibrils. The obtained spectra (Figure 
4.5) are dramatically different, and surprisingly indicate a less ordered internal structure than was 
present in the amorphous-looking deposits. Figure 4.5, a, shows that the 1D spectrum has 
broader peaks and a limited resolution, which is indicative of a higher degree of structural 
heterogeneity in these fibrils. The 2D data (Figure 4.5, b) feature notably fewer and broader 
peaks compared to the aggregates that form at pH 7. This can be appreciated for instance by 
comparing the Ala peaks in the boxed regions of Figure 4.4, b and Figure 4.5, b P23T hD has 
four Ala residues that give four well-resolved peaks in the pH 7 aggregates, but in the fibrils we 
see a much broader unresolved Ala peak. This observation suggests a lack of chemical shift 
differences among the observable residues, which points to them being in a similar structure and 
environment. That said, these CP-based experiments show only the immobilized parts of the 
protein aggregates; extensive dynamics of parts of the protein could also prevent specific 
residues from being detected. 
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Figure 4.5. MAS ssNMR spectra of U-
13
C,
15
N-labeled P23T hD aggregates formed at pH 3 
(a) 1D 
13
C CP spectrum. (b) 2D 
13
C-
13
C ssNMR spectrum with 8 ms DARR mixing. Both spectra were obtained at 
600 MHz (
1
H) and 12.5 kHz MAS. A spinning side-band peak is marked with an asterisk (*). Ala C-C and Thr 
C-C cross peaks are enclosed in dashed boxes.  
4.3.4 Detection of dynamic regions by ssNMR 
To probe for such dynamic protein segments, MAS ssNMR experiments based on the INEPT 
(Insensitive nuclei enhanced by polarization transfer) scheme were also performed. In these 
INEPT-based ssNMR experiments, only the most dynamic residues are seen, while signals from 
rigid and immobilized parts of the protein are eliminated [265]. When the same 
1
H-
13
C INEPT 
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experiment is applied to both types of aggregates, we see a striking difference (Figure 4.6, a). 
The aggregates formed at pH 3 feature a substantial number of mobile residues, as indicated by 
the presence of intense peaks in the INEPT spectrum. In striking contrast, the INEPT spectrum 
of the pH 7 aggregates is devoid of peaks (Figure 4.6, a; bottom). A 2D 
13
C-
13
C INEPT-based 
ssNMR spectrum for the acid-induced fibrils allows us to probe the identity of the highly mobile 
amino acids (Figure 4.6, b). No Ala peaks are detected, indicating a lack of highly mobile Ala 
residues, which implies that the broad Ala signal in the CP spectrum must contain the 
overlapping peaks from multiple residues in similar conformations. The spectra contain signals 
from both backbone and side chain atoms, including those of a Lys residue. Since it is the only 
Lys in the protein, those mobile Lys signals must stem from Lys-2 near the N-terminus of the 
NTD. Moreover, other visible peaks include Gly, Lys, Ile, Thr, and Leu residues, which happen 
to make up the initial five residues of the NTD (see Figure 4.1, a). Thus, these results are 
consistent with the initial segment of the NTD being unfolded and flexible, outside the mostly 
immobilized core of the amyloid fibril assemblies. Additional residues, such as Ser and Arg, are 
not found at the very N-terminus, indicating that other parts of the protein also end up in a 
similarly dynamic state. 
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Figure 4.6. MAS ssNMR spectra of mobile residues within aggregated P23T hD 
(a) 1D 
13
C INEPT spectra of U-
13
C,
15
N P23T hD aggregates formed at pH 3 (top) and at pH 7 (bottom). (b) 2D 
13
C-
13
C INEPT/TOBSY spectrum of the U-
13
C,
15
N fibrils formed at pH 3. Lys2, Arg, and Ser peaks are connected 
with dashed, dotted, and continuous (grey) lines, respectively. Spectra were obtained at 600 MHz (
1
H) and 8.33 kHz 
MAS.  
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4.3.5 Secondary structure content of the aggregates 
Solid- and liquid-state NMR resonance frequencies are determined largely by the local bond 
geometry. The dependence of 
13
C and 13C resonance frequencies on the local secondary 
structure is such that 
13
C-13C peaks occur in distinct spectral regions for residues in random 
coil, -helical and -sheet structures [266]. In Figure 4.7, a-c we visualize this for some well-
resolved amino acids by superimposing the canonical secondary-structure-dependent peak 
positions on our experimental ssNMR data. Note that these CP-based spectra detect specifically 
the immobilized parts of the protein aggregates. Independent of the aggregation condition, many 
of the experimental peaks line up with those typical of -sheets. The dominance of -sheet 
structure is most pronounced in the pH 3 fibrils (Figure 4.7, b-d). The fibrils lack peaks in the -
helical region, but signals are detected in the intervening spectral region where one expects the 
signals for residues that lack a well-defined -helical or -sheet structure. Interestingly, both Ser 
(Figure 4.7, a) and Ala peaks (Figure 4.7, c-d) with -helical chemical shifts are observed in the 
spectrum of the pH 7 aggregates. Thus, compared to the fibrils, these amorphous-looking 
aggregates have a more diverse secondary structure content that includes both -sheet and -
helical elements. 
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Figure 4.7. NMR chemical shift analysis of residue-specific secondary structure 
(a) Thr and Ser C/C region of the 2D 13C-13C ssNMR spectrum for P23T hD aggregated at neutral pH. The 
expected peak positions [266] for Thr and Ser in random coil (RC), -helix () and -sheet () structural motifs are 
indicated with red markers superimposed on the experimental spectrum (grey). Indicated peak assignments are 
based on 2D and 3D ssNMR spectra. (b) Analogous data overlay for the acid-induced P23T hD fibrils. (c) Overlay 
of the Ala C/C cross-peaks for the aggregates formed at pH 7 (dark grey) and pH 3 (light grey), along with the 
expected peak positions for Ala in different secondary structures. Indicated peak assignments are based on 2D and 
3D ssNMR spectra. (d) Secondary chemical shifts ((13C-13C)) calculated for the Ala (top) and Thr (bottom) 
residues of P23T hD in solution (left), aggregated at pH 7 (middle), or at pH 3 (right). These secondary shifts, 
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(13C-13C), are normalized relative to the shift of a random coil conformation, such that negative values are 
indicative of -sheet structure, whereas positive bars indicate -helical structure (as indicated on far right).  
4.3.6 Spectral modeling of misfolded and native-like aggregates 
As noted above, crystallin aggregation may proceed via mechanisms characterized by different 
extents of misfolding. Proposed aggregation mechanisms involving extensive un- and misfolding 
are expected to yield amyloid-like fibrils that feature a -sheet-based core stabilized by 
intermolecular hydrogen bonds [85, 239, 267]. Runaway domain-swapping [65-67] or surface-
mediated ‘condensation’ mechanisms [69-71] would generate aggregates that retain much of the 
native fold and lack an amyloid core [258, 268]. To evaluate and visualize the expected spectral 
differences between misfolded amyloid and native-like aggregates, we generated schematic 
simulated 
13
C-
13
C ssNMR spectra. To coarsely model a typical amyloid structure, we applied 
canonical parallel -sheet torsion angles (, = -119°, 113°) to the P23T hD primary sequence. 
This backbone structure model was then used to predict the 
13C’, 13C, and 13C chemical shifts, 
which were used to generate the 
13
C-
13
C peak patterns in Figure 4.8, a. To simulate the ssNMR 
spectrum of native-like aggregates, the NMR shifts of the soluble protein were used as a starting 
point [24]. These solution NMR shifts by definition correspond to the soluble protein’s native 
fold, and led to the simulated spectrum in Figure 4.8, b. The two simulated spectra illustrate the 
marked qualitative differences expected for amyloid-like fibrils and native-like aggregates. The 
former is characterized by a lack of peak dispersion for residues in the purely -sheet amyloid 
core. With their mixed secondary structure, the native-like aggregates have a much larger peak 
dispersion that resolves many of the individual amino acids. 
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Figure 4.8. Synthetic 
13
C-
13
C ssNMR spectra predicted for aggregates containing either typical 
amyloid-like misfolded proteins or natively folded P23T hD 
(a) Simulated spectrum predicted for P23T hD in a parallel in-register -sheet structure, as is typical for amyloid-
like fibrils. (b) Simulated spectrum generated from the solution NMR chemical shifts of natively folded P23T hD 
[24].  
4.3.7 Acid-induced P23T hD fibrils lack native-like structure 
The experimental ssNMR data for the acid-induced fibrils (Figure 4.5) match well to the 
amyloid-like fibril model, while showing little to no correspondence to the spectra expected for 
native-like aggregates. As noted above, the experimental spectrum features some peaks from 
non- residues that do not appear in the synthetic spectrum. We attribute these peaks to loops 
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and other segments that are outside the -sheet amyloid core, but are immobilized enough to be 
seen in the CP-based spectra, similar to the non-amyloid flanking domains of huntingtin exon 1 
fibrils [91]. Such non-core residues were not represented in our simplistic amyloid model 
designed to predict the spectral features of a canonical amyloid core architecture. 
4.3.8 The amorphous aggregates have a native-like structure 
In contrast to the acid-induced fibrils, the spectrum of amorphous-looking aggregates obtained at 
pH 7 (Figure 4.4) shows a striking resemblance to the simulated spectrum expected for native-
like aggregates. To provide more detailed insights into the structural similarities and differences 
between the aggregated and soluble state, Figure 4.9 overlays the 2D 
13
C-
13
C ssNMR spectrum 
of P23T hD aggregated at pH 7 with peak markers representing the solution NMR assignments. 
Even in absence of site-specific assignments (see below), a close peak-by-peak inspection of this 
single 2D spectrum reveals that the majority of peak positions are remarkably similar in the solid 
and solution states. A limited number of well-resolved solution peak markers do not overlap with 
a matching ssNMR peak, as indicated with circled crosses in Figure 4.9.  
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Figure 4.9. Experimental 
13
C-
13
C ssNMR spectrum of amorphous P23T hD aggregates annotated 
with the liquid-state NMR resonances of P23T hD in solution 
The grey spectrum is a 2D 
13
C-
13
C MAS ssNMR spectrum with 8 ms of 
13
C-
13
C DARR mixing. The off-diagonal 
peaks are mostly one-bond 
13
C-
13
C contacts, along with a few two-bond cross-peaks. Dark and light ‘x’ markers 
indicate one- and two-bond peak positions, respectively, as predicted from the solution NMR assignments of soluble 
P23T hD [24]. Circled crosses with their single-letter residue assignments mark well-resolved one-bond solution 
NMR peaks that do not overlap with peaks in the ssNMR spectrum. Conversely, colored lines connect sets of ssNMR 
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peaks that do not have overlapping solution NMR peak markers. Different coloring and line styles (dashed/solid) 
connect together individual residues (“spin systems”). Where available (see Table B.2), color-coded three letter 
residue assignments are provided; otherwise the residue type is indicated (also with its three-letter code).  
Conversely, a subset of ssNMR peaks do not have a matching solution NMR resonance 
(marked with colored lines in Figure 4.9). Assignment experiments (below) show that the 
‘missing’ solution NMR peaks and ‘unmatched’ ssNMR peaks represent the same specific 
residues. Thus, we are not seeing a disappearance of peaks, but rather a changing of NMR 
resonance frequencies. This is consistent with the fact that no highly flexible residues (which 
would be invisible in the CP spectra) were detected in the pH-7 aggregates (Figure 4.6).  
Residue-specific assignments of several key segments of the aggregated protein were 
obtained based on a backbone-walk analysis of 2D and 3D homo- and heteronuclear ssNMR 
experiments (see Figure B.1, Figure B.2). Comparing the available solid- and solution-state 
chemical shifts, Figure B.1 shows the residue-specific chemical shift perturbation (CSP) that 
accompanies the formation of the amorphous aggregates. These data support the visual analysis 
of the 2D 
13
C-
 13
C data above, showing that many residues have a CSP similar to the uncertainty 
in the chemical shifts (the average 
13
C CSP is 0.55 ppm). The largest 
13
C chemical shift 
deviations are ~2 ppm, but this represents only a few residues among those that were assigned: 
G1, T23, I81 and I170. The chemical shift differences between the pH 7 aggregates and the 
hypothetical amyloid-like -sheet model from Figure 4.8, a, are more than twice as large (Figure 
B.2).  
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Figure 4.10. Mapping of NMR-detected structural changes and similarities 
(a) Ala C-C cross-peaks for the aggregates obtained at pH 7 (top) and pH 3 (bottom). Experimental ssNMR cross 
peaks are depicted in dark grey and blue crosses mark the solution NMR shifts of the soluble protein [24]. (b) 
Analogous depiction of the Thr C-C cross peaks. (c) P23T hD structure [130] highlighting the locations of all 
eight Ala and Thr residues. (d) Structural mapping of residues whose NMR resonances change upon aggregation at 
pH 7 (see Figure 4.9 and Figure B.2) due to aggregation-associated changes in the local structure or environment. 
Residues whose resonances are different between the solution and aggregated (pH 7) states are labeled in green on 
the ribbon diagram. Residues marked with “+” have unambiguous ssNMR assignments (Table B.2); those marked 
with “*” were identified in the visual analysis of Figure 4.9.  
This overall pattern is visualized in Figure 4.10, a-b, based on the well-resolved Ala and 
Thr signals. Unlike the acid-induced fibrils (bottom panels), the amorphous-looking aggregates 
have Ala peaks that closely resemble the solution NMR shifts (marked with X). Given the Ala 
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distribution throughout the protein (Figure 4.10, c), this similarity in itself strongly suggests a 
retention of much of the native fold. Among the four Thr residues, two (T23 and T159) have 
significantly changed chemical shifts indicating a localized change in structure. Returning to a 
more global view of the protein aggregates formed at pH 7, Figure 4.10, d highlights those 
residues for which we observe significant (> 0.5 ppm) 
13
C shift changes between the solution and 
solid-state NMR data. The indicated residues are identified either based on de novo ssNMR 
assignments (Table B.2; marked with + in Figure 4.10, d), the spectral analysis of Figure 4.9 (*), 
or both. This representation indicates that residues that sense a structural change upon 
aggregation are mostly outside the core -strand segments of the Greek key motifs and are found 
instead on the surface-exposed regions of the protein’s folded subdomains. 
4.4 DISCUSSION 
We observed the aggregation of P23T hD across a range of pH conditions and found that the 
nature of the resulting aggregates is different at different pH values. The aggregates formed at 
non-physiological pH values showed high fluorescence in assays using the amyloid-binding ThT 
dye. The amyloid-like nature of the acid-induced aggregates was validated by their fibrillar 
morphology and characteristic cross- X-ray diffraction pattern (Figure 4.3, e). As is typical for 
amyloid-like fibrils, the ssNMR peak patterns of the fibrils differed dramatically from those 
expected for the protein’s native fold. The protein had undergone extensive restructuring during 
aggregation at pH 3. The ssNMR data we have obtained thus far are unable to distinguish the 
different kinds of -sheet amyloid core architectures [267]. That said, as previously suggested 
[85], it seems likely that the fibril core would feature the prototypical parallel in-register -sheet 
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structure most commonly seen in other amyloid-like fibrils [239]. The ssNMR spectra contained 
signals from residues lacking -sheet structure that are either dynamically (Figure 4.6, b) or 
statically disordered (Figure 4.7). The amino acids are presumably located outside the -sheet-
based amyloid core. Thus, our data support a model featuring fibrils built around a -sheet 
amyloid core that is decorated with disordered non- segments. This structural motif 
qualitatively resembles the fibril assembly model described in prior IR studies of hD aggregated 
under acidic conditions in vitro [85]. 
Consistent with prior studies [242, 243, 269], we found that denaturing conditions were 
not necessary for P23T hD to aggregate at concentrations well below the high solubility of WT 
hD. The P23T hD aggregates formed at physiological pH values lack the characteristic cross- 
signature of amyloids, have low ThT fluorescence, and have an amorphous appearance by TEM. 
A similar amorphous morphology was previously noted for P23T hD aggregated under similar 
conditions [243], and also for other - and -crystallins [250-252, 270]. As noted in the 
introduction, the same nomenclature is used to describe non-fibrillar aggregates formed by other 
aggregation-prone proteins [244-247]. Prior studies offer little insight into the internal structure 
of these deposits, which are often described as “unstructured” [243, 248, 249] or “disordered” 
[116, 249, 251, 271]. Our ssNMR studies paint quite a different picture. Both the dispersion and 
widths of our ssNMR peaks are reminiscent of those typically seen for crystalline protein 
preparations [272]. This means that the individual protein molecules in the sample all share a 
single, well-defined conformation. In CP-based spectra of the immobilized parts of the 
aggregates we observed residue counts that match the solution NMR data, with no sign of 
missing peaks. This was reaffirmed by INEPT spectra that were devoid of ‘mobile’ signals (in 
contrast to the acid-induced fibrils). Thus, the seemingly amorphous deposits are actually highly 
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homogeneous assemblies of well-structured protein monomers on the microscopic level, with no 
evidence of either dynamic or static disorder. Figure 4.9 shows the striking similarity between 
the 2D ssNMR spectra of the pH 7 aggregates and the known chemical shifts of the natively 
folded state present in solution. Residues featuring atoms with a significant change in their 
chemical shifts were found to be outside the -strand segments of the native fold’s Greek key 
motifs (Figure 4.10, d; Figure B.2). These sites of structural change likely co-localize at least in 
part with the intermolecular contacts that arise upon aggregation, but are absent in the 
monomeric soluble protein. The limited spectral changes detected in the aggregates’ ssNMR data 
are incompatible with large-scale un- or misfolding. 
The fact that the ssNMR spectra of the pH 7 aggregates indicate a native-like structure is 
most consistent with two types of aggregation mechanisms proposed in the literature. 
‘Condensation’ mechanisms suggest that minor changes in surface charges or surface 
hydrophobicity would be sufficient to increase the molecule’s aggregation propensity, without 
substantial mis- or re-folding (Figure 4.11, b) [69-71, 273]. Even relatively small changes in 
surface characteristics may disrupt the careful balance of inter-protein interactions that normally 
facilitate the remarkable protein concentrations in the eye lens. The proteins could then aggregate 
while preserving a largely native fold, with the mutations affecting the surface patches that 
mediate the protein-protein contacts in the aggregated state. Figure 4.10, d summarizes the 
identities and locations of residues for which we observe above-average chemical shift 
deviations between the soluble and aggregated protein (ref. Figure 4.9 and Figure B.2). These are 
the residues that experience a change in local structure as a result of the aggregation process. 
They are found to reside outside the core -strands of the NTD and CTD, and are instead 
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primarily on the surfaces of the domains, indicating an apparent preservation of the Greek key 
motifs. 
 
Figure 4.11. Proposed potential aggregation mechanisms 
(a) The native hD fold, with the NTD and CTD in blue and red, respectively. (b) Condensation into aggregates 
within which individual proteins retain a native-like fold. Mutations or chemical damage may lead to changes in 
surface charges or hydrophobicity, thus disrupting the native protein-protein interactions essential for high 
solubility. Individual protein monomers are depicted in different color shades. (c) Denaturing conditions, including 
low pH, induce a loss of the native fold and formation of fibrils with a -sheet-based amyloid core. Unfolding may 
also result from disruptive mutations or chemical damage to buried residues. (d) Hypothesized domain-swapping-
based mechanism that generates aggregates in which much of the native fold is preserved, except for loops that act 
as hinges and undergo substantial rearrangements. 
Deposits assembled from intertwined or 3D domain-swapped proteins, as previously proposed 
for cataract-associated aggregates [65-67], would also be predicted to have native-like spectra 
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[258]. On the basis of known domain swapped multimers as large as tetramers, it has been 
proposed that “runaway” domain swapping in a daisy-chain fashion could be a mechanism of 
protein aggregation. A hypothetical domain-swapped P23T hD assembly is shown in Figure 
4.11, d. We stress that this is a hypothetical graphic, purely meant to offer a schematic visual 
representation of the structural implications of run-away domain swapping. The swapped 
multimers reproduce much of the native fold, with structural changes centered on loop regions 
that act as hinges between the swapped domains. A characteristic feature of domain swapped 
assemblies would be that notable NMR chemical shift changes would primarily cluster in such a 
hinge loop region. The observed ssNMR shift differences (Figure 4.10, d) fail to match this 
particular pattern, leaving us unable to identify a specific hinge loop region, or build a 
particularly convincing runaway domain-swapped model. As a result, we interpret the available 
data to be most consistent with the kind of aggregates expected for a condensation-type 
aggregation process. That said, there are many different ways in which a domain-swapped 
assembly could be created, such that it is difficult to exclude a role for domain swapping until 
more structural data are available. 
Various -crystallins form amyloid-like fibrils in vitro, at acidic pH [71, 85, 252, 274] or 
when exposed to other denaturing conditions [65, 71, 250, 253, 254, 275-277]. A similar 
behavior has been reported for -and -crystallins [71, 255, 277]. However, numerous globular 
proteins can be induced to form amyloid-like fibrils when one destabilizes their native fold, 
independent of their propensity to form amyloid under physiological conditions [236, 258]. In 
the case of P23T hD, the mutation itself does not cause much change in the structure, as 
mentioned in the Introduction and discussed in detail in prior studies [24, 241]. Additional 
destabilization of the native fold, for instance by exposure to acidic or basic pH values, appears 
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to be necessary for amyloid formation to become the dominant aggregation pathway (Figure 
4.11, c). Thus, it is tempting to conclude that P23T hD aggregation under in vivo conditions is 
likely to occur via a non-amyloid mechanism. Of course, extrapolation to the complex in vivo 
conditions is always difficult, given the potential impacts of other -crystallins, -crystallin 
chaperones, and the build-up of aging-induced chemical modifications [71, 251]. That said, we 
do want to point out one way in which cataract-related protein aggregation would appear to be 
fundamentally different from amyloid formation in neurodegenerative disorders. In the latter 
case, the amyloid-forming proteins or peptides are often present at very low concentrations [278, 
279]. The concentration of protein in the eye lens is orders of magnitude higher, requiring the 
remarkable eye lens protein solubility that is based on a careful balancing of repulsive and 
attractive protein-protein interactions [280]. Amyloidogenic aggregation at low concentrations 
tends to involve exposure of hydrophobic sites through misfolding, and proceed via specific 
nucleation events [1, 281]. At very high protein concentrations, aggregation can result from 
surface-mediated changes in protein-protein interactions, well before large-scale structural 
changes trigger the formation of an amyloidogenic state. 
Protein aggregation processes involved in cataract formation may be qualitatively 
different from the misfolding-based amyloid formation associated with neurodegenerative 
disease. Recent efforts to develop and screen anti-cataract drugs have focused on their inhibition 
of amyloid formation [276, 277]. Our results argue that it may be important to also screen against 
disease-related crystallins that form non-amyloid aggregates. We showed that the amorphous-
looking aggregates are much more ordered and structured that one might have expected based on 
their morphology. As such, at least in this case, the “amorphous” label appears to be a misnomer 
when it comes to the atomic level structure of the aggregated protein. One implication of this 
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remarkable structural order and homogeneity is that the deposits presumably form via a 
reproducible and specific aggregation mechanism, rather than a multiplicity of parallel or non-
specific pathways. A better molecular understanding of this aggregation process may pave the 
way for the development and design of small-molecule aggregation inhibitors [282, 283]. Age-
dependent changes in the operation of nature’s own aggregation inhibitors, protein chaperones, 
play a key role in aging-dependent aggregation diseases. In the eye, the -crystallins perform 
this protective role. Intriguingly, -crystallins act on amorphous-looking and amyloid-like 
substrates through different mechanisms [118, 237]. Further structural studies of the crystallins’ 
polymorphic aggregates will enhance our understanding of these protective processes and may 
enhance ongoing efforts to develop new preventative or curative treatments. 
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5.0 MAGIC ANGLE SPINNING SOLID STATE NMR STUDIES OF METHIONINE 
OXIDIZED APOLIPOPROTEIN A-I AGGREGATES 
Adapted and reprinted with permission from: Witkowski, A., Chan, G. K. L, 
Boatz, J. C., Li, N. J., Wong, J. C., van der Wel, P. C. A., Cavigiolio, G. 
Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and 
amyloid formation, The FASEB Journal 32(6):3149-3165. Copyright (2018) 
Witkowski, A., et. al. 
 
I contributed data towards one figure in the main text of the published manuscript, 
and three figures in the supplemental information in the published manuscript, 
reprinted with permission as Figure 5.2, Figure 5.5, Figure 5.6, and Figure C.1. I 
built the cartoon of the amyloid structure reprinted with permission in Figure 5.7. 
I obtained images from samples using transmission electron microscopy, depicted 
in Figure 5.2 and Figure 5.3. I also performed several magic angle spinning solid 
state NMR experiments, depicted in Figure 5.5, Figure 5.6, Figure C.1, and Figure 
C.2.  
 
Atherosclerosis is a state of chronic inflammation in the arteries, initiated by deposition of 
oxidized lipids, and is one of the primary causes of cardiovascular disease. Incidence of amyloid 
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deposits in atherosclerotic lesions is very high; however, a causal relationship between arterial 
amyloid deposition and atherosclerosis development has not yet been unequivocally established. 
Surprisingly, the known anti-atherogenic factor apolipoprotein A-I (apoA-I) has been identified 
as the protein contributing to over 90% of amyloid deposits found in atherosclerotic plaques. 
Previously, it was demonstrated that methionine oxidation promotes apoA-I aggregation. In my 
doctoral work, I applied magic angle spinning solid state NMR to probe the structure of 
aggregated apoA-I. This technique is exquisitely sensitive to structural changes and readily 
allows direct comparison of secondary structure changes between samples. We find that 
methionine oxidized apoA-I forms amyloid-like fibrils that can propagate through seeding. 
Notably, a large portion of the aggregated protein retains a native-like structure. These results 
suggest that methionine oxidation can promote vascular amyloidosis, and that this phenomenon 
impacts the anti-atherosclerotic properties of apoA-I. 
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5.1 INTRODUCTION 
Cardiovascular disease accounts for 1 in 4 deaths in the United States [284]. One of the leading 
causes of cardiovascular diseases is atherosclerosis, which is defined as plaque buildup within 
arteries [285]. More specifically, oxidized lipids infiltrate the sub-endothelial space of arteries 
and initiate an inflammatory response. Within this inflammatory and oxidative milieu, foam cells 
and fatty deposits accumulate, forming atherosclerotic plaques [285]. Vascular amyloidosis (VA) 
and atherosclerosis are highly correlated, as high incidence of amyloid fibrils occurs in 
atherosclerotic plaques [89]. However, it is uncertain whether there is a causal relationship 
between VA and atherosclerosis and the role of protein aggregation in atherogenesis remains 
unclear. 
High density lipoproteins (HDL) are known anti-atherosclerotic factors [286]. The major 
protein component of HDL particles is apolipoprotein A-I (apoA-I). ApoA-I is a large (45 kDa) 
protein with high structural plasticity that readily binds to phospholipids and cholesterol and is 
important for lipid metabolism [287]. By extracting cholesterol from immune cells strongly 
implicated in the process of atherogenesis, such as macrophages, apoA-I reduces foam cell 
formation and atherosclerosis progression [287]. By binding cell membrane cholesterol and 
forming HDL particles, apoA-I facilitates transport of this excess of cholesterol out of the 
sub-endothelial space of the arteries and through the bloodstream, delivery to the liver for 
excretion, a process often called “reverse cholesterol transport” [287].  
The cholesterol release function of apoA-I is hindered in atherosclerosis [288]. The 
macrophage secreted enzyme myeloperoxidase (MPO), strongly implicated in atherosclerosis 
and found at high concentrations in the atherosclerotic plaques, has been shown to inhibit apoA-I 
function [289-291]. Under physiological conditions, MPO oxidizes methionine residues within 
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apoA-I and targets tryptophan, tyrosine, and lysine residues for additional modifications 
including chlorination, nitration, and hydroxylation [14, 15, 292-299]. It has been unclear which 
MPO induced modification is responsible for the loss of function of apoA-I, but the cholesterol 
release function of apoA-I is not altered when only methionine (Met) residues are oxidized [6, 
293, 295, 300, 301]. Conversely, when the MPO reaction is performed in the presence of 10-fold 
molar excess of H2O2, a condition that promotes Trp and Tyr modifications in addition to full 
Met oxidation, cholesterol release by oxidized apoA-I is significantly hindered [6]. Together, this 
indicates a possible causal relationship between oxidization at Met and amyloid formation.  
Although the cholesterol binding function of apoA-I is not altered by oxidation of 
methionines, recent results from the Cavigiolio lab indicate that Met oxidation by MPO is 
sufficient to promote amyloid formation in oxidized lipid-free apoA-I; amyloid formation is 
abolished when the three Met residues of apoA-I are substituted with Leu [302]. Interestingly, 
amyloid formation can also be induced by in vitro oxidation with up to 1000-fold molar excess 
of H2O2 (H2O2-wt-ApoA-I) [6], and even in such large molar excess, H2O2 exclusively oxidizes 
Met residues [6]. Consistent with the lack of detrimental consequences of the oxidation state of 
methionine residues on the cholesterol binding function of apoA-I, interaction with macrophages 
and cholesterol release not only is not hindered, but it is enhanced in H2O2-wt-ApoA-I [6, 303]. 
Intriguingly, the same phenomenon is observed after thermal treatment at 90 °C for 1h [6]. Both 
thermal treatment and treatment with H2O2 disrupt self-association of apoA-I, the latter 
irreversibly [6]. 
Thus, oxidation of Met residues promotes structural changes that disrupt self-association 
and facilitate lipid binding, while also facilitating protein aggregation in amyloid-like assemblies 
[6, 303]. As the formation of amyloid fibrils processed by a monomer-dependent mechanism, 
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and lipid free apoA-I amyloid fibrils can be propagated through seeding [6], a more thorough 
investigation of the structural changes that occur in apoA-I upon Met oxidation is warranted. 
ApoA-I primarily adopts an -helical structure that self-associates in the lipid-free state, 
and this self-association affects protein function [304]. Fluorescence studies indicate that Met 
oxidation and thermal treatment induces aromatic residues to become more solvent exposed, 
likely by disrupting an N-terminal 4-helix bundle [6, 305-309]. In this chapter, the structure and 
dynamics of H2O2-wt-ApoA-I were probed by MAS ssNMR in hopes of gaining atomic-level 
insight to answer this question. 
5.2 METHODS 
5.2.1 Preparation of apoA-I samples 
I thank G. K. L. Chan, who expressed, purified, and prepared all apoA-I samples. ApoA-I 
(wt-
13
C,
15
N-ApoA-I) was expressed in BL21(DE3)pLysS Escherichia coli (Agilent 
Technologies) containing a pET-20b bacterial expression vector (Novagen) and encoding for an 
N-terminal His tag [302, 304]. Uniformly 
13
C, 
15
N labeled protein was overexpressed in minimal 
media using U-
13
C-D-glucose and 
15
N-ammonium chloride as the only carbon and nitrogen 
sources [210, 310]. The protein was purified using nickel affinity chromatography and the His 
tag was then removed with TEV protease [302, 311]. Protein purity was confirmed by SDS-
PAGE. Samples were frozen were stored in 6M guanidine chloride buffer and then refolded 
before use. Samples were oxidized overnight at 37 °C in oxidation buffer (OB, 10 mM sodium 
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phosphate, 100 M DTPA, 100 mM NaCl, pH 7.5) with a 1000:1 molar excess of H2O2 
(H2O2-wt-
13
C,
15
N-ApoA-I), and then were dialyzed into fibrillation buffer (10 mM sodium 
phosphate, pH 6.0) [293, 302]. Samples were then diluted to 1.0 mg/mL and aggregated at 37 °C 
with continuous vortexing [302]. Aggregation of non-oxidized wt-
13
C,
15
N-ApoA-I was initiated 
by seeding with unlabeled pre-formed H2O2-wt-ApoA-I seeds. 
5.2.2 Thioflavin T fluorescence assays 
I thank G. K. L. Chan and G. Cavigiolio for performing the Thioflavin T fluorescence studies. 
ThT fluorescence was recorded during aggregation in samples with and without oxidized apoA-I 
seeds at the timepoints indicated in Figure 5.1. Samples were diluted into ThT stock solution 
(500 M ThT, 50 mM sodium phosphate, pH 7.4) for a final concentration of 2.84 M apoA-I. 
Fluorescence spectra were recorded on a Horiba Jobin-Yvon FluoroMax-4 spectrofluorometer. 
Samples were excited at 450 nm and the emission was recorded between 460 and 500 nm. Slit 
widths were 2.5 and 5.0 nm, respectively.  
5.2.3 Fourier transform infrared (FTIR) spectroscopy 
I thank G. K. L. Chan and G. Cavigiolio for obtaining the FTIR measurements. FTIR absorbance 
spectra were recorded between 4000 and 800 cm
-1
 on a Direct Detect™ spectrometer (EMD 
Millipore Co.) [302]. 
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5.2.4 Transmission electron microscopy 
Samples were adsorbed onto freshly glow discharged carbon-coated copper grids for 1 minute 
and stained with 1% (w/v) uranyl acetate for 30 s. Images were taken on a Tecnai T12 
transmission electron microscope (FEI; Hillsboro, OR) operating at 120 kV and equipped with 
an UltraScan 1000 CCD camera (Gatan; Pleasanton, CA) [3, 5]. 
5.2.5 MAS solid state NMR spectroscopy 
Hydrated samples were packed into thin-wall 3.2 mm zirconia MAS rotors (Bruker Biospin, 
Billerica, MA) at 100,500 g for 60 min using a home-built swinging-bucket ultracentrifugal 
packing device, and then rotors were sealed with epoxy [4]. All MAS ssNMR experiments were 
performed on a widebore Bruker Avance I NMR spectrometer operating at a 
1
H Larmor 
frequency of 600 MHz (14.1 T) and equipped with a 3.2 mm MAS ssNMR probe with a triple 
channel (HCN) “EFree” coil (Bruker Biospin). All spectra were obtained at 13 kHz MAS unless 
otherwise indicated. A constant flow of cooled gas was used to regulate sample temperature. 
Spectra were acquired with Bruker Topspin, processed with NMRPipe, and analyzed with the 
CcpNmr Analysis program [259, 260]. Chemical shifts were referenced to 
4,4-dimethyl-4-silapentane-1-1 sulfonic acid by indirectly referencing to the 
13
C signals of 
adamantane [261]. Secondary structure analysis was derived from empirical reference data [266, 
312]. Fully -helical and β-sheet models of apoA-I were created in Chimera [23]. Synthetic 
NMR spectra were generated using NMRPipe and Sparta+ as previously described from the 
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secondary structure models and also from a crystal structure of C-terminally truncated apoA-I 
(PDB 3R2P, ref. [313]) [5, 259, 262, 263]. 
5.3 RESULTS 
5.3.1 Amyloid formation occurs in non-oxidized apolipoprotein A-I upon seeding with 
pre-formed amyloid fibrils 
Amyloid fibrils often can act as nuclei to induce fibril formation in natively-folded protein. To 
test whether H2O2-wt-ApoA-I amyloid fibrils can induce amyloid formation in intact wt-ApoA-I, 
non-oxidized wt-ApoA-I was incubated in the presence of 0, 1, and 10% (w/w) pre-formed 
H2O2-ApoA-I amyloid seeds and ThT fluorescence was monitored over time. The results are 
summarized in Figure 5.1. As expected, no significant increase in ThT fluorescence was 
observed in the presence of 0% seeds even after 23 days of incubation. In the presence of 1% 
seeds, ThT fluorescence is observed to increase after a lag phase of about 14 days. The amyloid 
elongation phase lasts another 9 days, as indicated by a steady increase in ThT fluorescence 
before it plateaus. In the presence of 10% seeds fibrils form much more quickly; the lag phase 
ends after 8 days and the elongation phase begins to conclude at after another 6 days of 
incubation. 
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Figure 5.1. Seeding of non-oxidized wt-ApoA-I with molar 10% and 1% of pre-formed 
H2O2-wt-ApoA-I aggregates 
As a control, non-oxidized wt-ApoA-I was incubated in the absence of seeds (black dots). Total protein 
concentration in each sample was 1.0 mg/ml. The samples were incubated in fibrillation buffer (pH 6.0) at 37 °C 
with continuous vortexing at 800 rpm, and then ThT fluorescence was measured at the indicated time points. Solid 
lines are fitting of the experimental values by sigmoidal curves. Mean T1/2 and SEM values from ≥3 independent 
experiments are reported in figure. N/A = not applicable.  
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Figure 5.2. TEM analysis of H2O2-ApoA-I seeds and seeded non-oxidized apoA-I aggregates 
Negative staining EM analysis was performed on H2O2-ApoA-I seeds after 4 days under fibrillation conditions 
(panel A) and on non-oxidized apoA-I seeded with 10% H2O2-ApoA-I seeds and incubated for 20 days under 
fibrillation conditions (panel B). For each sample, two micrographs of different grid areas are reported at the top 
and bottom of each column. Two independent samples are reported in panel A, left and right columns. These images 
illustrate well the variability in morphology typical of amyloid fibrils of apoA-I that are oxidized at Met. Bars 
represent 100 nm.  
Both the seeds and the seeded samples form aggregates that are visible by eye. The 
H2O2-wt-ApoA-I seeds display morphological heterogeneity by TEM (Figure 5.2, a), visible as 
short single fibrils and large clusters of fibrils. Curly structures were also interspersed among the 
fibrils in the micrographs [302, 314]. The non-oxidized wt-ApoA-I fibrils formed in the presence 
of 10% H2O2-wt-ApoA-I seeds are not distinguishable from H2O2-wt-ApoA-I fibrils (Figure 5.2, 
b). Aggregates were not visible by eye in control samples of non-oxidized wt-ApoA-I following 
23 days of incubation, however TEM images revealed several small clusters of protein 
reminiscent of the amorphous-appearing aggregates of P23T hD (Figure 5.3) [5]. 
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Figure 5.3. TEM analysis of non-oxidized apoA-I in the absence of H2O2-ApoA-I seeds 
TEM images were obtained following 7 days under fibrillation conditions and 7 days at 4° C. Scale bar is 200 nm.  
5.3.2 Non-oxidized apolipoprotein A-I adopts a partial -sheet structure upon seeding 
with pre-formed oxidized amyloid seeds 
FTIR was employed to monitor the secondary structure of non-oxidized wt-ApoA-I in the 
presence and absence of 10% (w/w) H2O2-wt-ApoA-I seeds over an 8 day incubation period. 
Non-oxidized and natively folded wt-ApoA-I was found to be predominantly -helical and 
random coil in agreement with previous work, manifesting in the FTIR spectrum as single peak 
at about 1655 cm
-1
 in the amide I region (Figure 5.4, a) [302, 315]. The intensity of the peak does 
not appear to change significantly over 48 hours or 8 days of incubation, suggesting that the 
native fold of wt-ApoA-I remains intact. A peak at about 1622 cm
-1
 becomes visible in the 
seeded sample after 8 days of incubation (Figure 5.4, a). This band indicates the formation of a 
-sheet secondary structure that is characteristic of amyloid structures. The intensity of the 1655 
cm
-1
 band remains unchanged, in agreement with previous observations that substantial amounts 
of the native structure persists in the wt-ApoA-I fibrils [302, 315]. 
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Figure 5.4. FTIR spectra in the amide I region (1602-1708 cm
-1
) of non-oxidized wt-ApoA-I after 
seeding with pre-formed H2O2-wt-ApoA-I aggregates 
Control (panel A) and 10% (molar) seeded (panel B) mixtures before incubation under fibrillation conditions (T0) 
and after 48 h and 8 day incubations.  
5.3.3 Seeded non-oxidized apolipoprotein -I aggregates retain a partial native structure  
Oxidized H2O2-wt-ApoA-I seeds and non-oxidized wt-ApoA-I (10% seeded) were compared 
using MAS ssNMR in order to identify changes in the local secondary structure of individual 
residues and residue types [5, 258, 316]. Samples were uniformly labeled with 
13
C and 
15
N. We 
note that the seeds present in the non-oxidized seeded sample were prepared at isotopic natural 
abundance and attribute less than 1% towards the 
13
C signals in that sample. The one 
dimensional direct excitation 
13
C MAS ssNMR spectra of the seeds and seeded sample (Figure 
5.5, a, full size: Figure C.1, a,b) are very similar. The most obvious difference is observed as a 
decrease in the intensity of a resonance frequency at 33 ppm upon oxidation, as indicated by a 
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gray arrow (Figure 5.5, a). This resonance frequency is consistent with the chemical shifts 
expected for unoxidized Met C and C, which change dramatically upon oxidation of Met side 
chains [317, 318]. There is an additional decrease in the intensity of a resonance frequency at 17 
ppm (gray arrow), which we assign as Met C. We also note the appearance of a small peak near 
39 ppm (black arrow) that is observed in oxidized Met but is not present in unoxidized Met [317, 
318]. 
 
Figure 5.5. MAS ssNMR spectral analysis of pelleted [U-
13
C,
15
N] wt-ApoA-I aggregates 
(A) Direct excitation 
13
C spectra of H2O2-wt-
13
C,
15
N-ApoA-I aggregates (black; top) and aggregates formed by 
non-oxidized wt-
13
C,
15
N-ApoA-I incubated for 8 days with 10% (molar) of unlabeled H2O2-wt-ApoA-I seeds (light 
gray; middle). An overlay of the two spectra is reported at the bottom. The black and gray arrows mark the 
13
C 
signals of oxidized and unoxidized Met side chains, respectively. (B) 
13
C spectra obtained via 
1
H-
13
C refocused 
INEPT, which only shows highly dynamic residues. (C) 
13
C spectra of the same samples using 
1
H-
13
C cross 
polarization, which is selective for the more rigid parts of the pelleted protein samples. In panels (A-C) only 
aliphatic spectral regions are shown; full spectra are reported in Figure C.1. (D) 
1
H-
13
C CP spectra in the carbonyl 
region of H2O2-wt-
13
C,
15
N-ApoA-I (black; top) and non-oxidized wt-
13
C,
15
N-ApoA-I after seeding (light gray; 
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middle). Dotted lines (bottom) show simulated spectra for hypothetical fully -helical and β-sheet structural models 
of ApoA-I, to illustrate the secondary structure dependence. (E) 2D 
13
C-
13
C spectrum of the same 
H2O2-wt-
13
C,
15
N-ApoA-I as in panels (A-D), using 20 ms DARR mixing. The amino acid type assignments of select 
cross peaks are indicated. Color-coded lines connect sets of peaks from co-existing  -helical and β-sheet Val and 
Leu. All spectra were acquired at 600 MHz (
1
H frequency).  
Dynamic differences between the oxidized seeds and the non-oxidized seeded sample 
were also investigated by MAS ssNMR. Direct excitation spectra capture 
13
C signals from both 
rigid and mobile protein domains. The most dynamic parts of the aggregated samples are 
detected in spectra obtained from experiments modified from solution NMR (INEPT) (Figure 
5.5, b, full size: Figure C.1, c,d). As before, there is a striking similarity observed between the 
INEPT spectra of the seeds and the seeded samples. Met C, C, and C frequencies are assigned 
in the non-oxidized seeded sample at 16.7, 32.5, and 34.6 ppm, respectively and are marked with 
gray arrows in Figure 5.5, b. The intensity of the Met peaks is dramatically decreased in the 
oxidized seeds. A single peak at 39 ppm is observed in the oxidized seeds that is not present in 
the non-oxidized seeded sample. The remaining peaks do not differ significantly between 
samples.  
In addition to Met and some signals from aromatic residues (Phe and/or Tyr), Lys is also 
detected in the INEPT spectra. Interestingly, there are no observable signals that can readily be 
assigned to other residue types. The few signals observed indicate that the number of highly 
dynamic and unstructured residues is relatively small. This contrasts from the highly 
unstructured C-terminal domain of monomeric non-oxidized wt-ApoA-I observed by solution 
NMR [309]. However, it is feasible the lack of signals is a result of surrounding ordered domains 
interacting with the unstructured regions, resulting in partial immobilization [3, 37].  
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Rigid regions of the aggregates were probed using ramped cross-polarization (CP) based 
experiments (Figure 5.5, c, full size: Figure C.1, e,f). The spectra of the oxidized seeds and non-
oxidized seeded samples are again very similar, however there are several differences which we 
interpret as revealing subtle changes in the structure and dynamics of the immobilized core and 
assemblies within the aggregates. These differences are apparent not only in the Met side chain 
but also in the Met backbone (C and CO). The chemical shifts of backbone carbons are 
exquisitely sensitive to secondary structure changes, allowing for a direct comparison between 
the local secondary structure of individual residues in the seeds and the seeded samples. A 
mixture of -helical and -sheet structure are observed in both samples, consistent with the 
above FTIR data and earlier studies [302, 316]. There is a greater -sheet content in the core of 
the H2O2-wt-ApoA-I seeds than in the non-oxidized (but seeded) wt-ApoA-I aggregates (Figure 
5.5, d). Several amino acid types (including Ala, Val, Ser, and Leu) exhibit both -helical and -
sheet structure, as shown in the CP-based 2D 
13
C-
13
C DARR spectrum of the 
13
C,
15
N-labeled 
H2O2-wt-ApoA-I seeds (Figure 5.5, e), consistent with prior analysis and results [302, 315, 316]. 
The native fold of wt-ApoA-I is predominantly -helical without any -sheet content. 
This is demonstrated by a synthetic NMR spectrum simulated from predicted NMR chemical 
shifts for the native X-ray structure of C-terminal truncated (185-243)-ApoA-I (Figure 5.6, 
red). An overlay of the synthetic spectrum of the native protein and the experimental spectrum of 
H2O2 wt-
13
C,
15
N-ApoA-I aggregates clearly shows that there is extensive -helical content in the 
latter. There is greater heterogeneity in the non-native -sheet content than the native-like -
helical content in the H2O2 wt-
13
C,
15
N-ApoA-I aggregates, evident by broader peaks observed in 
the former. Taken together with an observed similar peak pattern between the synthetic and 
experimental spectra of the both the H2O2 wt-
13
C,
15
N-ApoA-I seeds and the non-oxidized but 
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seeded wt-
13
C,
15
N-ApopA-I aggregates (Figure C.2), it is likely that there is extensive native-like 
structure present in both samples, with more native-like structure found in the non-oxidized 
aggregates. 
 
Figure 5.6. Comparison of experimental MAS NMR 2D 
13
C-
13
C spectrum of H2O2 wt-
13
C,
15
N-ApoA-I 
aggregates to a simulated spectrum based on the X-ray determined -helical native structure of C-terminal 
truncated (185-243)-ApoA-I 
(A) Overlay of experimental and simulated data [313]. (B) Simulation by itself. Since the 
13
C chemical shift 
prediction with the SPARTA+ program [263] is limited to backbone and C carbons, only part of the spectrum is 
shown. Colored boxes mark side chain peaks visible in the experimental data that were not simulated.  
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5.4 DISCUSSION 
These results in context with the recent results from the Cavigiolio lab that were discussed in the 
Introduction are presented in a schematic summary in Figure 5.7. Briefly, exchangeable 
apolipoproteins display structural flexibility that aids in their transition between lipid-bound and 
lipid-free states. Lipid-free apoA-I self-associates and this phenomenon provides stabilization to 
the native state structure. Both apoA-I oxidized at Met and thermally treated apoA-I associate 
with macrophages to extract cellular cholesterol. Interestingly, both treatments disrupt self-
association; however, the thermal treatment disrupts self-association only temporarily, while 
disruption from oxidation at Met is non-reversible. This irreversibility lends apoA-I oxidized at 
Met vulnerable to aggregation. The self-associated native structure of the lipid-free apoA-I 
functions to protect apoA-I monomers from aggregating into amyloid-like fibrils. This is 
reminiscent of transthyretin, which is an amyloid forming protein in the monomeric state but 
remains soluble as a tetramer [319]. Of note, drugs that stabilize transthyretin tetramers are 
successful at protecting against cardiac amyloidosis [320]. 
ApoA-I oxidized at Met forms amyloid fibrils that fluoresce in the presence of ThT, have 
a significant amount of -sheet structure, and can propagate through seeding. Interestingly, the 
FTIR and MAS ssNMR results indicate that the oxidized apoA-I fibrils contain a higher amount 
of -sheet structure than the seeded (but not oxidized) apoA-I aggregates. Furthermore, although 
apoA-I fibrils adopt a -sheet structure in the amyloid core, the native structure of apoA-I is not 
completely abolished and much of the -helical content is retained in the aggregates. The N-
terminal 4-helix bundle motif present in lipid-free self-associated apoA-I likely becomes 
destabilized upon Met oxidation and monomerization, resulting in surface changes that expose 
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hydrophobic residues that readily bind to lipids including cholesterol. Although the specific 
residues within the amyloid core could not be assigned in the primary sequence, various 
algorithms exist that aid in predicting amyloidogenic sequences [321-324]. Four separate 
algorithms (3D Profile (via ZipperDB), Zyggregator, CamSol, and Tango) were used to identify 
residues potentially found within the amyloid core; the results are highlighted in Figure C.3 
[321-324]. Briefly, residues 13-22 and 50-59 at the N-terminal end and residues 224-332 at the 
C-terminal end were reproducibly identified as candidates for existing within the amyloid core.  
 
Figure 5.7. Schematic of the consequences of the destabilization of self-associated apolipoprotein A-I  
ApoA-I native self-association is disrupted by thermal treatment or Met-oxidation. Destabilized monomeric apoA-I 
associates with macrophages more strongly and extracts cholesterol more efficiently than native apoA-I. 
Destabilized monomeric Met(O)-ApoA-I is also amyloidogenic.  
These results give support to the idea that apoA-I can aggregate through both amyloid-
like and native-like aggregation pathways. The native-like aggregation pathway is most likely 
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driven by interactions between the -helices found in the native structure of lipid-free apoA-I, 
while the amyloid-like pathway is driven by -sheet elongation. It is unclear whether native-like 
intermolecular interactions between lipid-free apoA-I protects from or promotes further 
aggregation through the amyloid-like pathway following secondary nucleation events. If the 
former case is true, therapeutics that promote native-like apoA-I aggregation may be beneficial 
for fighting VA and atherosclerosis. 
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6.0 DISSERTATION SUMMARY AND THE BIG PICTURE 
The aggregation of normally soluble protein in tissues is rampant and directly correlated to tissue 
dysfunction in protein deposition diseases (PDDs). Several classes of protein aggregates are 
found in PDDs, including amyloid-like fibrils, native-like aggregates, and amorphous aggregates. 
Aggregate polymorphism is a common theme of PDDs that has implications in disease severity. 
In this dissertation, I explored aggregate polymorphism in proteins that have implications in 
neurodegenerative disease, cataract, and vascular amyloidosis. I specifically targeted my 
investigations towards httEx1, P23T hD, and apoA-I. HttEx1 forms amyloid fibrils that have 
implications in Huntington’s disease and P23T hD is an extremely aggregation prone crystallin 
that is associated with eye lens cataract formation in very young children. ApoA-I is an 
important anti-atherosclerotic factor that has been identified in vascular amyloidosis and may be 
involved in atherogenesis upon oxidation of Met residues. 
I show in Chapter 3.0 that httEx1 amyloid fibrils can form several polymorphs as a direct 
consequence of monomer concentration and the rate of monomer release into the aggregating 
reaction mixture. Furthermore, my results lend further support to the idea that the proline rich 
domain that flanks the polyQ amyloid core is an important factor in httEx1 fibril polymorphism. 
In Chapter 4.0, I show that cataract-associated P23T hD can be induced to form amyloid-like 
fibrils or native-like aggregates in a pH dependent manner. Of note, MAS ssNMR revealed that 
homogenous, well-structured native-like aggregates form at a pH that matches the pH of the eye 
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lens. Surprisingly, the native-like aggregates of P23T hD appear strikingly amorphous by TEM. 
In Chapter 5.0, I show that apoA-I amyloid fibrils retain a significant amount of native structure 
and apoA-I oxidized at Met residues can aggregate through native-like and amyloid-like 
aggregation pathways.  
These results illustrate several aspects of PDDs that extend beyond Huntington’s disease, 
cataract, and vascular amyloidosis. In amyloid forming proteins specifically, flanking domains 
have been repeatedly shown to be important for influencing fibril polymorphism. Of note, many 
proteins can be induced to adopt multiple classes of protein aggregates and some aggregates can 
be amyloid-like while retaining a surprising amount of native-like structure. Furthermore, it is 
important to study the amorphous-looking aggregates that are found in PDDs as they can be 
surprisingly well structured.  
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APPENDIX A 
A.1. SUPPORTING INFORMATION FOR CHAPTER 3 
 
Figure A.1. Q44-httEx1 fibril dimensions. 
(a) X-ray powder diffraction pattern of Q44-httEx1 reveals that the distance between -strands along the fibers axis 
is 4.8 Å and the distance between -sheets (depicted in different colors in cartoon) is 8.2 Å, in agreement with 
previously work [3, 325]. (b) Individual filaments are proposed to interact through interactions of the PRDs in Q44-
httEx1 polymorphs [3]. 
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Figure A.2. Cleavage kinetics of MBP-httEx1 fusion proteins by FXA protease.  
(a) Cleavage of MBP-Q44-httEx1 after 41 hours at fusion protein to protease molar ratios (FP:P ratios) of: 
15,000:1, 1500:1, and 150:1, and temperatures of 22 and 37 °C. Cleavage did not reach completion under all 
circumstances. (b) Cleavage of MBP-Q44-httEx1 over 64 minutes at 37 °C with an FP:P molar ratio of 16.7:1. 
Cleavage is nearly complete after 64 minutes. (c) Cleavage of MBP-Q44-httEx1 over 68 minutes at 37 °C at an 
FP:P molar ratio of 2:1. Cleavage appears complete at 16.5 minutes. (d) Cleavage of MBP-Q44-httEx1 at 37 °C 
after 5 and 15 minutes for various FP:P ratios: 2:1, 2.5:1, 3.3:1, 5:1, and 10:1. e) Cleavage of MBP-Q20-httEx1at 
22 °C and an FP:P molar ratio of 400:1. Most of the fusion protein has been cleaved after 180 minutes and is no 
longer observed after 3 days. 
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Figure A.3. ThT Fluorescence following cleavage with trypsin and FXA.  
(a) Average ThT fluorescence in the lag and plateau phase for MBP-Q44-httEx1 cleaved with trypsin (light gray) 
and FXA (dark gray). The average fluorescence of a control sample containing MBP-Q44-httEx1 only was 
subtracted for each. Lag phase was measured at 50 and 60 minutes for trypsin (n = 3) and FXA (n = 2), 
respectively. Plateau phase was measured at 4 and 3 days for trypsin (n = 3) and FXA (n = 2) respectively. (b) Red: 
ThT fluorescence of Q44-httEx1 in the absence of seeds (n = 2). The values recorded for the individual 
measurements are marked in empty and filled red circles. Blue: ThT fluorescence of Q44-httEx1 in the presence of 
20% (molar) Q44-httEx1 preformed seeds (n = 2). The values recorded for the individual measurements are marked 
as blue X’s and +’s. The data was fit using AmyloFit [225]. 
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Figure A.4. Distribution of fibril widths visible by TEM for Q44-httEx1 fibrils formed at 37 °C, 
varying concentrations of MBP-Q44-httEx1, and varying molar ratios of MBP-Q44-httEx1 to FXA protease.  
(a) 98.9 M MBP-Q44-httEx1, 847 moles per 1 mole FXA. (b) 98.9 M MBP-Q44-httEx1, 42.5 moles per 1 mole 
FXA. (c) 98.9 M MBP-Q44-httEx1, 4.25 moles per 1 mole FXA. (d) 88.9 M MBP-Q44-httEx1, 382 moles per 1 
mole FXA. (e) 78.8 M MBP-Q44-httEx1, 170 moles per 1 mole FXA. (f) 28.6 M MBP-Q44-httEx1, 250 moles per 
1 mole FXA. (g) 28.6 M MBP-Q44-httEx1, 62.5 moles per 1 mole FXA. (h) 28.6 M MBP-Q44-httEx1, 25 moles 
per 1 mole FXA. (i) 14.3 M MBP-Q44-httEx1, 1500 moles per 1 mole FXA. (j) 14.3 M MBP-Q44-httEx1, 150 
moles per 1 mole FXA. (k) 14.3 M MBP-Q44-httEx1, 62.5 moles per 1 mole FXA. (l) 7.2 M MBP-Q44-httEx1, 
510 moles per 1 mole FXA. (m) 7.2 M MBP-Q44-httEx1, 25 moles per 1 mole FXA. 
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Figure A.5. Branching and bundling of Q44-httEx1 fibrils.  
(a-b, left) Examples of fibrils which appear to branch, observed at high concentrations (88.9, and 98.9 M). Fibrils 
are outlined (right) to highlight differences in width across the fibril axis and branching. (c) Left: Bundle of fibrils, 
original unaltered image. Right: Image was subjected to a band-pass filter to increase contrast and highlight the 
density of the bundled fibrils. All scale bars are 100 nm. 
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Figure A.6. PDSD spectrum of N15-Q44-httEx1.  
Fully assigned 250 ms PDSD spectrum. ProRC is labeled as ProA and ProPPII is labeled as ProB. 
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Figure A.7. Polarization transfer curves. 
(a) PDSD buildup profiles for proline residues with random coil (RC), circles, and PPII-structured, diamonds, 
secondary structure in Q44-httEx1 [3], and (b) for RC, circles, and PPII-structured, triangles, Pro residues in 
N15-Q44-httEx1. Both Q44-httEx1 and N15-Q44-httEx1 were formed at 22 °C. Panel (a) reprinted with 
permission from Lin, H. K., Boatz, J. C., Krabbendam, I. E., Kodali, R., Hou, Z., Wetzel, R., Dolga, A. M., Poirier, 
M. A., van der Wel, P. C. A. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin 
exon1 rather than its polyglutamine core, Nature Communications 8:15462. Copyright (2017) Lin, H. K., et. al. [3] 
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Figure A.8. Hypothetical flanking domain distribution and implications for secondary nucleation 
(a) An extremely symmetric distribution of flanking domains is expected to promote secondary nucleation and 
elongation. (b) An extremely asymmetric distribution of flanking domains may experience some secondary 
nucleation but is not expected to experience any elongation of the nucleated fiber. 
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A.2.  TRYPSIN CLEAVAGE PRODUCTS OF MBP-Q44-HTTEX1 AND 
FREE MBP 
In Figure 3.6, d, the area under the curve of the MBP peak at 6 hours is 47% the area at 5 
minutes. Peak area in deconvoluted ESI-TOF MS spectra cannot be quantitatively compared to 
protein concentration in the injected sample, however the large difference in peak area between 
these two time points suggests that free MBP is degrading within the sample in the presence of 
trypsin. In contrast, free MBP appears stable by SDS-PAGE after 3 days of FXA cleavage [3]. 
The ESI-TOF MS spectrum at 6 hours was screened against the MW of 759 theoretical cleavage 
products of MBP-Q44-httEx1 by trypsin protease. A small peak was observed at 42623.5 Da that 
was not present at 30 seconds, 1 minute, or 5 minutes. This peak was identified as MBP(I[-391]-
R[-1]) (theoretical MW 42624.7 Da). To confirm the presence of MBP cleavage products, an 
additional seven trials were screened within the first six hours of the cleavage reaction. Three 
MBP cleavage products were observed in at least two of the seven trials: MBP(I[-391]-R[-1]), 
MBP(D[-363]-K[-256]) (theoretical MW 12115.9 Da), and MBP(D[-363]-R[-295]) (theoretical 
MW 7721.7 Da). Figure A.1, b shows the ESI-TOF MS spectrum of one of the seven trials, 
where all three products are observed. Two additional cleavage products are visible by SDS-
PAGE (Figure A.1, e), obtained from a reaction mixture with 10 M MBP-Q44-httEx1 and an 
FP:P ratio of 1:1. These products are MBP(Y[-294]-R[-1]) and MBP(E[-255]-R[-1]). MBP(E[-
255]-R[-1]) appears unstable, disappearing from the gel within the first five minutes of the 
reaction. 
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Figure A.1. Cleavage products of Q44-httEx1 by trypsin protease.  
(a, left) Mass spectra chromatogram from LC elution profile of MBPhttExQ44 and (b, left) its trypsin cleavage 
products. (a,b center) Mass spectra were deconvoluted by maximum entropy from 6.6-8.2 minutes. MBP-Q44-httEx1 
(56684.9 Da with z = 1 and 28342.8 Da with z = 2) is observed prior to trypsin cleavage, but not after. Free MBP 
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(42884.0 Da) is observed following trypsin cleavage but not prior to cleavage. (a,b, right) Zoomed in region of (b) 
from 12000-14000 m/z. N15-Q44-httEx1 (12096.7 Da), N9 htt exon1 (12772.6 Da), N6 htt exon1 (13146.0 Da), 
and htt exon1 (13819.3 Da) are observed prior to N15-Q44-httEx1 aggregation. (c,d) Cleavage of 10 M MBP-
Q44-httEx1 via trypsin protease with FP:P molar ratios of 1:1 (c) and 625:10 (d). (e) Cleavage with FP:P molar 
ratio of 1:2. Cleavage products with molecular weights of approximately 31.9 and 27.4 Da are observed. These 
bands likely represent MBP cleavage products MBP(Y100-R393) and MBP(E139-R393), respectively. MBP(E139-
R393) appears unstable, disappearing from the reaction mixture within 5 minutes.  
All MBP-Q44-httEx1 cleavage products observed, their MW, and their sequence are 
available in Table A.1. The cleavage products observed in each individual trial are recorded in 
Table A.2. Four additional trials were analyzed after 1 day of aggregation (Table A.3). N15-
Q44-httEx1 was not observed in these trials, suggesting complete aggregation into mature fibrils. 
Together these results suggest 8 total cleavage products of MBP-Q44-httEx1 resulting from 
cleavages at K2, K30, R[-295], and K[-256]: MBP(M1-K2), MBP(I[-391]-R[-1]), MBP(M1-
K30), MBP(D[-363]-K[-256]), MBP(E[-255]-R[-1]), MBP(D[-363]-R[-295]), and MBP(Y[-
294]-R[-1]). These cleavage sites were mapped onto the predicted structure of free MBP, derived 
from the X-ray crystal structure of MBP-L30 (1NMU in the protein data bank) as shown in 
Figure A.2 [226]. Notably, K30, R[-295], and K[-256] cleavage sites are surface residues 
exposed to water and located at the edges between -helices and random coil regions of the 
protein. K2 is not mapped due to the flexibility of the MBP N-termini that prevented 
crystallization of this region. Residue K2 is the most frequent cleavage site observed in free 
MBP by ESI-TOF MS. The dynamics of the MBP N termini likely increase the accessibility of 
the K2 residue to trypsin cleavage compared to the accessibility of the K30, R[-295], and K[-
256] cleavage sites. 
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Figure A.2. Trypsin cleavage of free MBP. 
(a) Free MBP (top, light gray, theoretical MW 42884.0, (bold) is cleaved by trypsin into several cleavage products. 
Cleavage sites are marked. Three cleavage products (light gray, I[-391]-R[-1], D[-363]-K[-256], and D[-363]-R[-
295]) with theoretical MW of 42624.7, 12116.4, and 7721.5 Da (bold) were reproducibly observed by ESI-TOF MS. 
Two cleavage products (dark gray, E[-255]-R[-1] and Y[-294]-R[-1]) with theoretical MW of 27409.1 and 31803.3 
Da were observed by SDS-PAGE but not by MS, likely due to low ionization or low stability of these products. 
Peptides (black, M1-K2, M1-K30) with theoretical MW of 259.4 and 3359.1 Da (oblique) are expected based on the 
presence of the other cleavage products observed, but below the ESI-TOF MS detection limit of 5000 Da/z. (b) Mass 
spectra chromatogram from LC elution profile of trypsin cleaved MBP-Q44-httEx1, with individual peaks observed 
between 6.5-7.2 and 7.2-7.9 minutes. (c) Deconvoluted mass spectrum from 6.5-7.2 minutes. N15-Q44-httEx1 is 
observed as 12096.7 Da. (d) Deconvoluted mass spectrum from 7.2-7.9 minutes. Free MBP is observed as 42883.3 
Da (e) Zoomed in region of deconvoluted mass spectrum from (c). MBP cleavage product D[-363]-R[-295] is 
observed at 7721.5 Da. (f) Zoomed in region of deconvoluted mass spectrum from (c). MBP cleavage product from 
D[-363]-K[-256] is observed at 12116.4 Da. (g) Zoomed in region of deconvoluted mass spectrum from (d). MBP 
cleavage product from I[-391]-R[-1] is observed at 42624.8 Da. (h) Predicted structure of free MBP, adapted from 
MBP fusion protein MBP-L30, 1NMU in the Protein Data Bank [226]. The C-terminal end of each Lys (pink) and 
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Arg (cyan) residue is a potential trypsin cleavage site, however cleavage is only observed at K2 (not shown), K30, 
R[-295], and K[-256]. 
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Table A.1. Observed trypsin cleavage products of MBP-Q44-httEx1. 
Name: Residues numbered 
relative to Q44-httEx1 
MW 
(Da) 
Sequence 
MBP-Q44-httEx1 56685.3 
MKIEEGKLVI WINGDKGYNG LAEVGKKFEK DTGIKVTVEH PDKLEEKFPQ VAATGDGPDI 
IFWAHDRFGG YAQSGLLAEI TPDKAFQDKL YPFTWDAVRY NGKLIAYPIA VEALSLIYNK 
DLLPNPPKTW EEIPALDKEL KAKGKSALMF NLQEPYFTWP LIAADGGYAF KYENGKYDIK 
DVGVDNAGAK AGLTFLVDLI KNKHMNADTD YSIAEAAFNK GETAMTINGP WAWSNIDTSK 
VNYGVTVLPT FKGQPSKPFV GVLSAGINAA SPNKELAKEF LENYLLTDEG LEAVNKDKPL 
GAVALKSYEE ELAKDPRIAA TMENAQKGEI MPNIPQMSAF WYAVRTAVIN AASGRQTVDA 
ALAAAQTNAA AASEFSSNNN NNNNNNNLGI EGRMATLEKL MKAFESLKSF QQQQQQQQQQ 
QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQPPPPPP PPPPPQLPQP PPQAQPLLPQ 
PQPPPPPPPP PPGPAVAEEP LHRPSGSHHH HHH 
Free MBP 42884.0 
MKIEEGKLVI WINGDKGYNG LAEVGKKFEK DTGIKVTVEH PDKLEEKFPQ VAATGDGPDI 
IFWAHDRFGG YAQSGLLAEI TPDKAFQDKL YPFTWDAVRY NGKLIAYPIA VEALSLIYNK 
DLLPNPPKTW EEIPALDKEL KAKGKSALMF NLQEPYFTWP LIAADGGYAF KYENGKYDIK 
DVGVDNAGAK AGLTFLVDLI KNKHMNADTD YSIAEAAFNK GETAMTINGP WAWSNIDTSK 
VNYGVTVLPT FKGQPSKPFV GVLSAGINAA SPNKELAKEF LENYLLTDEG LEAVNKDKPL 
GAVALKSYEE ELAKDPRIAA TMENAQKGEI MPNIPQMSAF WYAVRTAVIN AASGRQTVDA 
ALAAAQTNAA AASEFSSNNN NNNNNNNLGI EGR 
MBP(I[-391]-R[-1]) 42624.7 
  IEEGKLVI WINGDKGYNG LAEVGKKFEK DTGIKVTVEH PDKLEEKFPQ VAATGDGPDI 
IFWAHDRFGG YAQSGLLAEI TPDKAFQDKL YPFTWDAVRY NGKLIAYPIA VEALSLIYNK 
DLLPNPPKTW EEIPALDKEL KAKGKSALMF NLQEPYFTWP LIAADGGYAF KYENGKYDIK 
DVGVDNAGAK AGLTFLVDLI KNKHMNADTD YSIAEAAFNK GETAMTINGP WAWSNIDTSK 
VNYGVTVLPT FKGQPSKPFV GVLSAGINAA SPNKELAKEF LENYLLTDEG LEAVNKDKPL 
GAVALKSYEE ELAKDPRIAA TMENAQKGEI MPNIPQMSAF WYAVRTAVIN AASGRQTVDA 
ALAAAQTNAA AASEFSSNNN NNNNNNNLGI EGR 
MBP(Y[-294]-[-1])* 31803.3 
         Y NGKLIAYPIA VEALSLIYNK DLLPNPPKTW EEIPALDKEL KAKGKSALMF 
NLQEPYFTWP LIAADGGYAF KYENGKYDIK DVGVDNAGAK AGLTFLVDLI KNKHMNADTD 
YSIAEAAFNK GETAMTINGP WAWSNIDTSK VNYGVTVLPT FKGQPSKPFV GVLSAGINAA 
SPNKELAKEF LENYLLTDEG LEAVNKDKPL GAVALKSYEE ELAKDPRIAA TMENAQKGEI 
MPNIPQMSAF WYAVRTAVIN AASGRQTVDA ALAAAQTNAA AASEFSSNNN NNNNNNNLGI 
EGR 
MBP(E[-255]-R[-1])* 27409.1 
        EL KAKGKSALMF NLQEPYFTWP LIAADGGYAF KYENGKYDIK DVGVDNAGAK 
AGLTFLVDLI KNKHMNADTD YSIAEAAFNK GETAMTINGP WAWSNIDTSK VNYGVTVLPT 
FKGQPSKPFV GVLSAGINAA SPNKELAKEF LENYLLTDEG LEAVNKDKPL GAVALKSYEE 
ELAKDPRIAA TMENAQKGEI MPNIPQMSAF WYAVRTAVIN AASGRQTVDA ALAAAQTNAA 
AASEFSSNNN NNNNNNNLGI EGR 
Q44-httEx1 13819.3 
   MATLEKL MKAFESLKSF QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ 
QQQQPPPPPP PPPPPQLPQP PPQAQPLLPQ PQPPPPPPPP PPGPAVAEEP LHRPSGSHHH 
HHH 
N6-Q44-httEx1 13145.4 
         L MKAFESLKSF QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ 
QQQQPPPPPP PPPPPQLPQP PPQAQPLLPQ PQPPPPPPPP PPGPAVAEEP LHRPSGSHHH 
HHH 
N9-Q44-httEx1 12772.9 
  AFESLKSF QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQPPPPPP 
PPPPPQLPQP PPQAQPLLPQ PQPPPPPPPP PPGPAVAEEP LHRPSGSHHH HHH 
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Name: Residues numbered 
relative to Q44-httEx1 
MW 
(Da) 
Sequence 
MBP(D[-363]-K[-256]) 12115.9 
DTGIKVTVEH PDKLEEKFPQ VAATGDGPDI IFWAHDRFGG YAQSGLLAEI TPDKAFQDKL 
YPFTWDAVRY NGKLIAYPIA VEALSLIYNK DLLPNPPKTW EEIPALDK 
N15-Q44-httEx1 12097.1 
        SF QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQPPPPPP 
PPPPPQLPQP PPQAQPLLPQ PQPPPPPPPP PPGPAVAEEP LHRPSGSHHH HHH 
MBP(D[-363]-R[-295]) 7721.7 
DTGIKVTVEH PDKLEEKFPQ VAATGDGPDI IFWAHDRFGG YAQSGLLAEI TPDKAFQDKL 
YPFTWDAVR 
*MBP(Y[-294]-[-1]) and MBP(E[-255]-R[-1]) were observed by SDS-PAGE only. 
Table A.2. Observed trypsin cleavage products of MBP-Q44-httEx1 by ESI-TOF MS prior to aggregation of 
the N15-Q44-httEx1 monomer. 
Cleavage product 
Frequency 
observed (n=7) 
Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 Trial 6 Trial 7 
Free MBP 1.00 X X X X X X X 
MBP(I[-391]-R[-1]) 0.29 X X    X  
Q44-httEx1 0.29     X X  
N6-Q44-httEx1 0.29     X X  
N9-Q44-httEx1 0.43     X X X 
MBP(D[-363]-K[-256]) 0.57 X X X    X 
N15-Q44-httEx1 1.00 X X X X X X X 
MBP(D[-363]-R[-295]) 0.57 X X X    X 
 
Table A.3. Observed trypsin cleavage products of MBP-Q44-httEx1 by ESI-TOF MS following aggregation of 
N15-Q44-httEx1 into mature fibrils. 
Cleavage product 
Frequency 
observed (n=4) 
Trial 1 Trial 2 Trial 3 Trial 4 
Free MBP 1.00 X X X X 
MBP(I[-391]-R[-1]) 0.75 X X X  
Q44-httEx1 0     
N6-Q44-httEx1 0     
N9-Q44-httEx1 0     
MBP(D[-363]-K[-256]) 0     
N15-Q44-httEx1 0     
MBP(D[-363]-R[-295]) 0.25 X    
*Separate trials than indicated in Table A.2. 
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Table A.4. Experimental conditions for MAS ssNMR experiments. 
Abbreviations: NS, number of scans per t1 point; MAS, magic angle spinning rate; RD, recycle delay; TPPM, 
1
H 
decoupling power during evolution and acquisition using the two-pulse phase modulation scheme; t1 evol., t1 
evolution time = (real and imaginary t1 points) X t1 increment time; Mixing, 
13
C-
13
C or 
1
H-
1
H mixing time (ms). 
Fig. Sample Experiment NS 
Temp. 
(K) 
MAS 
(kHz) 
RD (s) 
TPPM 
(kHz) 
t1 evol. 
(s) 
Mixing 
(ms) 
Figure 3.8 Q44-httEx1, 22 °C [3] 1H-13C CP 1024 275 13 2.8 83 NA NA 
Figure 3.8 Q44-httEx1, 22 °C [3] 1H-13C INEPT 1024 275 10 2.8 83 NA NA 
Figure 3.8 N15-Q44-httEx1, 22 °C 1H-13C CP 1024 277 12.5 2.8 83 NA NA 
Figure 3.8 N15-Q44-httEx1, 22 °C 1H-13C INEPT 4096 277 14 3.0 83 NA NA 
Figure 3.8 N15-Q44-httEx1, 22 °C 
2D 13C-13C 
INEPT-TOBSY 
64 277 8.333 2.8 83 
256 * 
35.99 
25 
Figure 3.8 Q44-httEx1, 22 °C [3] 
2D 13C-13C 
INEPT-TOBSY 
96 275 8.333 2.6 83 
388 * 
83.33 
6 
Figure 3.8 N15-Q44-httEx1, 22 °C 
2D 13C-13C 
DARR 
64 277 14 2.8 83 
256 * 
31.10 
8 
Figure 3.8 Q44-httEx1, 22 °C [3] 
2D 13C-13C 
DARR 
325 275 13 2.8 83 724 * 27.6 15 
Figure A.7 Q44-httEx1, 22 °C [3] 
2D 13C-13C 
PDSD 
96 275 13 2.8 83 
526 * 
33.11 
1, 15, 50, 
100, 250, 
500 
Figure A.6 N15-Q44-httEx1, 22 °C 
2D 13C-13C 
PDSD 
32 277 13 2.8 83 
256 * 
35.99 
250 
Figure A.7 N15-Q44-httEx1, 22 °C 
2D 13C-13C 
PDSD 
128 277 13 2.8 83 
256 * 
35.99 
0, 25, 250, 
500 
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APPENDIX B 
B.1. SUPPORTING INFORMATION FOR CHAPTER 4 
 
Figure B.1. MAS ssNMR chemical shift assignments of amorphous P23T hD aggregates formed at 
physiological pH 
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(a) Sequential backbone walk for residues A158-V163 based on 3D NCOCX (navy) and 3D NCACX (red) spectra. 
(b) Secondary structure content of the solution-state structure. The -strands (arrows) and single-residue -bridges 
(*) are labeled as internal (i) or external (e) within Greek key motifs 1-4, while -helices are marked as red helices. 
The linker between the NTD and CTD is shown in blue. (c) Chemical shift perturbation (CSP) of P23T hD upon 
formation of amorphous aggregates, based on the difference between the assigned ssNMR shifts (Table B.2) and the 
P23T hD solution NMR chemical shifts. Bars indicate the combined RMSD of 13C and 15N atoms, 13C, backbone 13C 
(C’, C and C and backbone 15N, respectively. The average RMSDs of 0.75, 0.55, 0.62, and 0.91 are plotted as 
dashed lines. No 
15
N solution NMR shifts were available for G1, P27, and P82. Reprinted from: Boatz, J.C., Whitley 
M.J., Li M, Gronenborn A.M., and van der Wel, P.C.A. Cataract-associated P23T D-crystallin retains a native-like 
fold in amorphous-looking aggregates formed at physiological pH, Nature Communications 8, 15137. Copyright 
(2017) Boatz, J. C., et. al. under Creative Commons Attribution 4.0 International License. 
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Figure B.2. MAS ssNMR chemical shift differences between amorphous P23T hD aggregates and 
the simulated amyloid-like model 
Bars show the chemical shift differences between the experimental chemical shifts of the amorphous P23T hD 
aggregates Table B.2) and the chemical shifts predicted for our schematic amyloid-like model (Figure 4.8, a). 
Shown are the combined RMSD of the backbone 
13
C and 
15
N atoms, the backbone 
13C (C’, C and C) and 
backbone 
15
N, respectively. The employed prediction algorithm does not produce the 
13
C shifts of the entire side 
chain, leading us to omit the full-residue 
13
C chemical shift deviations present in Figure B.1. Note the different scale 
of the vertical axes compared to Figure B.1, reflecting the much larger chemical shift deviation between the 
schematic amyloid-like model and the observed ssNMR spectra. For comparison, the average RMSDs from Figure 
B.1 are included as dashed lines. Reprinted from: Boatz, J.C., Whitley M.J., Li M, Gronenborn A.M., and van der 
Wel, P.C.A. Cataract-associated P23T D-crystallin retains a native-like fold in amorphous-looking aggregates 
formed at physiological pH, Nature Communications 8, 15137. Copyright (2017) Boatz, J. C., et. al. under Creative 
Commons Attribution 4.0 International License. 
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Table B.1. Detailed experimental conditions of the MAS ssNMR experiments on P23T hD crystallin 
Abbreviations: NS, number of scans per t1 point; Temp., temperature of cooling gas; MAS, magic angle spinning 
rate; RD, recycle delay. TPPM, 
1
H decoupling power during evolution and acquisition using the two-pulse phase 
modulation scheme was 83 kHz for all experiments. 
Fig./ Table pH Experiment NS 
Temp 
(K) 
MAS 
(kHz) 
RD 
(s) 
t1 evol. 
(μs) 
t2 evol. 
(s) 
Mix. 
(ms) 
H-C/N, C-N CP 
time (ms) 
τ1, τ2 
(ms) 
Exp. 
time (h) 
Figure 4.4, a 7 1H-13C CP 102 298 12.5 3.0 NA NA NA 2.0, NA NA 0.8 
Figure 4.4, b 
Figure 4.10, a,b 
Figure 4.7 
Figure 4.9 
7 
2D 13C-13C 
CP-DARR 
40 283 12.5 2.8 
34.85* 
860 
NA 8.0 2.0, NA NA 54 
Figure 4.5, a 3 1H-13C CP 
102
4 
298 12.5 3.0 NA NA NA 1.5, NA NA 0.8 
Figure 4.5, a 
Figure 4.10, a,b 
3 
2D 13C-13C 
CP-DARR 
64 298 12.5 2.6 
37.84* 
792 
NA 8.0 1.5, NA NA 70 
Figure 4.6, a 7 
1H-13C 
INEPT 
256 298 8.333 2.8 NA NA NA NA, NA 
1.5, 
1.0 
0.2 
Figure 4.6, b 3 
2D 13C-13C 
TOBSY 
64 298 8.333 2.8 
50.94* 
400 
NA 6.0 NA, NA 
1.2, 
1.0 
20 
Figure 4.9 7 3D NCACX 80 298 12.5 2.5 
410.76
* 16 
275.89
*24 
15 2.0, 6.0 NA 87.0 
Figure 4.9 7 3D NCOCX 80 298 12.5 2.5 
410.76
* 16 
275.89
*24 
30 2.5, 5.5 NA 87.5 
Table B.1 7 2D NCACX 112 298 10.0 3.0 
100.00
* 100 
NA 25 1.5, 6.0 NA 19.0 
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Table B.2. Chemical shifts of residues assigned in amorphous P23T hD aggregates at physiological pH 
determined by MAS ssNMR 
The reported 
15
N and 
13
C chemical shifts are referenced relative to liquid ammonia and dilute aqueous DSS, 
respectively (see methods), and have an experimental error of 0.4 ppm for 
13
C and 0.5 ppm for 
15
N. 
Res. Num. Type N C' C C C C C C 
1 Gly  169.5 43.6      
2 Lys 124.4 172.9 57.8 35.7 24.6  26.6 42.1 
3 Ile 128.6 171.5 58.9 41.3 28.5 15.3 12.9  
4 Thr 122.5 172.5 61.8 69.2 20.9    
5 Leu 128.2 175.1 53.7 44.1 27.4    
23a Thr 113.2 176.4 64.3 72.3 22.9    
26 Gln 119.5 174.0 59.5 28.2     
27 Pro 130.6 175.7 64.6 30.4 28.0  50.7  
34 Ser 107.9 173.6 58.8 64.4     
35 Ala 118.9 175.4 52.7 22.8     
36 Arg 123.8 175.5 54.9 33.9     
37 Val 131.8 175.5 62.2 31.0 23.2    
62b Tyr 122.6 174.4 56.3* 39.8*   132.2  
63 Ala 126.5 175.7 53.8 19.3     
80 Leu 126.0 175.7 53.6 41.8 26.8    
81 Ile 130.3 173.8 60.0 42.2 27.7 18.6   
82 Pro 138.1 177.1 63.6 32.3 26.4  51.3  
89 Ile 130.0 170.7 59.1 42.1 28.1 15.7* 14.9  
98 Arg 117.7 175.2 54.4 33.1 27.5    
99 Gly 105.2 172.5 44.0      
100b Gln 119.6 174.2 57.7* 29.8* 32.6    
101 Met 120.0 175.3 53.4 36.1     
102 Ile 124.0 171.0 60.4 41.4 28.2 15.5 12.9  
103 Glu 127.4 175.3 53.7 33.8 37.5  183.6  
104 Phe 120.8 176.1 57.6 43.5     
105b Thr 108.8 173.3 61.0* 70.5* 21.5    
107 Asp 115.8 176.4 55.5 41.4     
108 Cys 121.3 174.2 57.8 28.7     
109b Ser 124.5 173.9 60.9* 62.8*     
120c Ile 122.7 173.9 57.9 38.7 26.9* 19.4 11.5*  
156 Trp 114.9 176.6 57.1 28.2     
157 Gly 108.0 173.4 46.1      
158 Ala 120.0 177.0 51.4 22.2     
159 Thr 106.3 175.4 61.3 70.7 22.2    
160 Asn 117.2 171.7 52.1 39.5 176.5    
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Res. Num. Type N C' C C C C C C 
161 Ala 119.6 176.4 51.4 19.3     
162 Arg 119.8 176.9 58.6 29.6     
163 Val 120.7 174.4 61.7 36.4     
169 Val 124.3 174.7 65.2 30.0 21.8 20.7   
170 Ile 130.1 173.9 58.1 40.4 25.3 20.2 17.0  
a 
The mutant residue T23 was assigned to these chemical shifts on the basis that the three other (out of four) Thr 
residues were unambiguously assigned in the 2D and 3D ssNMR spectra.  
b 
Atoms labeled with asterisk (*) are tentatively assigned based on close correspondence to solution NMR shifts. 
 
c
 Residue I120 was assigned to these chemical shifts on the basis that the other five (out of six) Ile residues were 
unambiguously assigned in the 2D and 3D ssNMR spectra. This tentative assignment finds further support in the 
observation that the C and C1 chemical shifts of this spin system match the distinct and characteristic pattern that 
sets I120 apart from the other Ile residues in the solution NMR data. 
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APPENDIX C 
C.1. SUPPORTING INFORMATION FOR CHAPTER 5 
 
Figure C.1. Full 1D MAS ssNMR spectra of [U-
13
C,
15
N] apoA-I 
(A-B) direct excitation 13C, (C-D) 
1
H-
13
C CP, and (E-F) 
1
H-
13
C refocused INEPT spectra. Aggregates of H2O2-wt-
13
C,
15
N-ApoA-I and aggregates of non-oxidized wt-
13
C,
15
N-ApoA-I seeded with unlabeled pre-aggregated H2O2-wt-
ApoA-I are reported in black (A, C, E) and gray (B, D, F), respectively. Reprinted with permission from Witkowski, 
A., Chan, G. K. L, Boatz, J. C., Li, N. J., Wong, J. C., van der Wel, P. C. A., Cavigiolio, G. Methionine oxidized 
apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation, The FASEB Journal 32(6):3149-
3165. Copyright (2018) Witkowski, A., et. al. 
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Figure C.2. MAS ssNMR spectral comparison between a replicate H2O2 wt-
13
C,
15
N-ApoA-I sample and the 
seeded intact wt-
13
C,
15
N-ApoA-I aggregates 
2D 
13
C-
13
C CP-based DARR MAS ssNMR spectra of H2O2 wt-
13
C,
15
N-ApoA-I (gray) and the seeded intact wt-
13
C,
15
N-ApoA-I aggregates (yellow). The spectrum of H2O2 wt-
13
C,
15
N-ApoA-I was obtained from a separate sample 
than was used to acquire the 2D spectrum shown in Figure 5.5, e and Figure 5.6.  
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Figure C.3. Amyloid-propensity prediction results. 
The primary sequence of apoA-I was analyzed for amyloid and aggregation propensity using four algorithms: 3D 
Profile (via ZipperDB), Zyggregator, CamSol, and Tango [321-324]. The sequence areas that appear to be 
consensus elements with high predicted amyloidogenicity are indicated with dashed boxes. The approximate 
sequence positions (underlined residues), with their primary sequence context, are indicated at the bottom. In the 
sequence, b-sheet residues detected by MAS ssNMR are shown in bold. Reprinted with permission from Witkowski, 
A., Chan, G. K. L, Boatz, J. C., Li, N. J., Wong, J. C., van der Wel, P. C. A., Cavigiolio, G. Methionine oxidized 
apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation, The FASEB Journal 32(6):3149-
3165. Copyright (2018) Witkowski, A., et. al. 
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